Use these links to rapidly review the document
TABLE OF CONTENTS

Table of Contents

2015 10-K


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended January 2, 2016

Commission file number 1-7685

AVERY DENNISON CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

Delaware   95-1492269
(State of Incorporation)   (I.R.S. Employer Identification No.)

207 Goode Avenue
Glendale, California
(Address of Principal Executive Offices)

 

91203
(Zip Code)

Registrant's telephone number, including area code:
(626) 304-2000

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
 
Name of each exchange on which registered
Common stock, $1 par value   New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:
Not applicable.

         Indicate by a check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ    No o

         Indicate by a check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o    No þ

         Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ    No o

         Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ    No o

         Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. þ

         Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer þ   Accelerated filer o                   Non-accelerated filer o
(do not check if a smaller reporting company)
  Smaller reporting company o

         Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o    No þ

         The aggregate market value of voting and non-voting common equity held by non-affiliates as of July 4, 2015, the last business day of the registrant's most recently completed second fiscal quarter, was $5,661,989,013.

         Number of shares of common stock, $1 par value, outstanding as of January 30, 2016, the end of the registrant's most recent fiscal month: 89,430,815.

         The following documents are incorporated by reference into the Parts of this Form 10-K below indicated:

Document
 
Incorporated by reference into:

Portions of Annual Report to Shareholders for fiscal year ended January 2, 2016

 

Parts I, II

Portions of Definitive Proxy Statement for Annual Meeting of Stockholders to be held on April 28, 2016

  Parts III, IV

   


Table of Contents


AVERY DENNISON CORPORATION

FISCAL YEAR 2015 ANNUAL REPORT ON FORM 10-K

TABLE OF CONTENTS

 
   
  Page
PART I        
Item 1.   Business   1
Item 1A.   Risk Factors   5
Item 1B.   Unresolved Staff Comments   17
Item 2.   Properties   17
Item 3.   Legal Proceedings   17
Item 4.   Mine Safety Disclosures   18

PART II

 

 

 

 
Item 5.   Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   19
Item 6.   Selected Financial Data   19
Item 7.   Management's Discussion and Analysis of Financial Condition and Results of Operations   19
Item 7A.   Quantitative and Qualitative Disclosures About Market Risk   19
Item 8   Financial Statements and Supplementary Data   20
Item 9.   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure   20
Item 9A.   Controls and Procedures   20
Item 9B.   Other Information   20

PART III

 

 

 

 
Item 10.   Directors, Executive Officers, and Corporate Governance   21
Item 11.   Executive Compensation   23
Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   23
Item 13.   Certain Relationships and Related Transactions, and Director Independence   23
Item 14.   Principal Accounting Fees and Services   23

PART IV

 

 

 

 
Item 15.   Exhibits, Financial Statement Schedules   24
Signatures   25
Power of Attorney   26

Table of Contents


PART I

Item 1.        BUSINESS

Company Background

        Avery Dennison Corporation ("Avery Dennison," the "Company," "Registrant," or "Issuer," which are generally referred to as "we" or "us") was incorporated in Delaware in 1977 as Avery International Corporation, the successor corporation to a California corporation of the same name that had been incorporated in 1946. In 1990, we merged one of our subsidiaries into Dennison Manufacturing Company ("Dennison"), as a result of which Dennison became our wholly-owned subsidiary and in connection with which our name was changed to Avery Dennison Corporation. You can learn more about us by visiting our website at www.averydennison.com. Our website address provided in this Form 10-K is not intended to function as a hyperlink and the information on our website is not, nor should it be considered, part of this report or incorporated by reference into this report.

Business Overview and Reportable Segments

        Our businesses include the production of pressure-sensitive materials and a variety of tickets, tags, labels and other converted products. Some pressure-sensitive materials are sold to label printers and converters that "convert" the materials into labels and other products through embossing, printing, stamping and die-cutting. Some materials are sold by us in converted form as tapes and reflective sheeting. We also manufacture and sell a variety of other converted products and items not involving pressure-sensitive components, such as fasteners, tickets, tags, radio-frequency identification ("RFID") inlays and tags, and imprinting equipment and related services, which we market to retailers, apparel manufacturers, and brand owners.

        Our reportable segments in 2015 were:

        In 2015, the PSM and RBIS segments contributed approximately 73% and 26%, respectively, of our total sales.

        In 2015, international operations constituted a substantial majority of our business, representing approximately 74% of our sales. As of January 2, 2016, we operated approximately 180 manufacturing and distribution facilities worldwide and had operations in over 50 countries.

        On July 1, 2013, we completed the sale our Office and Consumer Products ("OCP") and Designed and Engineered Solutions ("DES") businesses to CCL Industries Inc. We continue to be subject to indemnification obligations, including for breaches of certain representations, warranties and covenants, under the terms of the purchase agreement. In addition, the tax liability associated with the sale is subject to completion of tax return filings in the jurisdictions where we operated the OCP and DES businesses. The OCP and DES businesses are reported as discontinued operations in this Form 10-K.

Pressure-sensitive Materials Segment

        Our PSM segment manufactures and sells Fasson®-, JAC®-, and Avery Dennison®-brand pressure-sensitive label and packaging materials, Avery Dennison®-brand graphics, Avery Dennison®-brand reflective products, Avery Dennison®-brand tapes, and performance polymers (largely used to manufacture pressure-sensitive materials). The business of this segment tends not to be seasonal, except for certain outdoor graphics and reflective products and operations in Europe. Pressure-sensitive materials consist primarily of papers, plastic films, metal foils and fabrics, which are coated with company-developed

1


Table of Contents

and purchased adhesives, and then laminated with specially coated backing papers and films. They are sold in roll or sheet form with either solid or patterned adhesive coatings, and are available in a wide range of face materials, sizes, thicknesses and adhesive properties. These label and packaging materials are sold worldwide to label printers and converters for labeling, decorating, fastening, electronic data processing and special applications in the home and personal care, beer and beverage, durables, pharmaceutical, wine and spirits, and food market segments.

        A pressure-sensitive, or self-adhesive, material is one that adheres to a surface by press-on contact. It generally consists of four layers: a face material, which may be paper, metal foil, plastic film or fabric; an adhesive, which may be permanent or removable; a release coating; and a backing material to protect the adhesive against premature contact with other surfaces, which can also serve as the carrier for supporting and dispensing individual labels. When the products are to be used, the release coating and protective backing are removed, exposing the adhesive, and the label or other face material is pressed or rolled into place.

        Because self-adhesive materials are easy to apply without the need for adhesive activation, the use of self-adhesive materials can provide cost savings compared with other materials that require heat- or moisture-activated adhesives. When used in package decoration applications, the visual appeal of self-adhesive materials can help increase sales of the products on which the materials are applied. Self-adhesive materials are also used to convey a variety of variable information, such as bar codes for mailing or weight and price information for packaged meats and other foods. Self-adhesive materials provide consistent and versatile adhesion and are available in a large selection of materials in nearly every size, shape and color. Our graphics and reflective products include a variety of films and other products that are sold to the architectural, commercial sign, digital printing, and other related market segments. We also sell durable cast and reflective films to the construction, automotive, and fleet transportation market segments; and reflective films for traffic and safety applications. We provide sign shops, commercial printers and designers a broad range of pressure-sensitive materials to enable the creation of impactful and informative brand and decorative graphics. We have an array of pressure-sensitive vinyl and specialty materials designed for digital imaging, screen printing and sign cutting applications.

        Our performance tapes products include coated tapes and adhesive transfer tapes that are sold for use in non-mechanical fastening, bonding and sealing systems in various industries. These tapes are sold to industrial original equipment manufacturers, converters, and disposable diaper producers worldwide in roll form and are available in a wide range of face materials, sizes, thicknesses and adhesive properties.

        Performance polymer products include a range of solvent- and emulsion-based acrylic polymer adhesives, protective coatings and other polymer additives for our internal use, as well as for sale to other companies.

        In the PSM segment, our larger competitors in label and packaging materials include Raflatac, a subsidiary of UPM-Kymmene Corporation; MACTac; Ritrama, Inc.; Flexcon Corporation, Inc.; and various regional firms. For graphics and reflective products, our largest competitors are 3M Company ("3M") and the Orafol Group. For performance tapes, our primary competitors include 3M, Tesa-SE, and Nitto Denko Corporation. We believe that entry of competitors into the field of pressure-sensitive adhesives and materials is limited by technical knowledge and capital requirements. We believe that our technical expertise, relative size and scale of operations, ability to serve our customers with a broad line of quality products and service programs, distribution and brand strength, and new product innovation are among the more significant advantages in maintaining and further developing our competitive position.

Retail Branding and Information Solutions Segment

        Our RBIS segment designs, manufactures and sells a wide variety of branding and information solutions to retailers, brand owners, apparel manufacturers, distributors and industrial customers on a

2


Table of Contents

global basis. The business of this segment tends to be seasonal, with higher volume generally in advance of the spring, fall (back-to-school), and holiday shipping periods.

        The branding solutions of RBIS include creative services, brand embellishments, graphic tickets, tags, and labels, and sustainable packaging. RBIS information solutions include RFID-enabled inventory accuracy, visibility and loss prevention solutions; price ticketing and marking; care, content, and country of origin compliance solutions; and brand protection and security solutions.

        In the RBIS segment, our primary competitors include Checkpoint Systems, Inc., R-pac International Corporation, and SML Group Limited. We believe that our global distribution network, reliable service, product quality and consistency, and ability to serve customers consistently with comprehensive solutions wherever they manufacture are the key advantages in maintaining and further developing our competitive position.

Vancive Medical Technologies Segment

        Our Vancive segment is a leader in the development of innovative technologies for medical applications and manufactures an array of pressure-sensitive adhesive materials and products that address the needs of medical device manufacturers, clinicians, and patients for surgical, wound care, ostomy, electromedical, and wearable device applications. Vancive's recent advances include the development of BeneHoldTM CHG adhesive, a proprietary adhesive technology providing sustained antimicrobial performance for up to seven days. It can be used in multiple applications in which prevention of infection is a requirement, including vascular access cover dressings.

        Vancive competes with a variety of specialized medical products providers ranging from start-ups to multinational companies. We believe that entry of competitors into the medical solutions business is limited by capital and technical requirements. We believe that our ability to serve our customers with quality, cost-effective and innovative products are among the more significant factors in developing our competitive position.

Segment Financial Information

        Certain financial information on our reporting segments for fiscal years 2015, 2014, and 2013 appears in Note 15, "Segment Information," in the Notes to Consolidated Financial Statements contained in our 2015 Annual Report to Shareholders (our "2015 Annual Report") and is incorporated herein by reference.

Foreign Operations

        Certain financial information about our sales by geographic area for fiscal years 2015, 2014, and 2013 appears in Note 15, "Segment Information," in the Notes to Consolidated Financial Statements contained in our 2015 Annual Report and is incorporated herein by reference.

Working Capital

        Certain financial information about our working capital for fiscal years 2015, 2014, and 2013 appears in the "Financial Condition" section of "Management's Discussion and Analysis of Financial Condition and Results of Operations" (Part II, Item 7) and is incorporated herein by reference.

Research and Development

        Many of our current products are the result of our research and development efforts. Our research efforts are directed primarily toward developing new products and operating techniques and improving product performance, often in close association with customers. These efforts include patent and product development work relating to printing and coating technologies, as well as adhesive, release and ink

3


Table of Contents

chemistries. Additionally, we focus on research projects related to RFID in our RBIS segment and medical technologies in Vancive, for both of which we hold and license a number of patents.

        Our expenses for research and development were $91.9 million in 2015, $102.5 million in 2014, and $96 million in 2013.

Patents, Trademarks and Licenses

        The loss of individual patents or licenses would not be material to us taken as a whole, nor to our operating segments individually. Our principal trademarks are Avery Dennison, our logo, and Fasson. We believe these trademarks are strong in the market segments in which our products compete.

Manufacturing and Environmental Matters

        We use various raw materials – primarily paper, plastic films and resins, as well as specialty chemicals purchased from various commercial and industrial sources – that are subject to price fluctuations. Although shortages can occur from time to time, these raw materials are generally available.

        We produce a majority of our self-adhesive materials using water-based emulsion and hot-melt adhesive technologies. Emissions from these operations contain small amounts of volatile organic compounds, which are regulated by federal, state, local and foreign governments. We continue to evaluate the use of alternative materials and technologies to minimize these emissions.

        A portion of our manufacturing process for self-adhesive materials utilizes certain organic solvents which, unless controlled, could be emitted into the atmosphere. Emissions of these substances are regulated by federal, state, local and foreign governments. In connection with the maintenance and acquisition of certain manufacturing equipment, we invest in solvent capture and control units to assist in regulating these emissions.

        We have developed adhesives and adhesive processing systems that minimize the use of solvents. Emulsion adhesives, hot-melt adhesives, and solventless and emulsion silicone systems have been installed in many of our facilities.

        Based on current information, we do not believe that the cost of complying with applicable laws regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, will have a material effect upon our capital expenditures, consolidated financial position or results of operations.

        For information regarding our potential responsibility for cleanup costs at certain hazardous waste sites, see "Legal Proceedings" (Part I, Item 3) and "Management's Discussion and Analysis of Financial Condition and Results of Operations" (Part II, Item 7).

Available Information

        Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed with, or furnished to, the Securities and Exchange Commission ("SEC") pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are available free of charge on our investor website at www.investors.averydennison.com as soon as reasonably practicable after electronic filing with or furnishing to the SEC. We also make available on our website our (i) Amended and Restated Certificate of Incorporation, (ii) Amended and Restated Bylaws, (iii) Corporate Governance Guidelines, (iv) Code of Conduct, which applies to our directors, officers and employees, (v) Code of Ethics for the Chief Executive Officer and Senior Financial Officers, (vi) charters of the Audit and Finance, Compensation and Executive Personnel, and Governance and Social Responsibility Committees of our Board of Directors, and (vii) Audit Committee Complaint Procedures for Accounting and Auditing Matters. These documents are also available free of charge in

4


Table of Contents

print to stockholders who request them by writing to: Corporate Secretary, Avery Dennison Corporation, 207 Goode Avenue, Glendale, California 91203.

Item 1A.        RISK FACTORS

        The factors and risks discussed below, as well as the matters that are generally set forth in this Annual Report on Form 10-K and the documents incorporated herein by reference, could materially adversely affect our business, including our results of operations, cash flows and financial condition, and cause the value of our securities to decline. The risks described below are not exhaustive. Our ability to attain our goals and objectives is dependent on numerous factors and risks, including but not limited to, the following:

The demand for our products is impacted by the effects of, and changes in, worldwide economic, political and market conditions, which could have a material adverse effect on our business.

        In 2015, approximately 74% of our sales were from international operations. We have operations in over 50 countries and our domestic and international operations are strongly influenced by matters beyond our control, including changes in political, social, economic and labor conditions, tax laws (including U.S. taxes on foreign earnings), and international trade regulations (including tariffs), as well as the impact of these changes on the underlying demand for our products.

        Macroeconomic developments such as continued slower growth in China and parts of South America, the ongoing restructuring efforts relating to European sovereign and other debt obligations, the weakening of local economies in which we operate and uncertainty in the global credit or financial markets leading to the loss of consumer confidence could result in a material adverse effect on our business as a result of, among other things, reduced consumer spending, declines in asset valuations, diminished liquidity and credit availability, volatility in securities prices, credit rating downgrades, and fluctuations in foreign currency exchange rates, such as the recent decline in the value of the euro and Chinese yuan (renminbi). These declines could result in a variety of negative effects, including lower revenues, increased costs, lower gross margin percentages, increased allowances for doubtful accounts and/or write-offs of accounts receivable, and required recognition of impairments of capitalized assets, including goodwill and other intangibles.

        In addition, business and operational disruptions or delays caused by political, social or economic instability and unrest – such as the ongoing significant civil, political and economic disturbances in places like Russia, Ukraine, Syria, Iraq and the related impact on global stability, terrorist attacks and the potential for other hostilities, public health crises or natural disasters in various parts of the world – could contribute to a climate of economic and political uncertainty that in turn could have material adverse effects on our business. We are not able to predict the duration and severity of adverse economic, political or market conditions in the U.S. or other countries.

We are affected by competitive conditions and customer preferences. If we do not compete effectively, we could lose market share or reduce selling prices to maintain market share, which could materially adversely affect our business.

        We are at risk that our competitors, which include certain of our distributors, will expand in our key market segments and implement new technologies, enhancing their competitive position relative to ours. Competitors also may be able to offer additional products, services, lower prices, or other incentives that we cannot or would not offer or that would make our products less profitable. There can be no assurance that we will be able to compete successfully against current or future competitors.

        We also are at risk to changes in customer order patterns, such as changes in the levels of inventory maintained by customers and the timing of customer purchases, which may be affected by announced price changes, changes in our incentive programs, or changes in the customer's ability to achieve incentive

5


Table of Contents

targets. Changes in customers' preferences for our products can also affect the demand for our products. Decline in demand for our products could have a material adverse effect on our business.

As a manufacturer, our sales and profitability are dependent upon the cost and availability of raw materials and energy, which are subject to price fluctuations, and our ability to control or pass on raw material and labor costs. Raw material cost increases could materially adversely affect our business.

        The environment for raw materials used in our businesses could become challenging and volatile, impacting availability and pricing. Additionally, energy costs can be volatile and unpredictable. Shortages and inflationary or other increases in the costs of raw materials, labor and energy have occurred in the past, and could recur. In addition, we are subject to rules adopted by the SEC pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act requiring disclosure concerning the use of certain minerals that are mined from the Democratic Republic of Congo and adjoining countries ("Conflict Mineral Rules"). In an effort to verify our products as "conflict-free," we could make alternative sourcing and supply decisions for materials used in certain of our products, which could materially adversely affect our pricing terms, particularly if suppliers incur significant additional costs and expenses in making the determinations required to conduct this verification process or if the number of suppliers offering minerals identified as "conflict free" is limited. Our performance depends in part on our ability to pass on cost increases for raw materials to customers by raising the selling prices for our products and our ability to improve productivity. Depending on market dynamics and the terms of customer contracts, our ability to recover any increased costs of complying with conflict minerals disclosure requirements or obtaining raw materials from third party suppliers may be limited.

        Also, it is important for us to obtain timely delivery of materials, equipment, and other resources from suppliers, and to make timely delivery to customers. We may experience supply chain interruptions due to natural and other disasters or other events, or our existing relationships with suppliers could be terminated in the future. Any such disruption to our supply chain could have a material adverse effect on our sales and profitability, and any sustained interruption in our receipt of adequate supplies could have a material adverse effect on our business.

Because our products are sold by third parties, our business depends in part on the financial health of these parties.

        Our products are sold not only by us, but also by third-party distributors as well. Some of our distributors also market products that compete with our products. Changes in the financial or business conditions, including economic weakness, market trends or industry consolidation, or the purchasing decisions of these third parties or their customers could materially adversely affect our business.

We outsource some of our manufacturing. If there are significant changes in the quality control or financial or business condition of these outsourced manufacturers, our business could be negatively impacted.

        We manufacture most of our products, but we also occasionally use third-party manufacturers for specialty jobs or capacity overflow. Outsourcing manufacturing reduces our ability to prevent product quality issues, late deliveries, customer dissatisfaction and noncompliance with customer requirements for labor standards. Because of possible quality issues and customer dissatisfaction, deficiencies in the performance of outsourced manufacturers could have a material adverse effect on our business.

6


Table of Contents

Our operations and activities outside of the U.S. may subject us to risks different from and potentially greater than those associated with our domestic operations.

        A substantial portion of our employees and assets are located outside of the U.S. and, for the year ended January 2, 2016, approximately 74% of our sales were generated from customers located outside of the U.S. International operations and activities involve risks that are different from and potentially greater than the risks we face with respect to our domestic operations, including our less extensive knowledge of and relationships with contractors, suppliers, distributors and customers in certain of these markets; changes in foreign political, regulatory and economic conditions, including nationally, regionally and locally; materially adverse effects of changes in exchange rates for foreign currencies; challenges with respect to the repatriation of foreign earnings; challenges of complying with a wide variety of foreign laws and regulations, including those relating to sales, corporate governance, operations, taxes, employment and legal proceedings; establishing effective controls and procedures to regulate our international operations and monitor compliance with U.S. laws and regulations such as the Foreign Corrupt Practices Act and similar foreign laws and regulations, including the United Kingdom's Bribery Act of 2010; differences in lending practices; challenges of complying with applicable export and import control laws and regulations; and differences in languages, cultures and time zones.

        The realization of any of these risks or the failure to comply with any of these laws or regulations could expose us to liabilities and have a material adverse effect on our business.

Our reputation, sales, and earnings could be materially adversely affected if the quality of our products and services does not meet customer expectations. In addition, product liability claims or regulatory actions could materially adversely affect our financial results or reputation.

        There are occasions when we experience product quality issues resulting from defective materials, manufacturing, packaging or design. Many of these issues are discovered before shipping, causing delays in shipping, delays in the manufacturing process, and occasionally cancelled orders. When issues are discovered after shipment, they may result in additional shipping costs, discounts, refunds, or loss of future sales. Both pre-shipping and post-shipping quality issues could have material adverse effects on our business and negatively impact our reputation.

        Claims for losses or injuries purportedly caused by some of our products arise in the ordinary course of our business. In addition to the risk of substantial monetary judgments and penalties that could have a material adverse effect on our business, product liability claims or regulatory actions could result in negative publicity that could harm our reputation in the marketplace and the value of our brands. We also could be required to recall and possibly discontinue the sale of potentially defective or unsafe products, which could result in adverse publicity and significant expenses. Although we maintain product liability insurance coverage, potential product liability claims are subject to a deductible or could be excluded under the terms of the policy.

Changes in our business strategies may increase our costs and could affect the profitability of our businesses.

        As our business environment changes, we may need to adjust our business strategies or restructure our operations or particular businesses. In 2015, we announced a new multi-year plan for our RBIS segment focused on accelerating growth through a more regionally driven business model intended to simplify our go-to-market market strategy, optimize management efficiencies and consolidate our manufacturing footprint. In addition, we have initiated restructuring and investment actions across our businesses designed to increase profitability. As we continue to develop and adjust our growth strategies, we may invest in new businesses that have short-term returns that are negative or low and whose ultimate business prospects are uncertain or unprofitable. For example, in the fourth quarter of 2015, we made the decision to exit one of our anticipated growth platforms in the Vancive segment in order to refocus our efforts on more profitable strategic alternatives. We cannot provide assurance that we will achieve the

7


Table of Contents

intended results of any of our business strategies, which involve operational complexities, consume management attention and require substantial resources and effort. If we fail to achieve the intended results of such actions, our costs could increase, our assets could be impaired, and our returns on investments could be lower.

Our growth strategy includes increased concentration in emerging markets, which could create greater exposure to unstable political conditions, civil unrest, economic volatility and other risks applicable to international operations.

        An increasing percentage of our sales are derived from emerging markets, including countries in Asia, Latin America and Eastern Europe. The profitable growth of our business in emerging markets is a significant focus of our long-term growth strategy. If we are unable to successfully expand our business in emerging markets or achieve the return on capital we expect as a result of our investments in these countries, our financial performance could be materially adversely affected. In addition to the risks applicable to our international operations, factors that could have a material adverse effect on our operations in these developing and emerging markets include the lack of well-established or reliable legal systems and possible disruptions due to unstable political conditions, civil unrest or economic volatility. These factors could result in decreased consumer purchasing power, reduced demand for our products or an impaired ability to achieve our long-term growth strategy, thereby having a material adverse effect on our business.

If we are unable to develop and successfully market new products and applications, we could compromise our competitive position.

        The timely introduction of new products and improvements in current products helps determine our success. Many of our current products are the result of our research and development efforts. Our research efforts are directed primarily toward developing new products and operating techniques and improving product performance, often in close association with our customers or end users. These efforts include patent and product development work relating to printing and coating technologies, as well as adhesive, release and ink chemistries. Additionally, we focus on research projects related to RFID in our RBIS segment and medical technologies in Vancive, for both of which we hold and license a number of patents. However, research and development is complex and uncertain, requiring innovation and anticipation of market trends. We could focus on products that ultimately are not accepted by customers or end users or we could suffer delays in the production or launch of new products that may not lead to the recovery of our research and development expenditures and, as a result, could compromise our competitive position.

Miscalculation of our infrastructure needs could have a material adverse effect on our business.

        We may not be able to recoup the costs of our infrastructure investments if actual demand is not as we anticipate. For example, in September 2015, we completed an expansion of our manufacturing facility located in Kunshan, China and added a new coater to meet our projected demand for pressure-sensitive tapes in China. Our investment in the Kunshan facility and other infrastructure investments generally are long-term in nature, and it is possible that these investments may not generate the expected return due to changes in the marketplace, failures to complete implementation, and other factors. Significant changes from our expected need for and/or returns on our infrastructure investments could materially adversely affect our business.

Our future profitability may be materially adversely affected if we generate less productivity improvement than projected.

        We engage in restructuring actions intended to reduce our costs and increase efficiencies across our business segments. We intend to continue efforts to reduce costs in our operations, which have in the past included, and may continue to include, facility closures and square footage reductions, headcount

8


Table of Contents

reductions, organizational restructuring, process standardization, and manufacturing relocation. The success of these efforts is not assured and lower levels of productivity could reduce profitability. In addition, cost reduction actions could expose us to production risk, loss of sales and employee turnover.

Foreign currency exchange rates, and fluctuations in those rates, may materially adversely affect our business.

        With approximately 74% of our sales for the fiscal year ending January 2, 2016 arising from foreign sales, we are subject to fluctuations in foreign currencies, such as the euro, the Chinese yuan (renminbi), and the British pound, which can cause transaction, translation and other losses, and could negatively impact our sales and profitability. Margins on sales of our products in foreign countries could be materially adversely affected by foreign currency exchange rate fluctuations.

        We monitor our foreign currency exposures and may, from time to time, use hedging instruments to mitigate transactional exposure to changes in foreign currencies. The effectiveness of our hedges in part depends on our ability to accurately forecast future cash flows, which is particularly difficult during periods of uncertain demand for our products and services and highly volatile exchange rates. Further, hedging activities may only offset a portion, or none at all, of the material adverse financial effects of unfavorable movements in foreign exchange rates over the limited time the hedges are in place and we may incur significant losses from hedging activities due to factors such as demand volatility and currency fluctuations.

        Additionally, concerns regarding the short- and long-term stability of the euro and its ability to serve as a single currency for countries in the Eurozone could lead individual countries to revert, or threaten to revert, to their former local currencies, potentially dislocating the euro. If this were to occur, the assets we hold in a country that re-introduces its local currency could be significantly devalued, the cost of raw materials or our manufacturing operations could substantially increase, and the demand and pricing for our products could be materially adversely affected. Furthermore, if it were to become necessary for us to conduct business in additional currencies, we could be subject to additional earnings volatility as amounts in these currencies are translated into U.S. dollars.

We have acquired companies and may continue to acquire other companies. Acquisitions come with significant risks and uncertainties, including those related to integration, technology and personnel.

        To grow our product lines and expand into new markets, we have made acquisitions in the past and may do so in the future. Various risks, uncertainties, and costs are associated with acquisitions. Effective integration of systems, controls, objectives, personnel, product lines, market segments, customers, suppliers, and production facilities and cost savings can be difficult to achieve, and the results of integration actions are uncertain, particularly given our geographically dispersed organization. In addition, we may not be able to retain key personnel of an acquired company or successfully execute integration strategies and achieve projected performance targets for the business segment into which an acquired company is integrated. Both before and after the closing of an acquisition, our business and those of the acquired company or companies may suffer due to uncertainty or diversion of management attention. There can be no assurance that any acquisitions will be successful and contribute to our profitability and we may not be able to identify or execute new acquisition opportunities in the future.

Divestures of any of our businesses or product lines could have a material adverse effect on our business.

        We continually evaluate the performance of our businesses and may determine to sell a business or product line. While we believe these divestures are in the best interests of our long-term strategy, they may result in significant write-offs or impairments of assets, including goodwill and other intangible assets. For example, we completed the sale of certain of our assets and liabilities associated with a product line in our RBIS segment in May 2015 at a loss and incurred impairment charges as well as exit costs, including costs associated with severance payments. Any future divestitures we undertake may also involve additional risks, including separation of operations, products and personnel, diversion of management attention,

9


Table of Contents

disruption to our other businesses and loss of key employees. We may not successfully manage these or other risks we may confront in divesting a business or product line, which could have a material adverse effect on our business.

Difficulty in the collection of receivables as a result of economic conditions or other market factors could have a material adverse effect on our business.

        Although we have processes to administer credit granted to customers and believe our allowance for doubtful accounts is adequate, we have experienced, and in the future may experience, losses as a result of our inability to collect certain accounts receivable. The financial difficulties of a customer could result in reduced business with that customer. We may also assume higher credit risk relating to receivables of a customer experiencing financial difficulty. If these developments occur, our inability to collect on our accounts receivable from major customers could substantially reduce our cash flows and income and have a material adverse effect on our business.

Changes in our tax rates could affect our future results.

        Our future effective tax rate could be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, or changes in tax laws and regulations or their interpretation. There can be no assurance that these changes will not have a material adverse effect on our business.

The amount of various taxes we pay is subject to ongoing compliance requirements and audits by federal, state and foreign tax authorities.

        We are subject to regular examinations of our income tax returns by various tax authorities. We regularly assess the likelihood of material adverse outcomes resulting from these examinations to determine the adequacy of our provision for taxes. In addition, tax enforcement has become increasingly aggressive in recent years, including recent actions by the European Commission related to disallowed state aid, with increased focus on transfer pricing and intercompany documentation. Our estimate of the potential outcome of uncertain tax issues is subject to our assessment of relevant risks, facts, and circumstances existing at the time. We use these assessments to determine the adequacy of our provision for income taxes and other tax-related accounts. Our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may materially adversely impact our effective tax rate and have a material adverse effect on our business.

We have deferred tax assets that we may not be able to realize under certain circumstances.

        If we are unable to generate sufficient future taxable income in certain jurisdictions, or if there is a significant change in the time period within which the underlying temporary differences become taxable or deductible, we could be required to increase our valuation allowances against our deferred tax assets. This would result in an increase in our effective tax rate and could have a material adverse effect on our future results. In addition, changes in statutory tax rates may change our deferred tax asset or liability balances, with either a favorable or unfavorable impact on our effective tax rate. The computation and assessment of realizability of our deferred tax assets may also be materially impacted by new legislation or regulations.

Potential tax liabilities and proposed changes in U.S. tax legislation could materially impact our business.

        In 2015, approximately 74% of our sales were generated from customers located outside of the U.S., and a substantial portion of our assets and employees were located outside of the U.S. While we are taxed by local authorities on earnings from these sales, we have not accrued U.S. income taxes or foreign withholding taxes on unrepatriated earnings for most non-U.S. subsidiaries because we intend to indefinitely reinvest in the operations of those subsidiaries. Our results of operations and cash flows from

10


Table of Contents

operating activities may be materially adversely affected if tax rules regarding unrepatriated earnings change, if changes in our domestic cash needs require us to repatriate foreign earnings for which no tax provisions have been made, or if the U.S. international tax rules change as part of comprehensive tax reform or other tax legislation.

Significant disruption to the information technology infrastructure that stores our information could materially adversely affect our business.

        We rely on the efficient and uninterrupted operation of a large and complex information technology infrastructure to link our global business. Like other information technology systems, ours is susceptible to a number of risks including, but not limited to, damage or interruptions resulting from a variety of causes such as obsolescence, natural disasters, power failures, human error, viruses, social engineering, phishing, or other malicious attacks and data security breaches. We upgrade and install new systems, which, if installed or programmed incorrectly or on a delayed timeframe, could cause delays or cancellations of customer orders, impede the manufacture or shipment of products, or disrupt the processing of transactions. We have implemented measures to mitigate our risk related to system and network disruptions, but if a disruption were to occur, we could incur significant losses and remediation costs that could have a material adverse effect on our business. Additionally, we rely on services provided by third-party vendors for a significant portion of our information technology support, development and implementation, which makes our operations vulnerable to a failure by any one of these vendors to perform adequately or maintain effective internal controls.

Security breaches could compromise our information and expose us to liability, which could cause our business and reputation to suffer.

        We maintain information necessary to conduct our business in digital form, which is stored in data centers and on our networks and third-party cloud services, including confidential and proprietary information as well as personal information regarding our customers and employees. The secure maintenance of this information is critical to our operations. Data maintained in digital form is subject to the risk of intrusion, tampering and theft. We develop and maintain systems to prevent this from occurring, but the development and maintenance of these systems is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become more sophisticated. Moreover, despite our efforts, the possibility of intrusion, tampering and theft cannot be eliminated entirely. Our information technology and infrastructure may be vulnerable to attacks by hackers or breached due to employee error, malfeasance or other disruptions. Additionally, we provide confidential, proprietary and personal information to third parties when it is necessary to pursue business objectives. While we obtain assurances that these third parties will protect this information and, where appropriate, assess the protections employed by these third parties, there is a risk the confidentiality of data held by third parties may be compromised.

        Any such breach or attack could compromise our network, the network of a third party to whom we have disclosed confidential, proprietary or personal information, a data center where we have stored such information or a third-party cloud service provider, and the information stored there could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could result in legal claims or proceedings, disrupt our operations, damage our reputation, impair our ability to conduct business, or result in the loss or diminished value of profitable opportunities and the loss of revenue as a result of unlicensed use of our intellectual property. Contractual provisions with third parties, including cloud service providers, may limit our ability to recover these losses. If personal information of our customers or employees were misappropriated, our reputation with our customers and employees could be injured, resulting in loss of business or morale, and we could incur costs to compensate our customers or employees or pay damages or fines as a result of litigation or regulatory actions arising out of any such incident.

11


Table of Contents

        From time to time, we have experienced unauthorized intrusions into our network, and although these intrusions did not have a material adverse effect on our business, this may not be the case going forward. Following these attacks, we have taken additional steps designed to improve the security of our networks and computer systems. Despite these defensive measures, there can be no assurance that we are adequately protecting our information, that third parties to whom we have disclosed such information or with whom we have stored such information (in data centers and on the cloud) are taking similar precautions, or that we will not continue to experience future intrusions.

For us to remain competitive, it is important to recruit and retain our key management and highly-skilled employees. We also utilize various outsourcing arrangements for certain services, and related delays, resource availability, or errors by these service providers may lead to increased costs or disruption in our business.

        There is significant competition to recruit and retain key management and highly-skilled employees. In particular, due to expansion to additional geographies and our ongoing productivity efforts and recent employee restructuring actions, it may be difficult for us to recruit and retain sufficient numbers of highly-skilled employees. We may also be unable to recruit and retain key management and highly-skilled employees if we do not offer market-competitive employment and compensation terms. If we fail to recruit or retain our key management or sufficient numbers of highly-skilled employees, we could experience disruption in our businesses and difficulties managing our operations and implementing our business strategy.

        Executive succession planning is also important to our long-term success. For example, we experienced several recent key management changes, including the appointments of a Chief Operating Officer during 2014 and a new Chief Financial Officer during 2015. While we believe we have appropriate succession procedures in place, any failure to ensure effective transfer of knowledge and smooth transitions involving any of our key management or other highly-skilled employees could hinder our strategic planning and execution.

        In addition, we have outsourced certain services to third-party service providers, and may outsource other services in the future to achieve cost savings and operating efficiencies. Service provider delays, resource availability, business issues or errors may disrupt our businesses and/or increase costs. If we do not effectively develop, implement and manage outsourcing relationships, if third-party providers do not perform effectively or in a timely manner, or if we experience problems with transitioning work to a third party, we may not be able to achieve our expected cost savings, and may experience delays or incur additional costs to correct errors made by these service providers.

Our share price may be volatile.

        Changes in our stock price may affect our access to, or cost of financing from, capital markets and may affect our stock-based compensation arrangements, among other things. Our stock price, which has at times experienced, and may in the future experience, substantial volatility, is influenced by changes in the overall stock market and demand for equity securities in general. Other factors, including our financial performance on a standalone basis and relative to our peers and competitors, as well as market expectations of our future performance, the level of perceived growth of our industries, and other company-specific factors, can also materially adversely affect our share price. There can be no assurance that our stock price will not be volatile in the future.

If our indebtedness increases significantly or our credit ratings are downgraded, we may have difficulty obtaining acceptable short- and long-term financing.

        Our overall level of indebtedness and credit ratings are significant factors in our ability to obtain short- and long-term financing. Higher debt levels could negatively impact our ability to meet other business needs and could result in higher financing costs. The credit ratings assigned to us also impact the

12


Table of Contents

interest rates paid. A downgrade of our short-term credit ratings below our current levels could impact our ability to access the commercial paper markets and increase our borrowing costs. If our access to commercial paper markets were to become limited and we were required to obtain short-term funding under our revolving credit facility or our other credit facilities, we would face increased exposure to variable interest rates.

An increase in interest rates could have a material adverse effect on our business.

        In 2015, our average variable-rate borrowings were approximately $175 million. Increases in short-term interest rates would directly impact the amount of interest we pay. An assumed 40 basis point move in interest rates affecting our variable-rate borrowings (10% of our weighted-average interest rate on floating rate debt) would have increased interest expense by approximately $.7 million on variable-rate borrowings in 2015. Fluctuations in interest rates can increase borrowing costs and have a material adverse effect on our business.

        In response to the last global economic recession, extraordinary monetary policy actions of the U.S. Federal Reserve and other central banking institutions, including the utilization of quantitative easing, were taken to create and maintain a low interest rate environment. However, in December 2015, the U.S. Federal Reserve raised its benchmark interest rate by a quarter of a percentage point for the first time since 2006. While it is unclear whether this action suggests a change in previous monetary policy positions, including but not limited to an elimination of quantitative easing over time, any such change or market expectation of such change may result in significantly higher long-term interest rates. Such a transition may be abrupt and may, among other things, reduce the availability and/or increase the costs of obtaining new debt and refinancing existing indebtedness, and negatively impact the market price of our common stock.

Our current and future debt covenants may limit our flexibility.

        Our credit facilities and the indentures governing our notes contain, and any of our future indebtedness likely would contain, restrictive covenants that impose operating and financial restrictions on us. Among other things, these covenants restrict our ability to incur additional indebtedness, incur certain liens on our assets, make certain investments, sell our assets or merge with third parties, and enter into certain transactions. We are also required to maintain specified financial ratios under certain conditions. These restrictive covenants and ratios in our existing debt agreements and any future financing agreements may limit or prohibit us from engaging in certain activities and transactions that may be in our long-term best interests and could place us at a competitive disadvantage relative to our competitors, which could materially adversely affect our business.

Additional financings may dilute the holdings of our current shareholders.

        In order to provide capital for the operation of our business, we may enter into additional financing arrangements. These arrangements may involve the issuance of new shares of preferred or common stock, convertible debt securities and/or warrants. Any of these issuances could result in a material increase in the number of shares of common stock outstanding, which would dilute the ownership interests of our existing common shareholders. In addition, any new securities could contain provisions, such as priorities on distributions and voting rights, that could materially adversely affect the value of our existing common stock.

13


Table of Contents

The level of returns on our pension and postretirement plan assets and the actuarial assumptions used for valuation purposes could affect our earnings and cash flows in future periods. Changes in accounting standards and government regulations could also affect our pension and postretirement plan expense and funding requirements.

        We evaluate the assumptions used in determining projected benefit obligations and the fair value of plan assets for our pension plan and other postretirement benefit plans in consultation with outside actuaries. In the event that we were to determine that changes were warranted in the assumptions used, such as the discount rate, expected long-term rate of return, or health care costs, our future pension and projected postretirement benefit expenses and funding requirements could increase or decrease. Because of changing market conditions or changes in the participant population, the actuarial assumptions that we use may differ from actual results, which could have a significant impact on our pension and postretirement liability and related costs. Funding obligations for each plan are determined based on the value of assets and liabilities on a specific date as required under applicable government regulations. Future pension funding requirements, and the timing of funding payments, could also be affected by future legislation or regulation.

Our pension assets are significant and subject to market, interest and credit risk that may reduce their value.

        Changes in the value of our pension assets could materially adversely affect our earnings and cash flows. In particular, the value of our investments may decline due to increases in interest rates or volatility in the financial markets. Although we mitigate these risks by investing in high quality securities, ensuring adequate diversification of our investment portfolio and monitoring our portfolio's overall risk profile, the value of our investments may nevertheless decline.

An impairment in the carrying value of goodwill could negatively impact our results of operations and net worth.

        Goodwill is initially recorded at fair value and not amortized, but is reviewed for impairment annually (or more frequently if impairment indicators are present). We review goodwill for impairment by comparing the fair value of a reporting unit to its carrying value. In assessing fair value, we make estimates and assumptions about sales, operating margins, growth rates, and discount rates based on our business plans, economic projections, anticipated future cash flows and marketplace data. There are inherent uncertainties related to these factors and management's judgment in applying these factors. Goodwill valuations have been calculated primarily using an income approach based on the present value of projected future cash flows of each reporting unit. We could be required to evaluate the carrying value of goodwill prior to the annual assessment if we experience disruptions to our business, unexpected significant declines in operating results, divestiture of a significant component of our business or sustained market capitalization declines. These types of events could result in goodwill impairment charges in the future. Impairment charges could substantially affect our business in the periods in which they are made.

Unfavorable developments in legal proceedings, investigations and other legal, compliance and regulatory matters, could impact us in a materially adverse manner.

        Our financial results could be materially adversely affected by an unfavorable outcome to pending or future litigation and investigations, and other legal, compliance and regulatory matters. See "Legal Proceedings" (Part I, Item 3).

        In addition, the requirements set forth in the Conflict Mineral Rules required us to undertake due diligence efforts that are expected to continue into the future. We expect to continue incurring costs associated with complying with these disclosure requirements, including for conducting diligence procedures to determine the sources of conflict minerals that may be used or necessary to the production of our products and, if applicable, potential changes to products, processes or sources of supply as a consequence of these verification activities. We have identified products in certain businesses in our RBIS

14


Table of Contents

and Vancive segments that include metals and minerals subject to the Conflict Mineral Rules. Our due diligence efforts to verify the origins of these metals and minerals are ongoing. Our reputation may be harmed if we are not able to sufficiently verify the origins for the minerals and metals used in our products.

        There can be no assurance that any investigation or litigation outcome will be favorable.

We are required to comply with anti-corruption laws and regulations of the U.S. government and various international jurisdictions, and our failure to comply with these laws and regulations could have a material adverse effect on our business.

        We are required to comply with the anti-corruption laws and regulations of the U.S. government and various international jurisdictions, such as the U.S. Foreign Corrupt Practices Act and the United Kingdom's Bribery Act of 2010. If we fail to comply with anti-corruption laws, we could be subject to substantial civil and criminal penalties, including regulatory fines, monetary damages and incarceration for responsible employees and managers. In addition, if our distributors or agents fail to comply with these laws, we may also be materially adversely affected through reputational harm and penalties.

We are required to comply with global environmental, health, and safety laws. The costs of complying with these laws could materially adversely affect our business.

        We are subject to national, state, provincial and/or local environmental, health, and safety laws and regulations in the U.S. and abroad, including those related to the disposal of hazardous waste from our manufacturing processes. Compliance with existing and future environmental, health and safety laws could subject us to future costs or liabilities, impact our production capabilities, limit our ability to sell, expand or acquire facilities, and have a material adverse effect on our business. Environmental and product content and product safety laws and regulations can be complex and change often. We have accrued liabilities for the environmental clean-up of certain sites, including sites for which U.S. governmental agencies have designated us as a potentially responsible party, where it is probable that a loss will be incurred and the cost or amount of loss can be reasonably estimated. See "Legal Proceedings" (Part I, Item 3). However, because of the uncertainties associated with environmental assessment and remediation activities, future expense to remediate currently identified sites and other sites that could be identified for cleanup in the future could be higher than the liabilities accrued.

We are subject to governmental export and import control laws and regulations in certain jurisdictions where we do business that could subject us to liability or impair our ability to compete in these markets.

        Certain of our products are subject to export control laws and regulations and may be exported only with an export license or through an applicable export license exception. If we fail to comply with export licensing, customs regulations, economic sanctions or other laws, we could be subject to substantial civil or criminal penalties, including economic sanctions against us, incarceration for responsible employees and managers, and the possible loss of export or import privileges. In addition, if our distributors fail to obtain appropriate import, export or re-export licenses or permits, we may also be materially adversely affected through reputational harm and penalties. Obtaining the necessary export license for a particular sale may be time consuming and expensive and could result in the delay or loss of sales opportunities.

        Furthermore, export control laws and economic sanctions prohibit the shipment of certain products to embargoed or sanctioned countries, governments and persons. While we train our employees to comply with these regulations, we cannot guarantee that a violation will not occur. A prohibited shipment could have negative consequences, including government investigations, penalties, fines, civil and criminal sanctions and reputational harm. Any change in export or import regulations, economic sanctions or related legislation, shift in the enforcement or scope of existing regulations, or change in the countries, governments, persons or technologies targeted by such regulations, could decrease our ability to export or sell our products internationally. Any limitation on our ability to export or sell our products could materially adversely affect our business.

15


Table of Contents

Infringing intellectual property rights of third parties or inadequately acquiring or protecting our intellectual property could harm our ability to compete or grow.

        Because our products involve complex technology and chemistry, we are involved from time to time in litigation involving patents and other intellectual property. Parties have filed, and in the future may file, claims against us alleging that we have infringed their intellectual property rights. If we were held liable for infringement, we could be required to pay damages, obtain licenses or cease making or selling certain products. There can be no assurance that licenses would be available on commercially reasonable terms or at all. The defense of these claims, whether or not meritorious, or the development of new technologies could cause us to incur significant costs and divert the attention of management.

        We also have valuable intellectual property upon which third parties may infringe. We attempt to protect and restrict access to our intellectual property and proprietary information by relying on the patent, trademark, copyright and trade secret laws of the U.S. and other countries, as well as non-disclosure agreements. However, it may be possible for a third party to obtain our information without our authorization, independently develop similar technologies, or breach a non-disclosure agreement entered into with us. In addition, many of the countries in which we operate do not have intellectual property laws that protect proprietary rights as fully as do laws in the U.S. The use of our intellectual property by someone else without our authorization could reduce or eliminate certain competitive advantages we have, cause us to lose sales or otherwise harm our business. Further, the costs associated with protecting our intellectual property rights could materially adversely impact our business.

        We have obtained and applied for U.S. and foreign trademark registrations and patents, and will continue to evaluate whether to register additional trademarks and apply for additional patents. We cannot guarantee that any of the pending applications will be approved by the applicable government authorities. Further, we cannot assure that the validity of our patents or our trademarks will not be challenged. In addition, third parties may be able to develop competing products using technology that avoids our patents.

We are subject to risks associated with the availability and coverage of various types of insurance.

        We have various types of insurance, including property, workers' compensation, general liability, and environmental liability. Insurance costs can be unpredictable and may materially adversely impact our business. We retain some portion of our insurable risks, and therefore, unforeseen or catastrophic losses in excess of insured limits could have a material adverse effect on our business.

Healthcare reform legislation could have a material adverse effect on our business.

        During 2010, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (together, the "ACA") were signed into law in the U.S. Certain of the provisions that could most significantly increase our healthcare costs in the near term include the removal of annual plan limits, the changes in rules regarding eligibility for dependents and the mandate that health plans cover 100% of preventative care. In addition, our healthcare costs could increase if we are required to cover more employees than we do currently or pay penalty amounts in the event that employees do not elect our offered coverage. The complexities and ramifications of the ACA are significant and being implemented through a phased approach that is expected to continue over the next several years.

        As a result of political, economic and regulatory influences, scrutiny of the healthcare delivery system in the United States can be expected to continue at both the state and federal levels. For example, since its enactment, there have been several changes to the ACA and the law is likely to continue to evolve during the course of its implementation. As a result, the effects of health care reform and the resulting impact on our operations are not fully known. Any changes to our healthcare cost structure could have a material adverse effect on our business.

16


Table of Contents

Item 1B.        UNRESOLVED STAFF COMMENTS

        None.

Item 2.        PROPERTIES

        As of January 2, 2016, we operated manufacturing facilities in excess of 100,000 square feet in the locations listed below:

Pressure-sensitive Materials Segment

Domestic

  Peachtree City, Georgia; Fort Wayne, Greenfield, and Lowell, Indiana; Fairport Harbor, Mentor, and Painesville, Ohio; and Quakertown, Pennsylvania

Foreign

 

Turnhout, Belgium; Vinhedo, Brazil; Kunshan, China; Champ-sur-Drac, France; Gotha and Schwelm, Germany; Rodange, Luxembourg; Bangi, Malaysia; and Cramlington, United Kingdom

Retail Branding and Information Solutions Segment

Domestic

  Lenoir, North Carolina and Miamisburg, Ohio

Foreign

 

Nansha, Panyu, and Suzhou, China and Ancarano, Italy

        In addition to the manufacturing facilities described above, our other principal facilities include our corporate headquarters in Glendale, California, and our divisional offices located in Westborough, Massachusetts; Mentor, Ohio; Kunshan, China; and Oegstgeest, the Netherlands.

        We own all of the principal properties identified above, except for the following facilities, which are leased: Vinhedo, Brazil; Glendale, California; Panyu, China; Rodange, Luxembourg; Westborough, Massachusetts; Mentor, Ohio; and Oegstgeest, the Netherlands.

        We consider all our properties, whether owned or leased, suitable and adequate for our present needs. We generally expand production capacity as needed to meet increased demand. Owned buildings and plant equipment are insured against major losses from fire and other usual business risks, subject to deductibles. We are not aware of any material defects in title to, or significant encumbrances on, our properties, except for certain mortgage liens.

Item 3.        LEGAL PROCEEDINGS

        As of January 2, 2016, we have been designated by the U.S. Environmental Protection Agency ("EPA") and/or other responsible state agencies as a potentially responsible party ("PRP") at thirteen waste disposal or waste recycling sites, which are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination. No settlement of our liability related to any of the sites has been agreed upon. We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities.

        We have accrued liabilities for sites where it is probable that a loss will be incurred and the cost or amount of loss can be reasonably estimated. These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably

17


Table of Contents

estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.

        As of January 2, 2016, our estimated accrued liability associated with environmental remediation was $17.7 million.

        In addition, we are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business. We have accrued liabilities for matters where it is probable that a loss will be incurred and the amount of loss can be reasonably estimated. Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.

        See also Note 8, "Contingencies," in the Notes to Consolidated Financial Statements of our 2015 Annual Report, which is incorporated herein by reference.

Item 4.        MINE SAFETY DISCLOSURES

        Not applicable.

18


Table of Contents


PART II

Item 5.        MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

(a)
The information called for by Item 201 of Regulation S-K appears under "Corporate Information – Stock and Dividend Data" in our 2015 Annual Report and is incorporated herein by reference. We did not sell any unregistered securities during the fourth quarter of 2015.

(b)
Not applicable.

(c)
Repurchases of Equity Securities by Issuer

        Repurchases by us or our "affiliated purchasers" (as defined in Rule 10b-18(a)(3) of the Exchange Act) of registered equity securities in the three fiscal months of the fourth quarter of 2015 are listed in the following table.

Period(1)

  Total number of
shares
purchased(2)
  Average price
paid per
share
  Total number of
shares purchased
as part of publicly
announced
plans(2)(3)
  Approximate dollar
value of shares that
may yet be purchased
under the plans(4)
 

October 4, 2015 – October 31, 2015

  283.5   $59.93   283.5    

November 1, 2015 – November 28, 2015

  828.0   64.70   828.0    

November 29, 2015 – January 2, 2016

  826.6   64.32   826.6    
 

Total

  1,938.1   $63.84   1,938.1   $367.2

 
(1)
The periods shown are our fiscal periods during the thirteen-week quarter ended January 2, 2016.
(2)
Shares in thousands.
(3)
On December 4, 2014, our Board of Directors authorized the repurchase of shares of our common stock in the aggregate amount of up to $500 million (exclusive of any fees, commissions or other expenses related to such purchases), in addition to any outstanding shares authorized under any previous Board authorization. This authorization is the only one currently in effect and will remain in effect until the shares authorized thereby have been repurchased.
(4)
Dollars in millions.

        Repurchased shares may be reissued under our stock option and incentive plan or used for other corporate purposes.

Item 6.        SELECTED FINANCIAL DATA

        Selected financial data for each of our last five fiscal years appears under "Five-year Summary" in our 2015 Annual Report and is incorporated herein by reference.

Item 7.        MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

        The information called for by this Item is contained under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2015 Annual Report and incorporated herein by reference.

Item 7A.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

        The information called for by this Item is contained under "Market-Sensitive Instruments and Risk Management" in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2015 Annual Report and incorporated herein by reference.

19


Table of Contents

Item 8.        FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

        The information called for by this Item is contained in our 2015 Annual Report (including the Consolidated Financial Statements and the Notes thereto, Statement of Management Responsibility for Financial Statements and Management's Report on Internal Control Over Financial Reporting, and the Report of Independent Registered Public Accounting Firm) and incorporated herein by reference.

Item 9.        CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

        None.

Item 9A.        CONTROLS AND PROCEDURES

        Disclosure Controls and Procedures.    As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure.

        Management's Report on Internal Control Over Financial Reporting.    We are responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f) of the Exchange Act). Under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based upon the framework in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of January 2, 2016. (See Management's Report on Internal Control Over Financial Reporting in our 2015 Annual Report, which is incorporated herein by reference.)

        Management's assessment of the effectiveness of our internal control over financial reporting as of January 2, 2016 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in the Report of Independent Registered Public Accounting Firm contained in our 2015 Annual Report, which is also incorporated herein by reference.

        Changes in Internal Control over Financial Reporting.    We periodically assess our internal control environment. During 2014, we began a phased implementation of a new transactional system in our RBIS segment that is expected to continue through 2017. Processes affected by this implementation include, among other things, order management, pricing, shipping, general accounting and planning. Where appropriate, we are reviewing related internal controls and making changes. Except for these changes, there have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.        OTHER INFORMATION

        None.

20


Table of Contents


PART III

Item 10.        DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

        The information concerning directors and corporate governance called for by this Item is incorporated herein by reference from the definitive proxy statement for our Annual Meeting of Stockholders to be held on April 28, 2016 (our "2016 Proxy Statement"), which will be filed with the SEC pursuant to Regulation 14A within 120 days of the end of the fiscal year covered by this report. The information concerning executive officers called for by this Item appears, in part, on the next page of this report, and is also incorporated by reference from our 2016 Proxy Statement. The information concerning any late filings under Section 16(a) of the Exchange Act is incorporated by reference from our 2016 Proxy Statement.

        We have adopted a Code of Ethics for the Chief Executive Officer and Senior Financial Officers (the "Code"), which applies to our Chief Executive Officer, Chief Financial Officer, and Controller/Chief Accounting Officer. The Code is available on our investor website at www.investors.averydennison.com. We will satisfy disclosure requirements under Item 5.05 of Form 8-K regarding any amendment to, or waiver of, any provision of the Code that applies to these officers disclosing the nature of such amendment or waiver on our website or in a current report on Form 8-K. Our Code of Conduct, which applies to our directors, officers and employees, is also available on our investor website. Our website address is not intended to function as a hyperlink, and the contents of the website are not a part of this Form 10-K, nor are they incorporated herein by reference.

        The information called for by this Item concerning our Audit and Finance Committee is incorporated by reference from our 2016 Proxy Statement.

21


Table of Contents


EXECUTIVE OFFICERS OF AVERY DENNISON(1)

Name   Age   Served as
Executive Officer
since
  Former Positions within Past Five Years /
Prior Offices with Avery Dennison

Dean A. Scarborough

  60   August 1997   2010-2014   Chairman, President and

Chairman and

              Chief Executive Officer

Chief Executive Officer

          2005-2010   President and Chief Executive Officer

          2000-2005   President and Chief Operating Officer

Mitchell R. Butier

 

44

 

March 2007

 

2014-2015

 

President, Chief Operating Officer and

President and

              Chief Financial Officer

Chief Operating Officer

          2010-2014   Senior Vice President and

              Chief Financial Officer

          2007-2010   Vice President, Global Finance and

              Chief Accounting Officer

          2004-2006   Vice President, Finance, Retail Branding

              and Information Solutions

Anne L. Bramman

 

48

 

March 2015

 

2011-2015

 

Senior Vice President and

Senior Vice President and

              Chief Financial Officer,

Chief Financial Officer

              Carnival Cruise Line

          2008-2011   Senior Vice President and

              Chief Financial Officer, Henri Bendel

Lori J. Bondar

 

55

 

June 2010

 

2008-2010

 

Vice President and Controller

Vice President, Controller and

               

Chief Accounting Officer

               

Georges Gravanis

 

58

 

May 2015

 

2010-2015

 

Vice President and General Manager,

President, Materials Group

              Materials Group Asia Pacific

          2006-2010   Vice President of Sales,

              Roll Materials Europe

          2004-2006   Vice President and General Manager,

              Roll Materials Europe Southern Region

Anne Hill

 

56

 

May 2007

       

Senior Vice President and

               

Chief Human Resources Officer

               

Susan C. Miller

 

56

 

March 2008

 

2008-2009

 

Senior Vice President and

Senior Vice President,

              General Counsel

General Counsel and Secretary

          2007-2008   Vice President and General Counsel

          1998-2006   Assistant General Counsel

(1)
Officers are generally elected on the date of our annual stockholder meeting to serve a one-year term and until their successors are duly elected and qualified.

22


Table of Contents

Item 11.        EXECUTIVE COMPENSATION

        The information called for by this Item is incorporated by reference from our 2016 Proxy Statement.

Item 12.        SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

        The information called for by this Item is incorporated by reference from our 2016 Proxy Statement.

Item 13.        CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

        The information called for by this Item is incorporated by reference from our 2016 Proxy Statement.

Item 14.        PRINCIPAL ACCOUNTING FEES AND SERVICES

        The information called for by this Item is incorporated by reference from our 2016 Proxy Statement.

23


Table of Contents


PART IV

Item 15.        EXHIBITS, FINANCIAL STATEMENT SCHEDULES

        (a)   Financial Statements, Financial Statement Schedule and Exhibits

        (b) The exhibits required to be filed by Item 601 of Regulation S-K are set forth on the accompanying Exhibit Index and incorporated herein by reference.

24


Table of Contents


SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    AVERY DENNISON CORPORATION

 

 

By:

 

/s/

 

Anne L. Bramman
       
Anne L. Bramman
Senior Vice President and Chief Financial Officer

Dated: February 24, 2016

        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and as of the dates indicated.

Signature
 
Title
 
Date

 

 

 

 

 

 

 
/s/    Dean A. Scarborough

        Dean A. Scarborough
  Chairman and
Chief Executive Officer
  February 24, 2016

/s/    Anne L. Bramman

        Anne L. Bramman

 

Senior Vice President
and Chief Financial Officer
(Principal Financial Officer)

 

February 24, 2016

/s/    Lori J. Bondar

        Lori J. Bondar

 

Vice President, Controller,
and Chief Accounting Officer
(Principal Accounting Officer)

 

February 24, 2016

25


Table of Contents


POWER OF ATTORNEY

        KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Anne L. Bramman and Susan C. Miller, and each of them, with full power of substitution, his or her true and lawful attorney-in-fact to act for him or her in any and all capacities, to sign this Annual Report on Form 10-K and any or all amendments or supplements thereto, and to file each of the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as he or she could do in person, hereby ratifying and confirming all that said attorneys-in-fact or substitutes, or any of them, may lawfully do or cause to be done by virtue hereof.

        Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and as of the dates indicated.

Signature
 
Title
 
Date

 

 

 

 

 

 

 
/s/    Bradley A. Alford

        Bradley A. Alford
  Director   February 24, 2016

/s/    Anthony K. Anderson

        Anthony K. Anderson

 

Director

 

February 24, 2016

/s/    Peter K. Barker

        Peter K. Barker

 

Director

 

February 24, 2016

/s/    Ken C. Hicks

        Ken C. Hicks

 

Director

 

February 24, 2016

/s/    David E. I. Pyott

        David E. I. Pyott

 

Director

 

February 24, 2016

/s/    Patrick T. Siewert

        Patrick T. Siewert

 

Director

 

February 24, 2016

/s/    Julia A. Stewart

        Julia A. Stewart

 

Director

 

February 24, 2016

/s/    Martha N. Sullivan

        Martha N. Sullivan

 

Director

 

February 24, 2016

26


Table of Contents


AVERY DENNISON CORPORATION

INDEX TO FINANCIAL STATEMENTS

Data incorporated by reference from the attached portions of the 2015 Annual Report to Shareholders of Avery Dennison Corporation:

 

Consolidated Financial Statements:

   
 

Consolidated Balance Sheets as of January 2, 2016 and January 3, 2015

   
 

Consolidated Statements of Income for 2015, 2014 and 2013

   
 

Consolidated Statements of Comprehensive Income for 2015, 2014 and 2013

   
 

Consolidated Statements of Shareholders' Equity for 2015, 2014 and 2013

   
 

Consolidated Statements of Cash Flows for 2015, 2014 and 2013

   
 

Notes to Consolidated Financial Statements

   
 

Statement of Management Responsibility for Financial Statements and Management's Report on Internal Control Over Financial Reporting

   
 

Report of Independent Registered Public Accounting Firm

   

        Except for the Consolidated Financial Statements, Statement of Management Responsibility for Financial Statements, Management's Report on Internal Control Over Financial Reporting and Report of Independent Registered Public Accounting Firm listed above, and certain information referred to in Items 1, 5, 6, 7, and 7A of this report that is expressly incorporated herein by reference, our 2015 Annual Report to Shareholders is not to be deemed "filed" as part of this report.

S-1


Table of Contents


AVERY DENNISON CORPORATION

EXHIBIT INDEX

For the Year Ended January 2, 2016

Exhibit No.
  Exhibit Name   Originally
Filed as
Exhibit No.
  Filing(1)
2.1   Purchase Agreement, dated as of January 29, 2013, by and among CCL Industries, Inc. ("CCL"), a corporation organized under the laws of Canada, those subsidiaries of CCL to be designated pursuant to Section 5.8 thereof, Registrant, and those subsidiaries of Registrant listed in Annex A thereof   2.1   Current Report on Form 8-K, filed January 30, 2013

2.2

 

Amendment to Purchase Agreement, dated as of July 1, 2013, by and between Registrant and CCL

 

2.1

 

Current Report on Form 8-K, filed July 1, 2013

3.1(i)

 

Amended and Restated Certificate of Incorporation, as filed on April 28, 2011 with the Office of Delaware Secretary of State

 

3.1

 

Current Report on Form 8-K, filed April 29, 2011

3.1(ii)

 

Amended and Restated Bylaws, effective as of October 22, 2015

 

3.1(ii)

 

Current Report on Form 10-Q, filed November 3, 2015

4.1

 

Indenture, dated as of March 15, 1991, between Registrant and Security Pacific National Bank, as Trustee (the "1991 Indenture")

 

4.1

 

Registration Statement on Form S-3 (File No. 33-39491), filed March 19, 1991

4.2

 

First Supplemental Indenture, dated as of March 16, 1993, between Registrant and BankAmerica National Trust Company, as successor Trustee (the "Supplemental Indenture")

 

4.4

 

Registration Statement on Form S-3 (File No. 33-59642), filed March 17, 1993

4.3

 

Officers' Certificate establishing a series of Securities entitled "Medium-Term Notes, Series C" under the 1991 Indenture, as amended by the Supplemental Indenture

 

4.1

 

Current Report on Form 8-K, filed May 12, 1995

4.4

 

Officers' Certificate establishing a series of Securities entitled "Medium-Term Notes, Series D" under the 1991 Indenture, as amended by the Supplemental Indenture

 

4.1

 

Current Report on Form 8-K, filed December 16, 1996

i


Table of Contents

Exhibit No.
  Exhibit Name   Originally
Filed as
Exhibit No.
  Filing(1)
4.5   Indenture, dated as of July 3, 2001, between Registrant and Chase Manhattan Bank and Trust Company, National Association, as trustee ("2001 Indenture")   4.1   Registration Statement on Form S-3 (File No. 333-64558), filed July 3, 2001

4.6

 

Officers' Certificate establishing two series of Securities entitled "4.875% Notes due 2013" and "6.000% Notes due 2033" under the 2001 Indenture

 

4.2

 

Current Report on Form 8-K, filed January 16, 2003

4.7

 

6.000% Notes Due 2033

 

4.4

 

Current Report on Form 8-K, filed January 16, 2003

4.8

 

Indenture, dated as of September 25, 2007, among Avery Dennison Office Products Company ("ADOPC"), Registrant and The Bank of New York Trust Company, N.A., as Trustee ("Bank of NY")

 

99.1

 

Current Report on Form 8-K, filed October 1, 2007

4.9

 

Form of 6.625% Guaranteed Notes due 2017

 

99.1

 

Current Report on Form 8-K, filed October 1, 2007

4.10

 

Indenture, dated as of November 20, 2007, between Registrant and Bank of NY

 

4.2

 

Current Report on Form 8-K, filed November 20, 2007

4.11

 

First Supplemental Indenture, dated as of November 20, 2007, between Registrant and Bank of NY

 

4.3

 

Current Report on Form 8-K, filed November 20, 2007

4.12

 

Second Supplemental Indenture, dated as of April 13, 2010, between Registrant and Bank of NY

 

4.2

 

Current Report on Form 8-K, filed April 13, 2010

4.13

 

Form of 5.375% Senior Notes due 2020

 

4.3

 

Current Report on Form 8-K, filed April 13, 2010

4.14

 

Third Supplemental Indenture, dated as of April 8, 2013, between Registrant and Bank of NY

 

4.2

 

Current Report on Form 8-K, filed April 8, 2013

4.15

 

Form of 3.35% Senior Notes due 2023

 

4.3

 

Current Report on Form 8-K, filed April 8, 2013

10.1

 

Amended and Restated Credit Agreement, dated as of February 8, 2008, among ADOPC, Registrant, Bank of America, N.A. and Banc of America Securities LLC and JP Morgan Securities Inc. ("ADOPC Credit Agreement")

 

10.1

 

Quarterly Report on Form 10-Q, filed August 7, 2008

ii


Table of Contents

Exhibit No.
  Exhibit Name   Originally
Filed as
Exhibit No.
  Filing(1)
10.2   Second Amendment, dated as of January 23, 2009, to ADOPC Credit Agreement   99.4   Current Report on Form 8-K, filed January 27, 2009

10.3

 

Third Amended and Restated Credit Agreement, dated as of October 3, 2014, by and among Registrant, Bank of America, N.A., Citibank, N.A. and JPMorgan Chase Bank, N.A. and the other lenders party thereto

 

10.1

 

Current Report on Form 8-K, filed October 3, 2014

10.4*

 

Deferred Compensation Plan for Directors

 

10.3

 

1981 Annual Report on Form 10-K, filed February 29, 1982

10.5*

 

Amended and Restated Supplemental Executive Retirement Plan ("SERP")

 

10.11.1

 

Quarterly Report on Form 10-Q, filed August 12, 2009

10.6*

 

Letter of Grant to D.A. Scarborough under SERP

 

10.11.2.1

 

Quarterly Report on Form 10-Q, filed August 12, 2009

10.7*

 

Letter Agreement with D.A. Scarborough regarding SERP benefits

 

10.11.2.1

 

Current Report on Form 8-K, filed December 15, 2010

10.8*

 

Complete Restatement and Amendment of Executive Deferred Compensation Plan

 

10.12

 

1994 Annual Report on Form 10-K, filed March 30, 1995

10.9*

 

Amended and Restated Retirement Plan for Directors

 

10.13.1

 

2002 Annual Report on Form 10-K, filed March 28, 2003

10.10*

 

Amended and Restated Director Equity Plan ("Director Plan")

 

10.15.1

 

Current Report on Form 8-K, filed December 11, 2008

10.11*

 

Form of Non-Employee Director Stock Option Agreement under Director Plan

 

10.15.1

 

2003 Annual Report on Form 10-K, filed March 11, 2004

10.12*

 

Complete Restatement and Amendment of Executive Variable Deferred Compensation Plan ("EVDCP")

 

10.16

 

1994 Annual Report on Form 10-K, filed March 30, 1995

10.13*

 

Amendment No. 1 to EVDCP

 

10.16.1

 

1999 Annual Report on Form 10-K, filed March 30, 2000

10.14*

 

Complete Restatement and Amendment of Directors Deferred Compensation Plan

 

10.17

 

1994 Annual Report on Form 10-K, filed March 30, 1995

10.15*

 

Amended and Restated 2005 Directors Variable Deferred Compensation Plan

 

10.18.2

 

Quarterly Report on Form 10-Q, filed May 10, 2011

iii


Table of Contents

Exhibit No.
  Exhibit Name   Originally
Filed as
Exhibit No.
  Filing(1)
10.16*   Amended and Restated Stock Option and Incentive Plan ("Equity Plan")   A   2012 Proxy Statement on Schedule 14A, filed March 9, 2012

10.17*

 

First Amendment to Equity Plan

 

10.20

 

2014 Annual Report on Form 10-K, filed February 25, 2015

10.18*

 

Forms of NQSO Agreement under Equity Plan

 

10.19.5

 

2007 Annual Report on Form 10-K, filed February 27, 2008

10.19*

 

Forms of Equity Agreements under Equity Plan

 

10.19.6

 

Current Report on Form 8-K, filed April 30, 2008

10.20*

 

Forms of Equity Agreements under Equity Plan

 

10.10.19.9

 

Current Report on Form 8-K, filed December 11, 2008

10.21*

 

Additional Forms of Equity Agreements under Equity Plan

 

10.19.10

 

Current Report on Form 8-K/A, filed December 11, 2008

10.22*

 

Senior Executive Annual Incentive Plan

 

A

 

2014 Proxy Statement on Schedule 14A, filed March 7, 2014

10.23*

 

Annual Incentive Plan

 

10.26

 

2014 Annual Report on Form 10-K, filed February 25, 2015

10.24*

 

Complete Restatement and Amendment of Executive Deferred Retirement Plan ("EDRP")

 

10.28

 

1994 Annual Report on Form 10-K, filed March 30, 1995

10.25*

 

Amendment No. 1 to EDRP

 

10.28.1

 

1999 Annual Report on Form 10-K, filed March 30, 2000

10.26*

 

Amendment No. 2 to EDRP

 

10.28.2

 

2001 Annual Report on Form 10-K, filed March 4, 2002

10.27*

 

2005 Executive Variable Deferred Retirement Plan, amended and restated

 

10.1

 

Quarterly Report on Form 10-Q, filed May 7, 2013

10.28*

 

Benefit Restoration Plan, amended and restated ("BRP")

 

10.32.1

 

Current Report on Form 8-K/A, filed December 11, 2008

10.29*

 

First Amendment to BRP

 

10.32.1

 

2010 Annual Report on Form 10-K, filed February 28, 2011

10.30*

 

Amended and Restated Capital Accumulation Plan ("CAP")

 

10.34

 

1999 Annual Report on Form 10-K, filed March 30, 2000

10.31*

 

Amendment No. 1 to CAP

 

10.34.2

 

1999 Annual Report on Form 10-K, filed March 30, 2000

10.32*

 

Key Executive Change of Control Severance Plan

 

10.35

 

Quarterly Report on Form 10-Q, filed May 10, 2011

10.33*

 

Executive Severance Plan

 

10.36

 

Quarterly Report on Form 10-Q, filed May 10, 2011

iv


Table of Contents

Exhibit No.
  Exhibit Name   Originally
Filed as
Exhibit No.
  Filing(1)
10.34*   Long-Term Incentive Unit Plan   10.43   2012 Annual Report on Form 10-K, filed February 27, 2013

10.35*

 

Form of Restricted Stock Unit Agreement

 

10.38

 

2013 Annual Report on Form 10-K, filed February 26, 2014

10.36*

 

Form of Performance Unit Agreement

 

10.39

 

2013 Annual Report on Form 10-K, filed February 26, 2014

10.37*

 

Form of Market-Leveraged Stock Unit Agreement

 

10.40

 

2013 Annual Report on Form 10-K, filed February 26, 2014

10.38*

 

Form of Long-Term Incentive Unit Agreement

 

10.41

 

2013 Annual Report on Form 10-K, filed February 26, 2014

10.39*

 

Form of Performance Long-Term Incentive Unit Agreement

 

10.42

 

2013 Annual Report on Form 10-K, filed February 26, 2014

10.40*

 

Form of Director Restricted Stock Unit Agreement

 

10.43

 

2013 Annual Report on Form 10-K, filed February 26, 2014

10.41*

 

Offer Letter to Anne Bramman

 

10.46

 

2014 Annual Report on Form 10-K, filed February 25, 2015

10.42*

 

Offer Letter to Georges Gravanis

 

10.1

 

Quarterly Report on Form 10-Q, filed May 5, 2015

12†

 

Computation of Ratio of Earnings to Fixed Charges

 

N/A

 

N/A

13†

 

Portions of Annual Report to Shareholders for fiscal year ended January 2, 2016

 

N/A

 

N/A

21†

 

List of Subsidiaries

 

N/A

 

N/A

23†

 

Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm

 

N/A

 

N/A

24†

 

Power of Attorney (see Signatures – Power of Attorney)

 

N/A

 

N/A

31.1†

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

N/A

 

N/A

31.2†

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

N/A

 

N/A

32.1†

 

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

N/A

 

N/A

v


Table of Contents

Exhibit No.
  Exhibit Name   Originally
Filed as
Exhibit No.
  Filing(1)
32.2†   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   N/A   N/A

101INS

 

XBRL Instance Filing

 

N/A

 

N/A

101SCH

 

XBRL Extension Schema Filing

 

N/A

 

N/A

101CAL

 

XBRL Extension Calculation Linkbase Filing

 

N/A

 

N/A

101LAB

 

XBRL Extension Label Linkbase Filing

 

N/A

 

N/A

101PRE

 

XBRL Extension Presentation Linkbase Filing

 

N/A

 

N/A

101DEF

 

XBRL Extension Definition Linkbase Filing

 

N/A

 

N/A

(1)
Unless otherwise noted, the File Number for all filings is File No. 1-7685.
*
Management contract or compensatory plan or arrangement required to be filed as an exhibit to this Form 10-K pursuant to Item 15(b) of Form 10-K.
Filed herewith.

vi




Exhibit 12

 

AVERY DENNISON CORPORATION AND SUBSIDIARIES

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in millions)

 

 

 

2015

 

2014

 

2013

 

Earnings:

 

 

 

 

 

 

 

Income from continuing operations before taxes(2)

 

$

408.9

 

$

360.8

 

$

366.0

 

Add:   Fixed charges(1)

 

83.8

 

90.7

 

89.8

 

Amortization of capitalized interest

 

4.6

 

3.9

 

3.8

 

Less:  Capitalized interest

 

(3.0

)

(3.9

)

(3.4

)

 

 

$

494.3

 

$

451.5

 

$

456.2

 

Fixed charges:(1)

 

 

 

 

 

 

 

Interest expense(2)

 

$

60.5

 

$

63.3

 

$

60.8

 

Capitalized interest

 

3.0

 

3.9

 

3.4

 

Interest portion of leases

 

20.3

 

23.5

 

25.6

 

 

 

$

83.8

 

$

90.7

 

$

89.8

 

 

 

 

 

 

 

 

 

Ratio of Earnings to Fixed Charges

 

5.9

 

5.0

 

5.1

 

 

 

(1)          The ratios of earnings to fixed charges were computed by dividing earnings by fixed charges.  For this purpose, “earnings” consist of income from continuing operations before taxes plus fixed charges and amortization of capitalized interest, less capitalized interest.  “Fixed charges” consist of interest expense, capitalized interest and the portion of rent expense (estimated to be 35%) on operating leases deemed representative of interest.

(2)          Certain prior period amounts have been revised to reflect the impact of certain adjustments and to correct the timing of previously recorded out-of-period adjustments.

 




Use these links to rapidly review the document
Management's Discussion and Analysis of Financial Condition and Results of Operations


EXHIBIT 13


Businesses at a Glance

 
  Segment   Segment   Segment
    Pressure-sensitive Materials   Retail Branding and Information Solutions   Vancive Medical Technologies
BUSINESSES   Materials Group
Performance Tapes
  Retail Branding and Information Solutions
Printer and Fastener Solutions
  Vancive Medical Technologies
2015 SALES IN MILLIONS   $4,374   $1,520   $73
% OF SALES   73%   26%   1%
GLOBAL BRAND   Avery Dennison®   Avery Dennison®
Monarch®
  Vancive Medical Technologies®
DESCRIPTION   The technologies and materials of our Pressure-sensitive Materials businesses enhance brands' shelf, store and street appeal; inform shoppers of ingredients; protect brand security; improve operational efficiency and customer product performance; and provide visual information that enhances safety   RBIS provides intelligent, creative, and sustainable solutions that elevate brands and accelerate performance through the global retail supply chain   Vancive Medical Technologies addresses the unmet needs of medical device manufacturers, clinicians and patients worldwide through its focus on critical skin contact applications including wound care, ostomy and surgical products.
PRODUCTS/SOLUTIONS   Pressure-sensitive labeling materials; packaging materials and solutions; roll-fed sleeve; performance polymer adhesives and engineered films; graphic imaging media; reflective materials; pressure-sensitive tapes for automotive, building and construction; electronics; general industrial; diaper tapes and closures   Creative services; brand embellishments; graphic tickets; tags and labels; sustainable packaging; inventory visibility and loss prevention solutions; data management services; price tickets; printers and scanners; radio-frequency identification (RFID) inlays; fasteners; brand protection and security solutions   Skin-contact adhesives; surgical, wound care, ostomy and securement products; medical barrier films
MARKET SEGMENTS   Food; beverage; wine and spirits; home and personal care products; pharmaceuticals; durables; fleet vehicle/automotive; architectural/ retail; promotional/advertising; traffic; safety; transportation; original equipment manufacturing; personal care; electronics; building and construction   Apparel manufacturing and retail supply chain; food service and supply chain; hard goods and supply chain; pharmaceutical supply chain; logistics   Medical
CUSTOMERS   Label converters; package designers; packaging engineers and manufacturers; industrial manufacturers; printers; distributors; designers; advertising agencies; government agencies; sign manufacturers; graphic vendors; tape converters; original equipment manufacturers; original design manufacturers; construction firms; personal care product manufacturers   Apparel and footwear brands; manufacturers and retailers; food service, grocery and pharmaceutical supply chains; consumer goods brands; automotive manufacturers; transportation companies   Medical device manufacturers
WEBSITES   www.label.averydennison.com
www.graphics.averydennison.com
www.reflectives.averydennison.com
www.tapes.averydennison.com
  www.rbis.averydennison.com
www.rfid.averydennison.com
  www.vancive.averydennison.com
LEADERS   Georges Gravanis, President, Materials Group
 
Michael Johansen, Vice President and General Manager, Performance Tapes
  Deon Stander Vice President/General Manager Retail Branding and Information Solutions
  
Erik Schafer
Global Vice President
Printer and Fastener Solutions
  Howard Kelly, Vice President and General Manager, Vancive Medical Technologies


Avery Dennison Corporation

Safe Harbor Statement

        The matters discussed in this Annual Report contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, which may or may not occur. Words such as "aim," "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "foresee," "guidance," "intend," "may," "might," "objective," "plan," "potential," "project," "seek," "shall," "should," "target," "will," "would," or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties, which could cause our actual results to differ materially from the expected results, performance or achievements expressed or implied by such forward-looking statements.

        Certain risks and uncertainties are discussed in more detail under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the fiscal year ended January 2, 2016 and include, but are not limited to, risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; worldwide and local economic conditions; fluctuations in currency exchange rates and other risks associated with foreign operations, including in emerging markets; the financial condition and inventory strategies of customers; changes in customer preferences; fluctuations in cost and availability of raw materials; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; the impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; integration of acquisitions and completion of potential dispositions; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; fluctuations in pension, insurance, and employee benefit costs; impact of legal and regulatory proceedings, including with respect to environmental, health and safety; changes in governmental laws and regulations; protection and infringement of intellectual property; changes in political conditions; the impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.

        We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impacts of economic conditions on underlying demand for our products and foreign currency fluctuations; (2) competitors' actions, including pricing, expansion in key markets, and product offerings; and (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume.

        Our forward-looking statements are made only as of the date hereof. We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.

11        Avery Dennison Corporation 2015 Annual Report


Avery Dennison Corporation

Five-Year Summary

(Dollars in millions, except percentages

    2015           2014  (1)(2)         2013  (2)         2012  (2)         2011  (2)      

and per share amounts)

    Dollars     %     Dollars     %     Dollars     %     Dollars     %     Dollars     %  

For the Year

                                                             

Net sales

  $ 5,966.9     100.0   $ 6,330.3     100.0   $ 6,140.0     100.0   $ 5,863.5     100.0   $ 5,844.9     100.0  

Gross profit

    1,645.8     27.6     1,651.2     26.1     1,637.7     26.7     1,529.5     26.1     1,474.0     25.2  

Marketing, general and administrative expense

    1,108.1     18.6     1,158.9     18.3     1,174.2     19.1     1,152.6     19.7     1,142.5     19.5  

Interest expense

    60.5     1.0     63.3     1.0     60.9     1.0     72.5     1.2     70.7     1.2  

Other expense, net (3)

    68.3     1.1     68.2     1.1     36.6     .6     68.8     1.2     51.6     .9  

Income from continuing operations before taxes

    408.9     6.9     360.8     5.7     366.0     6.0     235.6     4.0     209.2     3.6  

Provision for income taxes

    134.5     2.3     113.5     1.8     124.3     2.0     76.1     1.3     66.1     1.1  

Income from continuing operations

    274.4     4.6     247.3     3.9     241.7     3.9     159.5     2.7     143.1     2.4  

(Loss) income from discontinued operations, net of tax

    (.1 )   N/A     (2.2 )   N/A     (28.5 )   N/A     57.8     N/A     48.4     N/A  

Net income

    274.3     4.6     245.1     3.9     213.2     3.5     217.3     3.7     191.5     3.3  

   
2015
   
 
   
2014
   
 
   
2013
   
 
   
2012
   
 
   
2011
       

Per Share Information

                                                             

Income per common share from continuing operations

  $ 3.01         $ 2.64         $ 2.46         $ 1.56         $ 1.35        

Income per common share from continuing operations, assuming dilution

    2.95           2.58           2.41           1.54           1.34        

(Loss) income per common share from discontinued operations

              (.03 )         (.29 )         .56           .46        

(Loss) income per common share from discontinued operations, assuming dilution

              (.02 )         (.28 )         .56           .45        

Net income per common share

    3.01           2.61           2.17           2.12           1.81        

Net income per common share, assuming dilution

    2.95           2.56           2.13           2.10           1.79        

Dividends per common share

    1.46           1.34           1.14           1.08           1.00        

Weighted average number of common shares outstanding (in millions)

    91.0           93.8           98.4           102.6           105.8        

Weighted average number of common shares outstanding, assuming dilution (in millions)

    92.9           95.7           100.1           103.5           106.8        

Market price per share at fiscal year-end

  $ 62.66         $ 51.79         $ 50.48         $ 34.40         $ 28.68        

Market price per share range

    51.07 to
66.18
          41.28 to
52.67
          34.92 to
50.65
          26.38 to
34.97
          23.97 to
43.11
       

At End of Year

                                                             

Property, plant and equipment, net (4)

  $ 847.9         $ 875.3         $ 922.5         $ 1,015.5         $ 1,079.4        

Total assets (5)

    4,133.7           4,356.9           4,608.3           5,113.2           4,989.7        

Long-term debt and capital leases (4)(6)

    963.6           940.1           944.6           697.6           948.7        

Total debt (4)(6)

    1,058.9           1,144.4           1,021.5           1,217.8           1,175.8        

Shareholders' equity (5)

    965.7           1,047.7           1,468.1           1,536.6           1,614.7        

Other Information

                                                             

Depreciation and amortization expense (4)

  $ 188.3         $ 201.6         $ 204.3         $ 211.0         $ 220.0        

Research and development expense (4)

    91.9           102.5           96.0           98.6           93.8        

Effective tax rate (4)

   
32.9

%
       
31.5

%
       
34.0

%
       
32.3

%
       
31.6

%
     
(1)
Results for 2014 reflected a 53-week period.
(2)
Certain prior period amounts have been revised to reflect the impact of certain adjustments and to correct the timing of previously recorded out-of-period adjustments.
(3)
Included pre-tax charges for severance and related costs, asset impairment, lease and other contract cancellation charges, and other items.
(4)
Amounts are for continuing operations only.
(5)
Amounts are for continuing and discontinued operations.
(6)
In the fourth quarter of 2015, we elected to adopt the revised guidance on the presentation of debt issuance costs earlier than required. This revised guidance requires that debt issuance costs related to a recognized debt liability be classified as a direct deduction from the carrying amount of that debt liability instead of being recorded separately in other assets. The new guidance was applied on a retrospective basis and prior period amounts have been reclassified to conform to the current year presentation.
12

Stockholder Return Performance

        The following graph compares the cumulative stockholder return on our common stock, including the reinvestment of dividends, with the return on the S&P 500® Stock Index, the average return (weighted by market capitalization) of the S&P 500® Materials and Industrials subsets (the "Market Basket"), and the median return of the Market Basket, in each case for the five-year period ending December 31, 2015.

Comparison of Five-Year Cumulative Total Return as of December 31, 2015

GRAPHIC

Total Return Analysis (1)

 
  12/31/2010
  12/31/2011
  12/31/2012
  12/31/2013
  12/31/2014
  12/31/2015
 

Avery Dennison Corporation

  $ 100.00   $ 64.10   $ 79.00   $ 109.71   $ 116.32   $ 141.12  

S&P 500 Index

    100.00     102.09     117.25     150.14     169.40     171.73  

Market Basket (Weighted Average) (2)

    100.00     97.10     126.68     203.74     248.02     240.43  

Market Basket (Median)

    100.00     96.73     113.90     153.00     169.72     156.24  
(1)
Assumes $100 invested on December 31, 2010 and the reinvestment of dividends.
(2)
Average weighted by market capitalization.

        Historical stock price performance is not necessarily indicative of future stock price performance.

13        Avery Dennison Corporation 2015 Annual Report


Management's Discussion and Analysis of Financial Condition and Results of Operations

ORGANIZATION OF INFORMATION

        Management's Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides management's views on our financial condition and results of operations, should be read in conjunction with the accompanying Consolidated Financial Statements and notes thereto, and includes the following sections:

Non-GAAP Financial Measures

  14

Overview and Outlook

  14

Analysis of Results of Operations

  16

Results of Operations by Reportable Segment

  18

Financial Condition

  19

Critical Accounting Estimates

  23

Recent Accounting Requirements

  26

Market-Sensitive Instruments and Risk Management

  26

NON-GAAP FINANCIAL MEASURES

        We report financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from our investors and financial analysts, we believe that supplemental non-GAAP financial measures provide information that is useful to the assessment of our performance and operating trends, as well as liquidity. The measures we use may not be comparable to similarly named non-GAAP measures used by other companies.

        Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. By excluding certain accounting effects, both positive and negative, of certain items, we believe that we are providing meaningful supplemental information to facilitate an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing.

        We use the following non-GAAP financial measures in this MD&A:

OVERVIEW AND OUTLOOK

Fiscal Year

        Normally, our fiscal years consist of 52 weeks, but every fifth or sixth fiscal year consists of 53 weeks. Our 2015 and 2013 fiscal years consisted of 52-week periods ending January 2, 2016 and December 28, 2013, respectively. Our 2014 fiscal year consisted of a 53-week period ending January 3, 2015.

Prior Period Financial Statement Revision

        Certain prior period amounts have been revised to reflect the impact of certain adjustments. Refer to Note 1, "General," to the Consolidated Financial Statements for more information.

Net Sales

 
  2015
  2014
 

Estimated change in sales due to

             

Organic sales change

    5 %   3 %

Foreign currency translation

    (9 )   (1 )

Extra week in 2014 fiscal year

    (1 )   1  

Product line divestiture

    (1 )    

Reported sales change

    (6 )%   3 %
14


Management's Discussion and Analysis of Financial Condition and Results of Operations

        In both years, sales increased on an organic basis primarily due to higher volume.

Income from Continuing Operations

        Income from continuing operations increased from approximately $247 million in 2014 to approximately $274 million in 2015. Major factors affecting the change in income from continuing operations in 2015 compared to 2014 included:

        Positive factors:

        Offsetting factors:

Cost Reduction Actions

2015/2016 Actions

        In 2015, we recorded $26.1 million in restructuring charges, net of reversals, related to restructuring actions initiated during the third quarter of 2015 ("2015/2016 Actions"), which we expect to continue through 2016. These charges consisted of severance and related costs for the reduction of approximately 430 positions, lease cancellation costs, and asset impairment charges.

        No employees impacted by our 2015/2016 Actions taken through January 2, 2016 remained employed with us as of such date. We expect charges and payments related to these actions to be substantially completed in 2016.

2014/2015 Actions

        In 2015, we recorded $33.4 million in restructuring charges, net of reversals, related to restructuring actions we initiated in 2014 that continued through the second quarter of 2015 ("2014/2015 Actions"). These charges consisted of severance and related costs for the reduction of approximately 605 positions, lease cancellation costs, and asset impairment charges.

        In 2014, we recorded $66.5 million in restructuring charges, net of reversals, related to our 2014/2015 Actions. These charges consisted of severance and related costs for the reduction of approximately 1,420 positions, lease cancellation costs, and asset impairment charges.

        Approximately 125 employees impacted by our 2014/2015 Actions remained employed with us as of January 2, 2016. We expect charges and payments related to these actions to be substantially completed in 2016.

Impact of Cost Reduction Actions

        In 2015, we realized approximately $70 million in savings, net of transition costs, from our 2015/2016 Actions and 2014/2015 Actions. We anticipate incremental savings of approximately $75 million in 2016.

        Restructuring charges were included in "Other expense, net" in the Consolidated Statements of Income. Refer to Note 13, "Cost Reduction Actions," to the Consolidated Financial Statements for more information.

Free Cash Flow

(In millions)
  2015
  2014
  2013
 

Net cash provided by operating activities

  $ 473.7   $ 354.9   $ 319.6  

Purchases of property, plant and equipment

    (135.8 )   (147.9 )   (129.2 )

Purchases of software and other deferred charges

    (15.7 )   (27.1 )   (52.2 )

Proceeds from sales of property, plant and equipment

    7.6     4.3     38.7  

(Purchases) sales of investments, net

    (.5 )   .3     .1  

Plus: charitable contribution to Avery Dennison Foundation utilizing proceeds from divestitures

            10.0  

Plus: discretionary contributions to pension plans utilizing proceeds from divestitures

            50.1  

Plus: divestiture-related payments and free cash outflow from discontinued operations

    .1     .2     92.7  

Free cash flow

  $ 329.4   $ 184.7   $ 329.8  

        Free cash flow in 2015 increased compared to 2014 primarily due to the timing of vendor payments, higher operating income, lower incentive compensation paid in 2015 for the 2014 performance year, and lower capital and software expenditures, partially offset by the timing of collections from customers and higher payments for taxes.

        Free cash flow in 2014 decreased compared to 2013 primarily due to higher working capital requirements (including larger than usual differences in the year-end timing of vendor payments and customer receipts), the impact of currency fluctuations, higher bank draft balances, and higher incentive compensation paid in 2014 for the 2013 performance year, partially offset by lower income tax payments and lower pension contributions (excluding discretionary pension plan contributions utilizing proceeds from divestitures).

        In 2013, we completed the sale of our former Office and Consumer Products ("OCP") and Designed and Engineered Solutions ("DES") businesses. Refer to Note 2, "Discontinued Operations, Sale of Product Line, and Sale of Assets," to the Consolidated Financial Statements for more information.

        See "Analysis of Results of Operations" and "Liquidity" for more information.

Outlook

        Certain factors that we believe may contribute to results for 2016 are described below:

15        Avery Dennison Corporation 2015 Annual Report


Management's Discussion and Analysis of Financial Condition and Results of Operations

ANALYSIS OF RESULTS OF OPERATIONS

Income from Continuing Operations Before Taxes

(In millions, except percentages)
  2015
  2014
  2013
 

Net sales

  $ 5,966.9   $ 6,330.3   $ 6,140.0  

Cost of products sold

    4,321.1     4,679.1     4,502.3  

Gross profit

    1,645.8     1,651.2     1,637.7  

Marketing, general and administrative expense

    1,108.1     1,158.9     1,174.2  

Interest expense

    60.5     63.3     60.9  

Other expense, net

    68.3     68.2     36.6  

Income from continuing operations before taxes

  $ 408.9   $ 360.8   $ 366.0  

 
   
   
   
 

As a Percentage of Sales

                   

Gross profit

    27.6 %   26.1 %   26.7 %

Gross Profit Margin

        Gross profit margin in 2015 improved compared to 2014 primarily reflecting benefits from productivity initiatives, including savings from restructuring, net of transition costs, higher volume, the impact of changes in foreign currency rates, and the net impact of pricing and raw material input costs, partially offset by higher employee-related costs and changes in product mix in our RBIS reportable segment.

        Gross profit margin in 2014 declined compared to 2013 primarily reflecting changes in segment and product mix, the impact of pricing and raw material input costs, and higher employee-related costs, partially offset by benefits from productivity initiatives, including savings from restructuring, and higher volume.

Marketing, General and Administrative Expense

        Marketing, general and administrative expense decreased in 2015 compared to 2014 reflecting the impact of currency and benefits from productivity initiatives, including savings from restructuring, net of transition costs, partially offset by higher employee-related costs.

        Marketing, general and administrative expense decreased in 2014 compared to 2013 due to benefits from productivity initiatives, including savings from restructuring, partially offset by higher employee-related costs.

Interest Expense

        Interest expense decreased approximately $3 million in 2015 compared to 2014 reflecting a decrease in foreign short-term debt, the extra week in our 2014 fiscal year, and maturation of a medium-term note, partially offset by an increase in commercial paper borrowings.

        Interest expense increased approximately $2 million in 2014 compared to 2013 reflecting the impact of timing between maturation and issuance of senior notes in the prior year, as well as the extra week in our 2014 fiscal year.

Other Expense, net

(In millions)
  2015
  2014
  2013
 

Other expense, net by type

                   

Restructuring charges:

                   

Severance and related costs

  $ 52.5   $ 54.7   $ 27.2  

Asset impairment charges and lease and other contract cancellation costs

    7.0     11.4     13.1  

Other items:

                   

Charitable contribution to Avery Dennison Foundation

            10.0  

Indefinite-lived intangible asset impairment charge

        3.0      

Gains on sales of assets

    (1.7 )   (2.5 )   (17.8 )

Net loss (gain) from curtailment and settlement of pension obligations

    .3     1.6     (1.6 )

Legal settlements

    (.3 )       2.5  

Loss on sale of a product line and related exit costs

    10.5          

Divestiture-related costs (1)

            3.2  

Other expense, net

  $ 68.3   $ 68.2   $ 36.6  
(1)
Represents only the portion allocated to continuing operations.

        Refer to Note 13, "Cost Reduction Actions," to the Consolidated Financial Statements for more information regarding charges associated with restructuring.

        Refer to Note 6, "Pension and Other Postretirement Benefits," to the Consolidated Financial Statements for more information regarding losses (gains) from curtailment and settlement of pension obligations.

        Refer to Note 2, "Discontinued Operations, Sale of Product Line, and Sale of Assets," to the Consolidated Financial Statements for more information regarding the loss on sale of a product line and related exit costs.

Net Income and Earnings per Share

(In millions, except percentages and per share amounts)
  2015
  2014
  2013
 

Income from continuing operations before taxes

  $ 408.9   $ 360.8   $ 366.0  

Provision for income taxes

    134.5     113.5     124.3  

Income from continuing operations

    274.4     247.3     241.7  

Loss from discontinued operations, net of tax

    (.1 )   (2.2 )   (28.5 )

Net income

  $ 274.3   $ 245.1   $ 213.2  

Net income per common share

  $ 3.01   $ 2.61   $ 2.17  

Net income per common share, assuming dilution

    2.95     2.56     2.13  

Effective tax rate for continuing operations

   
32.9

%
 
31.5

%
 
34.0

%
16


Management's Discussion and Analysis of Financial Condition and Results of Operations

Provision for Income Taxes

        The 2015 effective tax rate for continuing operations included the following: tax expense of $20 million associated with the tax cost to repatriate non-permanently reinvested 2015 earnings of certain foreign subsidiaries; tax benefits for changes in certain tax reserves, including interest and penalties, of $5.8 million resulting from settlements of audits and $8.2 million resulting from lapses and statute expirations; and a tax benefit of $2.6 million from the extension of the federal research and development credit.

        The 2014 effective tax rate for continuing operations included the following: tax benefits for changes in certain tax reserves, including interest and penalties, of $10.2 million resulting from settlements of audits and $18.1 million resulting from lapses and statute expirations; a repatriation tax benefit of $9.8 million related to certain foreign losses; tax expense of $9.1 million from the taxable inclusion of a net foreign currency gain related to the revaluation of certain intercompany loans; tax expense of $10.6 million related to our change in estimate of the potential outcome of uncertain tax issues in China and Germany; and state tax expense of $2.5 million primarily related to gains arising as a result of certain foreign reorganizations.

        The 2013 effective tax rate for continuing operations reflected $11 million of benefit from adjustments to federal income tax, primarily due to the enactment of the American Taxpayer Relief Act of 2012 ("ATRA"), and $24.9 million of net expense related to changes in certain tax reserves and valuation allowances. Additionally, the effective tax rate for 2013 reflected a benefit of $11.2 million from favorable tax rates on certain earnings from our operations in lower-tax jurisdictions throughout the world, offset by $12.1 million of expense related to the accrual of U.S. taxes on certain foreign earnings.

        On December 18, 2015, the Protecting Americans from Tax Hikes Act of 2015 ("PATH Act") was enacted, which included a provision making permanent the federal research and development tax credit for tax years 2015 and beyond. The PATH Act also retroactively extended the controlled foreign corporation ("CFC") look-through rule that had expired on December 31, 2014. For periods in which the look-though rule was effective, U.S. federal income tax on certain dividends, interest, rents, and royalties received or accrued by a CFC of a U.S. multinational enterprise from a related CFC are deferred. The retroactive effects of the extension of the CFC look-through rule did not have a material impact on our effective tax rate or operating results. The extension of the CFC look-through rule is currently scheduled to expire on December 31, 2019.

        Refer to Note 14, "Taxes Based on Income," to the Consolidated Financial Statements for more information.

17        Avery Dennison Corporation 2015 Annual Report


Management's Discussion and Analysis of Financial Condition and Results of Operations

RESULTS OF OPERATIONS BY REPORTABLE SEGMENT

        Operating income (loss) refers to income (loss) from continuing operations before interest and taxes.

Pressure-sensitive Materials

(In millions)
  2015
  2014
  2013
 

Net sales including intersegment sales

  $ 4,434.6   $ 4,721.3   $ 4,519.6  

Less intersegment sales

    (60.9 )   (63.2 )   (64.6 )

Net sales

  $ 4,373.7   $ 4,658.1   $ 4,455.0  

Operating income (1)

    496.6     434.4     442.8  

(1) Included charges associated with restructuring in all years, gain on sale of asset in 2015, and losses from curtailment and settlement of pension obligations in 2015 and 2014.

  $ 16.3   $ 41.6   $ 10.8  

Net Sales

 
  2015
  2014
 

Estimated change in sales due to

             

Organic sales change

    5 %   5 %

Foreign currency translation

    (10 )   (1 )

Extra week in 2014 fiscal year

    (1 )   1  

Reported sales change

    (6 )%   5 %

        In both years, sales increased on an organic basis primarily due to higher volume.

        In 2015, sales increased on an organic basis at mid-single digit rates in both emerging markets and Western Europe and at a low-single digit rate in North America. Sales increased on an organic basis at mid-single digit rates for both the Materials and Performance Tapes product groups.

        In 2014, sales increased on an organic basis at a high-single digit rate in emerging markets, at a mid-single digit rate in Western Europe, and at a low-single digit rate in North America. Sales increased on an organic basis at a mid-single digit rate and at a mid-teens rate for the Materials and Performance Tapes product groups, respectively.

Operating Income

        Operating income increased in 2015 compared to 2014 due to benefits from productivity initiatives, including savings from restructuring, net of transition costs, higher volume, the net impact of pricing and changes in raw material input costs, and lower restructuring charges, partially offset by higher employee-related costs and the unfavorable impact of foreign currency translation.

        Operating income decreased in 2014 due to higher restructuring charges and transition costs, the impact of pricing and changes in raw material input costs, and higher employee-related costs, partially offset by higher volume and benefits from productivity initiatives, including savings from restructuring.

Retail Branding and Information Solutions

(In millions)
  2015
  2014
  2013
 

Net sales including intersegment sales

  $ 1,522.2   $ 1,594.0   $ 1,613.5  

Less intersegment sales

    (1.9 )   (2.4 )   (2.4 )

Net sales

  $ 1,520.3   $ 1,591.6   $ 1,611.1  

Operating income (1)

    70.0     87.9     81.7  

(1) Included charges associated with restructuring in all years, loss on sale of a product line and related exit costs in 2015, legal settlement in 2015, indefinite-lived intangible asset impairment charge in 2014, gains on sales of assets in 2014 and 2013, and gains and losses from curtailment and settlement of pension obligations in 2014 and 2013.

  $ 45.9   $ 22.0   $ 20.0  

Net Sales

 
  2015
  2014
 

Estimated change in sales due to

             

Organic sales change

    3 %   (2 )%

Foreign currency translation

    (4 )   (1 )

Extra week in 2014 fiscal year

    (1 )   1  

Product line divestiture

    (2 )    

Reported sales change (1)

    (4 )%   (1 )%
(1)
Totals may not sum due to rounding.

        In 2015, sales increased on an organic basis primarily due to higher volume. In 2014, sales decreased on an organic basis primarily due to lower volume.

Operating Income

        Operating income decreased in 2015 compared to 2014 due to higher employee-related costs, the impact of unfavorable product mix and pricing, higher restructuring charges, and the loss on sale of a product line and related exit costs, partially offset by benefits from productivity initiatives, including savings from restructuring, net of transition costs, as well as higher volume.

        Operating income increased in 2014 primarily reflecting benefits from productivity initiatives, including savings from restructuring as well as lower restructuring charges, partially offset by lower volume and higher employee-related costs.

Vancive Medical Technologies

(In millions)
  2015
  2014
  2013
 

Net sales including intersegment sales

  $ 77.8   $ 90.2   $ 77.5  

Less intersegment sales

    (4.9 )   (9.6 )   (3.6 )

Net sales

  $ 72.9   $ 80.6   $ 73.9  

Operating loss (1)

    (4.5 )   (11.7 )   (8.3 )

(1) Included charges associated with restructuring in all years.

  $ 3.6   $ 4.2   $ .1  
18


Management's Discussion and Analysis of Financial Condition and Results of Operations

Net Sales

 
  2015
  2014
 

Estimated change in sales due to

             

Organic sales change

    (1 )%   8 %

Foreign currency translation

    (8 )    

Extra week in 2014 fiscal year

    (1 )    

Reported sales change (1)

    (10 )%   9 %
(1)
Totals may not sum due to rounding.

        In 2015, sales decreased on an organic basis primarily due to lower volume. In 2014, sales increased on an organic basis primarily due to higher volume.

Operating Loss

        Operating loss decreased in 2015 compared to 2014 primarily due to a reduction in operating costs, including reduced spending associated with a discontinued product platform.

        Operating loss increased in 2014 compared to 2013 primarily due to higher restructuring charges related to an asset impairment and lower payments from a business partner for development of a new product, partially offset by higher volume.

FINANCIAL CONDITION

Liquidity

Cash Flow from Operating Activities

(In millions)
  2015
  2014
  2013
 

Net income

  $ 274.3   $ 245.1   $ 213.2  

Depreciation and amortization

    188.3     201.6     204.6  

Provision for doubtful accounts and sales returns

    46.5     45.2     41.5  

Loss (gain) on sale of businesses

        3.4     (49.3 )

Indefinite-lived intangible asset impairment charge

        3.0      

Net losses (gains) from long-lived asset impairments and sales/disposals of assets

    12.2     10.2     (5.8 )

Stock-based compensation

    26.3     28.3     34.0  

Other non-cash expense and loss

    50.1     44.2     50.1  

Other non-cash income and gain

            (11.8 )

Trade accounts receivable

    (135.9 )   (65.4 )   (136.0 )

Inventories

    (34.4 )   (33.0 )   (75.9 )

Other current assets

    3.9     (33.7 )   3.0  

Accounts payable

    65.5     (62.8 )   108.2  

Accrued liabilities

    7.0     (18.2 )   (19.3 )

Income taxes (deferred and accrued)

    (10.8 )   (2.6 )   47.4  

Other assets

    (.3 )   (3.5 )   (5.4 )

Long-term retirement benefits and other liabilities

    (19.0 )   (6.9 )   (78.9 )

Net cash provided by operating activities

  $ 473.7   $ 354.9   $ 319.6  

        For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in "Analysis of Selected Balance Sheet Accounts").

        In 2015, cash flow provided by operating activities increased compared to 2014 due to the timing of vendor payments, higher operating income and lower incentive compensation paid in 2015 for the 2014 performance year, partially offset by the timing of collections from customers and higher payments for taxes.

        In 2014, cash flow provided by operating activities improved compared to 2013 due to the impact of cash outflows related to our former OCP and DES businesses, higher pension contributions, including discretionary pension plan contributions utilizing the net proceeds from divestitures, and a charitable contribution to the Avery Dennison Foundation, all in 2013, as well as lower income tax payments in 2014. These factors were partially offset by higher working capital requirements (including larger than usual differences in year-end timing of vendor payments and customer receipts), the effect of currency fluctuations, higher bank draft balances, and higher incentive compensation paid in 2014 for the 2013 performance year.

Cash Flow from Investing Activities

(In millions)
  2015
  2014
  2013
 

Purchases of property, plant and equipment

  $ (135.8 ) $ (147.9 ) $ (129.2 )

Purchases of software and other deferred charges

    (15.7 )   (27.1 )   (52.2 )

Proceeds from sales of property, plant and equipment

    7.6     4.3     38.7  

(Purchases) sales of investments, net

    (.5 )   .3     .1  

Proceeds from sale of businesses, net of cash provided

            481.2  

Other

    1.5         .8  

Net cash (used in) provided by investing activities

  $ (142.9 ) $ (170.4 ) $ 339.4  

Capital and Software Spending

        In 2015, 2014 and 2013, we invested in new equipment to support growth, primarily in Asia and Europe, and to improve manufacturing productivity.

        Information technology investments in 2015, 2014 and 2013 were primarily associated with standardization initiatives.

Proceeds from Sales of Property, Plant and Equipment

        In September 2014, we sold properties in Framingham, Massachusetts used primarily as the former headquarters of our RBIS business for $3.3 million, recognizing a pre-tax gain of $1.9 million.

        In April 2013, we sold the property and equipment of our former corporate headquarters in Pasadena, California for approximately $20 million, recognizing a pre-tax gain of $10.9 million. In 2013, proceeds from sales of property, plant and equipment also included approximately $11 million from the sale of assets in China, as well as $5 million from the sale of a research facility located in Pasadena, California.

        These gains were recorded in "Other expense, net" in the Consolidated Statements of Income.

Proceeds from Sale of Businesses, Net of Cash Provided

        In July 2013, we completed the sale of our former OCP and DES businesses and received $481.2 million, net of cash provided.

19        Avery Dennison Corporation 2015 Annual Report


Management's Discussion and Analysis of Financial Condition and Results of Operations

Other

        In May 2015, we received $1.5 million from the sale of a product line in our RBIS reportable segment.

Cash Flow from Financing Activities

(In millions)
  2015
  2014
  2013
 

Net change in borrowings and payments of debt

  $ (105.8 ) $ 124.9   $ (187.2 )

Dividends paid

    (133.1 )   (125.1 )   (112.0 )

Share repurchases

    (232.3 )   (355.5 )   (283.5 )

Proceeds from exercises of stock options, net

    104.0     34.2     44.8  

Other

    (.1 )   (2.0 )   (8.3 )

Net cash used in financing activities

  $ (367.3 ) $ (323.5 ) $ (546.2 )

Borrowings and Repayment of Debt

        We had $28 million and $87 million of borrowings from commercial paper issuances outstanding (weighted-average interest rate of .7% and .4%, respectively) at year-end 2015 and 2014, respectively.

        Short-term borrowings outstanding under uncommitted lines of credit were $65 million (weighted-average interest rate of 8.7%) at year-end 2015 compared to $111.6 million (weighted-average interest rate of 9.4%) at year-end 2014.

        In 2015 and 2014, given the seasonality of our cash flow during the year, our commercial paper borrowings were used mainly to fund share repurchase activity, dividends, and capital and software expenditures.

        We had medium-term notes of $45 million and $50 million outstanding at year-end 2015 and 2014, respectively. During the second quarter of 2015, we repaid a $5 million medium-term note.

        No balances were outstanding under our revolving credit facility (the "Revolver") as of year-end 2015 or 2014. Commitment fees associated with the Revolver in 2015, 2014, and 2013 were $1.9 million, $1.3 million, and $1.4 million, respectively.

        In April 2013, we issued $250 million of senior notes due April 2023. The notes bear an interest rate of 3.35% per year, payable semiannually in arrears. Net proceeds from the offering, after deducting underwriting discounts and offering expenses, of approximately $247.5 million were used to repay a portion of the indebtedness outstanding under our commercial paper program during the second quarter of 2013.

        In January 2013, we repaid $250 million of senior notes at maturity using commercial paper borrowings.

        Refer to Note 4, "Debt and Capital Leases," to the Consolidated Financial Statements for more information.

        Refer to "Capital Resources" below for further information on 2015 and 2014 borrowings and repayment of debt.

Dividend Payments

        We paid dividends of $1.46 per share in 2015 compared to $1.34 per share in 2014. In April 2015, we increased our quarterly dividend to $.37 per share, representing a 6% increase from our previous dividend rate of $.35 per share.

Share Repurchases

        From time to time, our Board of Directors ("Board") authorizes the repurchase of shares of our outstanding common stock. Repurchased shares may be reissued under our stock option and incentive plan or used for other corporate purposes. In 2015, we repurchased approximately 3.9 million shares of our common stock at an aggregate cost of $232.3 million. In 2014, we repurchased approximately 7.4 million shares of our common stock at an aggregate cost of $355.5 million.

        On December 4, 2014, our Board authorized the repurchase of shares of our common stock in the aggregate amount of up to $500 million (exclusive of any fees, commissions or other expenses related to such purchases), in addition to any outstanding shares authorized under any previous Board authorization. This authorization is the only one currently in effect and will remain in effect until the shares authorized thereby have been repurchased.

        As of January 2, 2016, shares of our common stock in the aggregate amount of approximately $367 million remained authorized for repurchase under this Board authorization.

Analysis of Selected Balance Sheet Accounts

Long-lived Assets

        Goodwill decreased by approximately $35 million to $686 million at year-end 2015 mainly as a result of the impact of foreign currency translation.

        Other intangibles resulting from business acquisitions, net, decreased by approximately $22 million to $46 million at year-end 2015 as a result of current year amortization expense and the impact of foreign currency translation.

        Refer to Note 3, "Goodwill and Other Intangibles Resulting from Business Acquisitions," to the Consolidated Financial Statements for more information.

        Other assets decreased by approximately $52 million to $406 million at year-end 2015, which primarily reflected amortization expense related to software and other deferred charges, net of purchases, a decrease in long-term pension assets, and the impact of foreign currency translation.

Shareholders' Equity Accounts

        The balance of our shareholders' equity decreased by approximately $82 million to $966 million at year-end 2015, which reflected the effect of share repurchases, an increase in "Accumulated other comprehensive loss" due to the unfavorable impacts of foreign currency translation, and dividend payments. These decreases were partially offset by net income and the use of treasury shares to settle exercises of stock options and vesting of stock-based awards and fund contributions to our U.S. defined contribution plan.

        The balance of our treasury stock increased by approximately $116 million to $1.59 billion at year-end 2015, which primarily reflected share repurchase activity, partially offset by the use of treasury shares to settle exercises of stock options and vesting of stock-based awards and fund contributions to our U.S. defined contribution plan.

        Accumulated other comprehensive loss increased by approximately $138 million to $683 million at year-end 2015 primarily due to the unfavorable impact of foreign currency translation.

Impact of Foreign Currency Translation

(In millions)
  2015
  2014
  2013
 

Change in net sales

  $ (528 ) $ (67 ) $ 8  

Change in net income from continuing operations

    (34 )   (5 )   4  
20


Management's Discussion and Analysis of Financial Condition and Results of Operations

        In 2015, international operations generated approximately 74% of our net sales. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

        The unfavorable impact of foreign currency translation on net sales in 2015 compared to 2014 was primarily related to euro-denominated sales.

        Operations are treated as being in a hyperinflationary economy based on the cumulative inflation rate over the past three years. We had no operations in hyperinflationary economies in fiscal years 2015, 2014, or 2013.

Effect of Foreign Currency Transactions

        The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate.

Analysis of Selected Financial Ratios

        We utilize the financial ratios discussed below to assess our financial condition and operating performance.

Working Capital and Operational Working Capital Ratios

        Working capital (current assets minus current liabilities and net assets held for sale), as a percentage of net sales, increased in 2015 compared to 2014 primarily due to decreases in short-term borrowings and current portion of long-term debt and capital leases and accrued liabilities, largely offset by decreases in current deferred taxes and cash and cash equivalents. The decrease in current deferred taxes was a result of the prospective adoption of accounting guidance to classify deferred taxes as non-current in 2015.

        Operational working capital, as a percentage of net sales, is reconciled with working capital below. Our objective is to minimize our investment in operational working capital, as a percentage of sales, to maximize cash flow and return on investment.

(In millions, except percentages)
  2015
  2014
 

(A) Working capital

  $ 313.8   $ 327.5  

Reconciling items:

             

Cash and cash equivalents

    (158.8 )   (207.2 )

Current deferred and refundable income taxes and other current assets

    (170.7 )   (263.4 )

Short-term borrowings and current portion of long-term debt and capital leases

    95.3     204.3  

Current deferred and payable income taxes and other current accrued liabilities

    549.2     590.9  

(B) Operational working capital

  $ 628.8   $ 652.1  

(C) Net sales

  $ 5,966.9   $ 6,330.3  

Working capital, as a percentage of net sales (A) ÷ (C)

    5.3 %   5.2 %

Operational working capital, as a percentage of net sales (B) ÷ (C)

    10.5 %   10.3 %

Accounts Receivable Ratio

        The average number of days sales outstanding was 60 days in 2015 compared to 62 days in 2014, calculated using the four-quarter average accounts receivable balance divided by the average daily sales for the year. The decrease in the current year average number of days sales outstanding reflected the timing of collections.

Inventory Ratio

        Average inventory turnover, calculated using the annual cost of sales divided by the four-quarter average inventory balance, was 8.6 in both 2015 and 2014.

Accounts Payable Ratio

        The average number of days payable outstanding was 70 days in 2015 compared to 68 days in 2014, calculated using the four-quarter average accounts payable balance divided by the average daily cost of products sold for the year. The increase in the current year average number of days payable outstanding primarily reflected the timing of vendor payments and longer payment terms with certain suppliers.

Net Debt to EBITDA Ratio

(In millions)
  2015
  2014
  2013
 

Net income

  $ 274.3   $ 245.1   $ 213.2  

Reconciling items:

                   

Interest expense

    60.5     63.3     60.9  

Provision for income taxes

    134.5     113.5     124.3  

Depreciation

    125.2     135.5     135.2  

Amortization

    62.9     65.9     69.1  

EBITDA

  $ 657.4   $ 623.3   $ 602.7  

Total debt

  $ 1,058.9   $ 1,144.4   $ 1,021.5  

Less cash and cash equivalents

    (158.8 )   (207.2 )   (351.1 )

Net debt

  $ 900.1   $ 937.2   $ 670.4  

Net debt to EBITDA ratio

    1.4     1.5     1.1  

        The net debt to EBITDA ratio was lower in 2015 compared to 2014 primarily due to higher net income and lower net debt as a result of lower commercial paper borrowings.

        The net debt to EBITDA ratio was higher in 2014 compared to 2013 primarily due to higher total debt and a decrease in cash and cash equivalents as a result of funding share repurchase activity and supporting operational requirements and capital expenditures.

Financial Covenants

        The Revolver contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. As of January 2, 2016 and January 3, 2015, we were in compliance with our financial covenants.

Fair Value of Debt

        The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities on notes with similar rates, credit rating, and remaining maturities. The fair value of short-term borrowings, which include commercial paper issuances and short-term lines of credit, approximates carrying value given the short duration of these obligations. The fair value of our total debt was $1.08 billion at January 2, 2016 and $1.22 billion at January 3, 2015. Fair value amounts

21        Avery Dennison Corporation 2015 Annual Report


Management's Discussion and Analysis of Financial Condition and Results of Operations

were determined primarily based on Level 2 inputs. Refer to Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements for more information.

Capital Resources

        Capital resources include cash flows from operations, cash and cash equivalents and debt financing. At year-end 2015, we had cash and cash equivalents of $158.8 million held in accounts at third-party financial institutions.

        Our cash balances are held in numerous locations throughout the world. At January 2, 2016, the majority of our cash and cash equivalents was held by our foreign subsidiaries.

        To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings. However, if we were to repatriate incremental foreign earnings, we may be subject to additional taxes in the U.S.

        In October 2014, we amended and restated the Revolver with certain domestic and foreign banks, increasing the amount available thereunder from $675 million to $700 million. The amendment also extended the Revolver's maturity date from December 22, 2016 to October 3, 2019 and adjusted pricing to reflect favorable market conditions. The maturity date may be extended for additional one-year periods under certain circumstances. The commitments under the Revolver may be increased by up to $325 million, subject to lender approval and customary requirements. The Revolver is used as a back-up facility for our commercial paper program and can be used to finance other corporate requirements. No balances were outstanding under the Revolver as of January 2, 2016 or January 3, 2015.

        Refer to Note 4, "Debt and Capital Leases," to the Consolidated Financial Statements for more information.

        We are exposed to financial market risk resulting from changes in interest and foreign currency rates, and to possible liquidity and credit risks of our counterparties.

Capital from Debt

        Our total debt decreased by approximately $86 million to $1.06 billion at year-end 2015 compared to $1.15 billion at year-end 2014, primarily reflecting a decrease in commercial paper borrowings and the seasonality of our cash flow during the year. Refer to "Borrowings and Repayment of Debt" above for more information.

        In April 2013, we issued $250 million of senior notes due April 2023. The notes bear an interest rate of 3.35% per year, payable semiannually in arrears. Net proceeds from the offering, after deducting underwriting discounts and offering expenses, of approximately $247.5 million were used to repay a portion of the indebtedness outstanding under our commercial paper program during the second quarter of 2013.

        In January 2013, we repaid $250 million of senior notes at maturity using commercial paper borrowings.

        Uncommitted lines of credit were approximately $300 million at year-end 2015. These lines may be cancelled at any time by us or the issuing banks.

        Credit ratings are a significant factor in our ability to raise short-term and long-term financing. The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings below current levels could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, the Revolver and our other credit facilities would be available to meet our short-term funding requirements, if necessary. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

22


Management's Discussion and Analysis of Financial Condition and Results of Operations

Contractual Obligations, Commitments and Off-Balance Sheet Arrangements

Contractual Obligations at End of Year 2015

 
  Payments Due by Period  
(In millions)
  Total
  2016
  2017
  2018
  2019
  2020
  Thereafter
 

Short-term borrowings

  $ 92.8   $ 92.8   $   $   $   $   $  

Long-term debt

    945.0         250.0             265.0     430.0  

Long-term capital leases

    44.5     5.0     5.0     5.0     4.9     4.7     19.9  

Interest on long-term debt

    327.4     50.8     46.6     34.2     34.2     24.0     137.6  

Operating leases

    143.0     43.1     27.9     19.0     13.9     9.9     29.2  

Pension and postretirement benefit payments (unfunded plans)

    131.2     16.5     16.4     33.7     10.5     9.3     44.8  

Total contractual obligations

  $ 1,683.9   $ 208.2   $ 345.9   $ 91.9   $ 63.5   $ 312.9   $ 661.5  

        We enter into operating leases primarily for office and warehouse space and equipment for information technology, machinery, and transportation. The table above includes minimum annual rental commitments on operating leases having initial or remaining non-cancelable lease terms of one year or more.

        The table above does not include:

CRITICAL ACCOUNTING ESTIMATES

        The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions for the reporting period and as of the financial statement date. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expense. Actual results could differ from those estimates.

        Critical accounting estimates are those that are important to our financial condition and results, and which require us to make difficult, subjective and/or complex judgments. Critical accounting estimates cover accounting matters that are inherently uncertain because their future resolution is unknown. We believe our critical accounting estimates include accounting for goodwill, pension and postretirement benefits, taxes based on income, long-term incentive compensation, litigation matters, and environmental expenditures.

Goodwill

        Our reporting units are composed of either a discrete business or an aggregation of businesses with similar economic characteristics. We have the following reporting units: materials; retail branding and information solutions; reflective solutions; performance tapes; and medical solutions. Goodwill relates to our materials, retail branding and information solutions, and reflective solutions reporting units. In performing the required impairment tests, we primarily apply a present value (discounted cash flow) method to determine the fair value of the reporting units with goodwill. We perform our annual impairment test of goodwill during the fourth quarter.

        Certain factors may result in the need to perform an impairment test prior to the fourth quarter, including significant underperformance of a business relative to expected operating results, significant adverse economic and industry trends, significant decline in our market capitalization for an extended period of time relative to net book value, or a decision to divest a portion of a reporting unit.

23        Avery Dennison Corporation 2015 Annual Report


Management's Discussion and Analysis of Financial Condition and Results of Operations

        We determine goodwill impairment using a two-step process. The first step is to identify if a potential impairment exists by comparing the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not considered to have a potential impairment and the second step of the impairment test is not necessary. However, if the carrying amount of a reporting unit exceeds its fair value, the second step is performed to determine if goodwill is impaired and to measure the amount of impairment loss to recognize, if any.

        The second step, if necessary, compares the implied fair value of goodwill with the carrying amount of goodwill. If the implied fair value of goodwill exceeds the carrying amount, then goodwill is not considered impaired. However, if the carrying amount of goodwill exceeds the implied fair value, an impairment loss is recognized in an amount equal to that excess.

        In consultation with outside specialists, we estimate the fair value of our reporting units using various valuation techniques, with the primary technique being a discounted cash flow analysis. A discounted cash flow analysis requires us to make various assumptions about the reporting units, including sales, operating margins, growth rates, and discount rates. Assumptions about discount rates are based on a weighted-average cost of capital for comparable companies. Assumptions about sales, operating margins, and growth rates are based on our forecasts, business plans, economic projections, anticipated future cash flows and marketplace data. Assumptions are also made for varying perpetual growth rates for periods beyond the long-term business plan period. We base our fair value estimates on projected financial information and assumptions that we believe are reasonable. However, actual future results may differ from those estimates and projections, and those differences may be material. The valuation methodology used to estimate the fair value of reporting units requires inputs and assumptions that reflect current market conditions, as well as the impact of planned business and operational strategies that require management judgment. The estimated fair value could increase or decrease depending on changes in the inputs and assumptions. Our annual first step impairment analysis in the fourth quarter of 2015 indicated that the fair values of our reporting units exceeded their respective carrying amounts, including goodwill. The fair value of the reporting units tested exceeded their carrying amounts by 80% to 461%.

Pension and Postretirement Benefits

        Assumptions used in determining projected benefit obligations and the fair value of plan assets for our defined benefit pension plans and other postretirement benefit plans are evaluated by management in consultation with outside actuaries. In the event that we determine that changes are warranted in the assumptions used, such as the discount rate, expected long-term rate of return, or health care costs, future pension and postretirement benefit expenses could increase or decrease. Due to changes in market conditions or participant population, the actuarial assumptions that we use may differ from actual results, which could have a significant impact on our pension and postretirement liability and related cost.

Discount Rate

        In consultation with our actuaries, we annually review and determine the discount rates to be used in connection with valuing our postretirement obligations. The assumed discount rate for each pension plan reflects market rates for high quality corporate bonds currently available. In the U.S., our discount rate is determined by evaluating yield curves consisting of large populations of high quality corporate bonds. The projected pension benefit payment streams are then matched with the bond portfolios to determine a rate that reflects the liability duration unique to our plans. As of January 2, 2016, a .25% increase in the discount rate in the U.S. would have decreased our year-end projected benefit obligation by approximately $32 million and would have increased expected periodic benefit cost for the coming year by approximately $.2 million. Similarly, a .25% decrease in the discount rate in the U.S. would have increased our year-end projected benefit obligation by approximately $34 million and would have decreased expected periodic benefit cost for the coming year by approximately $.3 million.

        Beginning in 2016, we will use a full yield curve approach to estimate the service and interest cost components of net periodic benefit cost for our pension and other postretirement benefit plans. Under this approach, we will apply multiple discount rates from a yield curve composed of the rates of return on several hundred high-quality, fixed income corporate bonds available at the measurement date. We believe the new approach will provide a more precise measurement of service and interest cost by aligning the timing of the plans' liability cash flows to the corresponding rates on the yield curve. Historically, we estimated the service and interest cost components using a single weighted-average discount rate derived from the yield curve used to measure the benefit obligation at the beginning of the period.

Long-term Return on Assets

        We determine the long-term rate of return assumption for plan assets by reviewing the historical and expected returns of both the equity and fixed income markets, taking into account our asset allocation, the correlation between returns in our asset classes, and the mix of active and passive investments. Additionally, current market conditions, including interest rates, are evaluated and market data is reviewed for reasonableness and appropriateness. An increase or decrease of .25% on the long-term return on assets in the U.S. would have decreased or increased, respectively, our 2016 periodic benefit cost by approximately $2 million.

Taxes Based on Income

        Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. These assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating loss and tax credit carryforwards. These amounts are adjusted, as appropriate, to reflect changes in tax rates expected to be in effect when the temporary differences reverse. We evaluate the recoverability of these future tax deductions and credits by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. Our assessment of these sources of income relies heavily on estimates. We use historical experience along with operating forecasts in evaluating expected taxable income for the future. To the extent we do not consider it more likely than not that a deferred tax asset will be recovered, a valuation allowance is established in the period we make such a determination. A tax planning strategy is defined as "an action that: is prudent and feasible; an enterprise ordinarily might not take, but would take to prevent an

24


Management's Discussion and Analysis of Financial Condition and Results of Operations

operating loss or tax credit carryforward from expiring unused; and would result in realization of deferred tax assets." We also acquired certain net deferred tax assets with existing valuation allowances in prior years. If, based on our estimates of future taxable income, it is later determined that it is more likely than not that a deferred tax asset will be realized, we would release the valuation allowance to current earnings or adjust purchase price allocation.

        Our income tax rate is significantly affected by the different tax rates applicable to our operations in the jurisdictions in which we do business. In addition to local country tax law and regulations, this rate depends on the extent earnings are indefinitely reinvested outside the United States. Indefinite reinvestment is determined in accordance with the Accounting Standards Codification ("ASC") 740-30-25-17 using management's judgment about and intentions concerning estimates of our future financial results, cash flows, capital investment plans and our discretionary actions to return cash to shareholders.

        We calculate our current and deferred tax provision based on estimates and assumptions that could differ from the actual results reflected in income tax returns filed in subsequent years. Adjustments based on filed returns are recorded when identified.

        Tax laws are complex and subject to different interpretations by taxpayers and respective governmental taxing authorities. We review our tax positions quarterly and adjust the balances as new information becomes available. Significant judgment is required in determining our tax expense and in evaluating our tax positions, including evaluating uncertainties. Our estimate of the potential outcome of any uncertain tax issue is subject to management's assessment of relevant facts and circumstances existing at the balance sheet date, taking into consideration existing laws, regulations and practices of any governmental authorities exercising jurisdiction over our operations. For example, in June 2014, the European Commission opened a formal investigation of various European countries to examine whether the corporate income taxes paid within such jurisdictions comply with the European Union rules on state aid. The European Commission's formal investigation of tax rulings issued by countries including The Netherlands and Luxembourg was concluded in September 2015, and required The Netherlands and Luxembourg to recover past taxes covering multiple years from various taxpayers as disallowed state aid. We continue to monitor the state aid developments, since it involves jurisdictions in which we have significant operations, and it is considered in the determination of our uncertain tax positions.

        Further information is available in Note 14, "Taxes Based on Income," to the Consolidated Financial Statements.

Long-Term Incentive Compensation

        We have not capitalized expense associated with our long-term incentive compensation.

        Changes in estimated forfeiture rates are recorded as cumulative adjustments in the period estimates are revised.

Valuation of Stock-Based Awards

        Our stock-based compensation expense is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a straight-line basis over the requisite service period for stock options, restricted stock units ("RSUs"), and performance units ("PUs"). The compensation expense related to market-leveraged stock units ("MSUs") is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a graded-vesting basis over their respective performance periods.

        Compensation expense for awards with a market condition as a performance objective, which includes PUs and MSUs, is not adjusted if the condition is not met, as long as the requisite service period is met.

        The fair value of stock options is estimated as of the date of grant using the Black-Scholes option-pricing model. This model requires input assumptions for our expected dividend yield, expected stock price volatility, risk-free interest rate and the expected option term.

        The following assumptions are used in estimating the fair value of granted stock options:

        Risk-free interest rate is based on the 52-week average of the Treasury-Bond rate that has a term corresponding to the expected option term.

        Expected stock price volatility represents an average of implied and historical volatility.

        Expected dividend yield is based on the current annual dividend divided by the 12-month average of our monthly stock price prior to the date of grant.

        Expected option term is determined based on historical experience under our stock option and incentive plans.

        The fair value of RSUs and certain PUs that are subject to achievement of performance objectives based on a performance condition is determined based on the fair market value of our common stock as of the date of grant, adjusted for foregone dividends.

        The fair value of stock-based awards that are subject to achievement of performance objectives based on a market condition, which includes MSUs and certain PUs, is determined using the Monte-Carlo simulation model, which utilizes multiple input variables, including expected stock price volatility and other assumptions appropriate for determining fair value, to estimate the probability of satisfying the target performance objectives established for the award.

        Certain of these assumptions are based on management's estimates, in consultation with outside specialists. Significant changes in assumptions for future awards and actual forfeiture rates could materially impact stock-based compensation expense and our results of operations.

Valuation of Cash-Based Awards

        Cash-based awards consist of long-term incentive units ("LTI Units") granted to eligible employees. Cash-based awards are classified as liability awards and remeasured at each quarter-end over the applicable vesting or performance period. In addition to LTI Units with terms and conditions that mirror those of RSUs, we also grant certain employees LTI Units with terms and conditions that mirror those of PUs and MSUs.

Accounting for Income Taxes for Stock-Based Compensation

        We elected to use the short-cut method to calculate the historical pool of windfall tax benefits related to employee and non-employee director stock-based compensation awards. In addition, we elected to follow the tax law ordering approach to determine the sequence in which deductions and net operating loss carryforwards are utilized, as well as the direct-only approach to calculate the amount of windfall or shortfall tax benefits.

25        Avery Dennison Corporation 2015 Annual Report


Management's Discussion and Analysis of Financial Condition and Results of Operations

Litigation Matters

        We are involved in various lawsuits, claims, inquiries and other regulatory and compliance matters, most of which are routine to the nature of our business. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these claims could affect future results of operations should our exposure be materially different from our estimates or should liabilities be incurred that were not previously accrued. Potential insurance reimbursements are not offset against potential liabilities, and such liabilities are not discounted.

Environmental Expenditures

        Environmental expenditures are generally expensed. However, environmental expenditures for newly acquired assets and those which extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset. We review our estimates of costs of compliance with environmental laws related to remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. Potential insurance reimbursements are not offset against potential liabilities, and such liabilities are not discounted.

RECENT ACCOUNTING REQUIREMENTS

        Refer to Note 1, "Summary of Significant Accounting Policies," to the Consolidated Financial Statements for this information.

MARKET-SENSITIVE INSTRUMENTS AND RISK MANAGEMENT

Risk Management

        We are exposed to the impact of changes in interest rates and foreign currency exchange rates.

        We generally do not purchase or hold foreign currency or interest rate or commodity contracts for trading purposes.

        Our objective in managing our exposure to foreign currency changes is to reduce the risk to our earnings and cash flow associated with foreign exchange rate changes. As a result, we enter into foreign exchange forward, option and swap contracts to reduce risks associated with the value of our existing foreign currency assets, liabilities, firm commitments and anticipated foreign revenues and costs, when available and appropriate. The gains and losses on these contracts are intended to offset changes in the related exposures. We do not hedge our foreign currency exposure in a manner that would entirely eliminate the effects of changes in foreign exchange rates on our net income.

        Our objective in managing our exposure to interest rate changes is to reduce the impact of interest rate changes on earnings and cash flows. To achieve our objectives, we may periodically use interest rate contracts to manage our exposure to interest rate changes.

        Additionally, we enter into certain natural gas futures contracts to reduce the risks associated with domestic natural gas anticipated to be used in manufacturing and operations. These amounts are not material to our financial statements.

        In the normal course of operations, we also face other risks that are either non-financial or non-quantifiable. These risks principally include changes in economic or political conditions, other risks associated with foreign operations, commodity price risk and litigation risk, which are not reflected in the analyses that follow.

Foreign Exchange Value-At-Risk

        We use a Value-At-Risk ("VAR") model to determine the estimated maximum potential one-day loss in earnings associated with our foreign exchange positions and contracts. This approach assumes that market rates or prices for foreign exchange positions and contracts are normally distributed. VAR model estimates were made assuming normal market conditions. The model includes all of our debt as well as all interest rate and foreign exchange derivative contracts and market sensitive equity investments. Forecasted transactions, firm commitments, and accounts receivable and accounts payable denominated in foreign currencies, which certain of these instruments are intended to hedge, were excluded from the model.

        In both 2015 and 2014, the VAR was estimated using a variance-covariance methodology. The currency correlation was based on one-year historical data obtained from one of our domestic banks. A 95% confidence level was used for a one-day time horizon.

        The estimated maximum potential one-day loss in earnings for our foreign exchange positions and contracts was $1 million at both years-end 2015 and 2014.

        The VAR model is a risk analysis tool and does not purport to represent actual losses in fair value that we could incur, nor does it consider the potential effect of favorable changes in market factors.

Interest Rate Sensitivity

        In 2015, an assumed 40 basis point move in interest rates affecting our variable-rate borrowings (10% of our weighted-average interest rate on floating rate debt) would have increased interest expense by approximately $.7 million.

        In 2014, an assumed 50 basis point move in interest rates affecting our variable-rate borrowings (10% of our weighted-average interest rate on floating rate debt) would have increased interest expense by approximately $1 million.

26


Consolidated Balance Sheets

(Dollars in millions)
  January 2,
2016

  January 3,
2015

 

Assets

             

Current assets:

             

Cash and cash equivalents

  $ 158.8   $ 207.2  

Trade accounts receivable, less allowances of $31.5 and $30.5 at year-end 2015 and 2014, respectively

    964.7     958.1  

Inventories, net

    478.7     491.8  

Current deferred and refundable income taxes

    30.9     107.5  

Assets held for sale

    2.5     .8  

Other current assets

    139.8     155.9  

Total current assets

    1,775.4     1,921.3  

Property, plant and equipment, net

    847.9     875.3  

Goodwill

    686.2     721.6  

Other intangibles resulting from business acquisitions, net

    45.8     67.4  

Non-current deferred income taxes

    372.2     312.9  

Other assets

    406.2     458.4  

  $ 4,133.7   $ 4,356.9  

Liabilities and Shareholders' Equity

   
 
   
 
 

Current liabilities:

             

Short-term borrowings and current portion of long-term debt and capital leases

  $ 95.3   $ 204.3  

Accounts payable

    814.6     797.8  

Accrued payroll and employee benefits

    194.6     173.7  

Accrued trade rebates

    85.4     90.5  

Current deferred and payable income taxes

    45.1     60.1  

Other accrued liabilities

    224.1     266.6  

Total current liabilities

    1,459.1     1,593.0  

Long-term debt and capital leases

    963.6     940.1  

Long-term retirement benefits and other liabilities

    637.4     648.3  

Non-current deferred and payable income taxes

    107.9     127.8  

Commitments and contingencies (see Notes 7 and 8)

             

Shareholders' equity:

             

Common stock, $1 par value per share, authorized – 400,000,000 shares at year-end 2015 and 2014; issued – 124,126,624 shares at year-end 2015 and 2014; outstanding – 89,967,697 shares and 90,458,956 shares at year-end 2015 and 2014, respectively

    124.1     124.1  

Capital in excess of par value

    834.0     823.9  

Retained earnings

    2,277.6     2,116.5  

Treasury stock at cost, 34,158,927 shares and 33,667,668 shares at year-end 2015 and 2014, respectively

    (1,587.0 )   (1,471.3 )

Accumulated other comprehensive loss

    (683.0 )   (545.5 )

Total shareholders' equity

    965.7     1,047.7  

  $ 4,133.7   $ 4,356.9  

See Notes to Consolidated Financial Statements

27        Avery Dennison Corporation 2015 Annual Report


Consolidated Statements of Income

(In millions, except per share amounts)
  2015
  2014
  2013
 

Net sales

  $ 5,966.9   $ 6,330.3   $ 6,140.0  

Cost of products sold

    4,321.1     4,679.1     4,502.3  

Gross profit

    1,645.8     1,651.2     1,637.7  

Marketing, general and administrative expense

    1,108.1     1,158.9     1,174.2  

Interest expense

    60.5     63.3     60.9  

Other expense, net

    68.3     68.2     36.6  

Income from continuing operations before taxes

    408.9     360.8     366.0  

Provision for income taxes

    134.5     113.5     124.3  

Income from continuing operations

    274.4     247.3     241.7  

Loss from discontinued operations, net of tax

    (.1 )   (2.2 )   (28.5 )

Net income

  $ 274.3   $ 245.1   $ 213.2  

Per share amounts:

   
 
   
 
   
 
 

Net income (loss) per common share:

                   

Continuing operations

  $ 3.01   $ 2.64   $ 2.46  

Discontinued operations

        (.03 )   (.29 )

Net income per common share

  $ 3.01   $ 2.61   $ 2.17  

Net income (loss) per common share, assuming dilution:

   
 
   
 
   
 
 

Continuing operations

  $ 2.95   $ 2.58   $ 2.41  

Discontinued operations

        (.02 )   (.28 )

Net income per common share, assuming dilution

  $ 2.95   $ 2.56   $ 2.13  

Dividends per common share

  $ 1.46   $ 1.34   $ 1.14  

Weighted average number of shares outstanding:

   
 
   
 
   
 
 

Common shares

    91.0     93.8     98.4  

Common shares, assuming dilution

    92.9     95.7     100.1  

See Notes to Consolidated Financial Statements

28


Consolidated Statements of Comprehensive Income

(In millions)
  2015
  2014
  2013
 

Net income

  $ 274.3   $ 245.1   $ 213.2  

Other comprehensive (loss) income, net tax:

                   

Foreign currency translation:

                   

Translation loss

    (139.0 )   (149.8 )   (50.2 )

Reclassifications to net income

            10.8  

Pension and other postretirement benefits:

                   

Net (loss) gain recognized from actuarial gain/loss and prior service cost/credit

    (18.9 )   (125.2 )   48.1  

Reclassifications to net income

    22.9     16.9     10.0  

Cash flow hedges:

                   

(Losses) gains recognized on cash flow hedges

    (.5 )   .1     .8  

Reclassifications to net income

    (2.0 )   .9     .2  

Other comprehensive (loss) income, net of tax

    (137.5 )   (257.1 )   19.7  

Total comprehensive income (loss), net of tax

  $ 136.8   $ (12.0 ) $ 232.9  

See Notes to Consolidated Financial Statements

29        Avery Dennison Corporation 2015 Annual Report


Consolidated Statements of Shareholders' Equity

(Dollars in millions, except per share amounts)
  Common
stock, $1
par value

  Capital in
excess of
par value

  Retained
earnings

  Treasury
stock

  Accumulated
other
comprehensive
loss

  Total
 

Balance as of December 29, 2012

  $ 124.1   $ 801.8   $ 1,896.6   $ (977.8 ) $ (308.1 ) $ 1,536.6  

Net income

            213.2               213.2  

Other comprehensive income, net of tax

                    19.7     19.7  

Repurchase of 6,555,672 shares for treasury

                (283.5 )       (283.5 )

Issuance of 2,240,185 shares under stock-based compensation plans, including tax of $1.7

        10.5     (11.6 )   70.7         69.6  

Contribution of 578,441 shares to 401(k) Plan

            6.1     18.4         24.5  

Dividends: $1.14 per share

            (112.0 )           (112.0 )

Balance as of December 28, 2013

  $ 124.1   $ 812.3   $ 1,992.3   $ (1,172.2 ) $ (288.4 ) $ 1,468.1  

Net income

            245.1               245.1  

Other comprehensive loss, net of tax

                    (257.1 )   (257.1 )

Repurchase of 7,416,167 shares for treasury

                (355.5 )       (355.5 )

Issuance of 1,299,931 shares under stock-based compensation plans, including tax of $(4.1)

        11.6     (2.0 )   43.2         52.8  

Contribution of 396,781 shares to 401(k) Plan

            6.2     13.2         19.4  

Dividends: $1.34 per share

            (125.1 )           (125.1 )

Balance as of January 3, 2015

  $ 124.1   $ 823.9   $ 2,116.5   $ (1,471.3 ) $ (545.5 ) $ 1,047.7  

Net income

            274.3               274.3  

Other comprehensive loss, net of tax

                    (137.5 )   (137.5 )

Repurchase of 3,858,376 shares for treasury

                (232.3 )       (232.3 )

Issuance of 3,019,001 shares under stock-based compensation plans, including tax of $10.6

        10.1     11.8     104.5         126.4  

Contribution of 348,116 shares to 401(k) Plan

            8.1     12.1         20.2  

Dividends: $1.46 per share

            (133.1 )           (133.1 )

Balance as of January 2, 2016

  $ 124.1   $ 834.0   $ 2,277.6   $ (1,587.0 ) $ (683.0 ) $ 965.7  

See Notes to Consolidated Financial Statements

30


Consolidated Statements of Cash Flows

(In millions)
  2015
  2014
  2013
 

Operating Activities

                   

Net income

  $ 274.3   $ 245.1   $ 213.2  

Adjustments to reconcile net income to net cash provided by operating activities:

                   

Depreciation

    125.2     135.5     135.6  

Amortization

    63.1     66.1     69.0  

Provision for doubtful accounts and sales returns

    46.5     45.2     41.5  

Loss (gain) on sale of businesses

        3.4     (49.3 )

Indefinite-lived intangible asset impairment charge

        3.0      

Net losses (gains) from asset impairments and sales/disposals of assets

    12.2     10.2     (5.8 )

Stock-based compensation

    26.3     28.3     34.0  

Other non-cash expense and loss

    50.1     44.2     50.1  

Other non-cash income and gain

            (11.8 )

Changes in assets and liabilities and other adjustments:

                   

Trade accounts receivable

    (135.9 )   (65.4 )   (136.0 )

Inventories

    (34.4 )   (33.0 )   (75.9 )

Other current assets

    3.9     (33.7 )   3.0  

Accounts payable

    65.5     (62.8 )   108.2  

Accrued liabilities

    7.0     (18.2 )   (19.3 )

Taxes on income

    (23.7 )   15.3     (5.0 )

Deferred taxes

    12.9     (17.9 )   52.4  

Other assets

    (.3 )   (3.5 )   (5.4 )

Long-term retirement benefits and other liabilities

    (19.0 )   (6.9 )   (78.9 )

Net cash provided by operating activities

    473.7     354.9     319.6  

Investing Activities

   
 
   
 
   
 
 

Purchases of property, plant and equipment

    (135.8 )   (147.9 )   (129.2 )

Purchases of software and other deferred charges

    (15.7 )   (27.1 )   (52.2 )

Proceeds from sales of property, plant and equipment

    7.6     4.3     38.7  

(Purchases) sales of investments, net

    (.5 )   .3     .1  

Proceeds from sale of businesses, net of cash provided

            481.2  

Other

    1.5         .8  

Net cash (used in) provided by investing activities

    (142.9 )   (170.4 )   339.4  

Financing Activities

   
 
   
 
   
 
 

Net (decrease) increase in borrowings (maturities of 90 days or less)

    (98.4 )   126.5     (435.3 )

Additional borrowings (maturities longer than 90 days)

            250.0  

Payments of debt (maturities longer than 90 days)

    (7.4 )   (1.6 )   (1.9 )

Dividends paid

    (133.1 )   (125.1 )   (112.0 )

Share repurchases

    (232.3 )   (355.5 )   (283.5 )

Proceeds from exercises of stock options, net

    104.0     34.2     44.8  

Other

    (.1 )   (2.0 )   (8.3 )

Net cash used in financing activities

    (367.3 )   (323.5 )   (546.2 )

Effect of foreign currency translation on cash balances

    (11.9 )   (4.9 )   2.9  

(Decrease) increase in cash and cash equivalents

    (48.4 )   (143.9 )   115.7  

Cash and cash equivalents, beginning of year

    207.2     351.1     235.4  

Cash and cash equivalents, end of year

  $ 158.8   $ 207.2   $ 351.1  

See Notes to Consolidated Financial Statements

31        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

        We develop identification and decorative solutions primarily for businesses worldwide. Our products include pressure-sensitive labeling technology and materials; films for graphic and reflective applications; performance tapes; brand and price tickets, tags and labels (including radio-frequency identification ("RFID") inlays); and pressure-sensitive adhesive products for surgical, wound care, ostomy, and electromedical applications.

Principles of Consolidation

        The consolidated financial statements include the accounts of majority-owned subsidiaries. Intercompany accounts, transactions and profits are eliminated in consolidation.

Fiscal Year

        Normally, our fiscal years consist of 52 weeks, but every fifth or sixth fiscal year consists of 53 weeks. Our 2015 and 2013 fiscal years consisted of 52-week periods ending January 2, 2016 and December 28, 2013, respectively. Our 2014 fiscal year consisted of a 53-week period ending January 3, 2015.

Financial Presentation

        As further discussed in Note 2, "Discontinued Operations, Sale of Product Line, and Sale of Assets," we have classified the operating results of our Office and Consumer Products ("OCP") and Designed and Engineered Solutions ("DES") businesses, together with certain costs associated with their divestiture, as discontinued operations in the Consolidated Statements of Income for all periods presented. Unless otherwise noted, the results and financial condition of discontinued operations have been excluded from the notes to our Consolidated Financial Statements.

Prior Period Financial Statement Revision, Reclassifications, and Accounting Changes

        In 2015, we determined that certain of our benefit plans (that were frozen between 1994 and 2003) were not properly accounted for since their inception between 1984 and 1988. This resulted in an understatement of long-term retirement benefits and other liabilities and the cumulative historical expenses related to these benefit plans. Additionally, we identified certain liquid short-term bank drafts with maturities greater than 90 days that were improperly classified as cash and cash equivalents instead of other current assets, which resulted in an overstatement of operating cash flows, and tax effects related to certain foreign pension plans that were not properly accounted for on our consolidated financial statements.

        We assessed the materiality of these errors on our financial statements for prior periods in accordance with United States Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 99, Materiality, codified in Accounting Standards Codification ("ASC") 250, Presentation of Financial Statements, and concluded that they were not material to any prior annual or interim periods. However, the aggregate amount of the prior period revisions of approximately $24 million would have been material to our current Consolidated Statements of Income. Consequently, in accordance with ASC 250 (SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements), we have corrected these errors for all prior years presented by revising the consolidated financial statements and other financial information included herein. We also corrected the timing of immaterial previously recorded out-of-period adjustments and reflected them in the revised prior period financial statements, where applicable. Periods not presented herein will be revised, as applicable, in future filings.

        Additionally, as further discussed in "Recent Accounting Requirements" below, we adopted the provisions of an accounting standard amendment earlier than required, resulting in the retrospective reclassification of debt issuance costs from other assets to a reduction of long-term debt. The effects on the Consolidated Balance Sheets are included in the information below.

        Certain prior year amounts have been reclassified to conform to the current year presentation. The Consolidated Statements of Comprehensive Income have been reclassified to present the components of comprehensive income, net of tax.

        The effects of the revision and adoption of accounting standard on our Consolidated Balance Sheets were as follows:

(In millions)
  As Previously
Reported
January 3, 2015

  Debt Issuance
Cost
Reclassification

  Adjustment
  As Revised
January 3, 2015

 

Cash and cash equivalents

  $ 227.0   $   $ (19.8 ) $ 207.2  

Other current assets

    136.1         19.8     155.9  

Non-current deferred income taxes

    311.0         1.9     312.9  

Other assets

    463.6     (5.2 )       458.4  

Total assets

    4,360.2     (5.2 )   1.9     4,356.9  

Current deferred and payable income taxes

    64.9         (4.8 )   60.1  

Total current liabilities

    1,597.8         (4.8 )   1,593.0  

Long-term debt and capital leases

    945.3     (5.2 )       940.1  

Long-term retirement benefits and other liabilities

    622.8         25.5     648.3  

Retained earnings

    2,137.1         (20.6 )   2,116.5  

Accumulated other comprehensive loss

    (547.3 )       1.8     (545.5 )

Total shareholders' equity

    1,066.5         (18.8 )   1,047.7  

Total liabilities and shareholders' equity

    4,360.2     (5.2 )   1.9     4,356.9  
32


Notes to Consolidated Financial Statements

        The effects of the revision on our Consolidated Statements of Income were as follows:

 
  2014   2013  
(In millions)
  As
Previously
Reported

  Adjustment
  As
Revised

  As
Previously
Reported

  Adjustment
  As
Revised

 

Marketing, general and administrative expense

  $ 1,155.3   $ 3.6   $ 1,158.9   $ 1,179.0   $ (4.8 ) $ 1,174.2  

Interest expense

    63.3         63.3     59.0     1.9     60.9  

Income from continuing operations before taxes

    364.4     (3.6 )   360.8     363.1     2.9     366.0  

Provision for income taxes

    113.3     .2     113.5     118.8     5.5     124.3  

Income from continuing operations

   
251.1
   
(3.8

)
 
247.3
   
244.3
   
(2.6

)
 
241.7
 

Loss from discontinued operations, net of tax

    (2.2 )       (2.2 )   (28.5 )       (28.5 )

Net income

    248.9     (3.8 )   245.1     215.8     (2.6 )   213.2  

Per share amounts:

   
 
   
 
   
 
   
 
   
 
   
 
 

Net income (loss) per common share:

                                     

Continuing operations

  $ 2.68   $ (.04 ) $ 2.64   $ 2.48   $ (.02 ) $ 2.46  

Discontinued operations

    (.03 )       (.03 )   (.29 )       (.29 )

Net income per common share

  $ 2.65   $ (.04 ) $ 2.61   $ 2.19   $ (.02 ) $ 2.17  

Net income (loss) per common share, assuming dilution:

                                     

Continuing operations

  $ 2.62   $ (.04 ) $ 2.58   $ 2.44   $ (.03 ) $ 2.41  

Discontinued operations

    (.02 )       (.02 )   (.28 )       (.28 )

Net income per common share, assuming dilution

  $ 2.60   $ (.04 ) $ 2.56   $ 2.16   $ (.03 ) $ 2.13  

        The effects of the revision on our Consolidated Statements of Comprehensive Income were as follows:

 
  2014   2013  
(In millions)
  As
Previously
Reported

  Adjustment
  As
Revised

  As
Previously
Reported

  Adjustment
  As
Revised

 

Net income

  $ 248.9   $ (3.8 ) $ 245.1   $ 215.8   $ (2.6 ) $ 213.2  

Translation loss

    (154.7 )   4.9     (149.8 )   (53.3 )   3.1     (50.2 )

Pension and other postretirement benefits:

                                     

Net (loss) gain recognized from actuarial gain/loss and prior service cost/credit

    (129.4 )   4.2     (125.2 )   29.4     18.7     48.1  

Reclassifications to net income

    16.9         16.9     9.0     1.0     10.0  

Other comprehensive (loss) income, net of tax

    (266.2 )   9.1     (257.1 )   (3.1 )   22.8     19.7  

Total comprehensive (loss) income, net of tax

    (17.3 )   5.3     (12.0 )   212.7     20.2     232.9  

        The effects of the revision on our Consolidated Statements of Cash Flows were as follows:

 
  2014   2013  
(In millions)
  As
Previously
Reported

  Adjustment
  As
Revised

  As
Previously
Reported

  Adjustment
  As
Revised

 

Net cash provided by operating activities

  $ 374.2   $ (19.3 ) $ 354.9   $ 320.1   $ (.5 ) $ 319.6  

(Decrease) increase in cash and cash equivalents

    (124.6 )   (19.3 )   (143.9 )   116.2     (.5 )   115.7  

Use of Estimates

        The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions for the reporting period and as of the date of the financial statements. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expense. Actual results could differ from these estimates.

Cash and Cash Equivalents

        Cash and cash equivalents generally consist of cash on hand, deposits in banks, as well as bank drafts and short-term investments with maturities of three months or less when purchased or received. The carrying value of these assets approximates fair value due to the short maturity of the instruments.

33        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

Accounts Receivable

        We record trade accounts receivable at the invoiced amount. The allowance for doubtful account reserve represents allowances for customer trade accounts receivable that are estimated to be partially or entirely uncollectible. The customer complaint reserve represents estimated sales returns and allowances. These allowances are used to reduce gross trade receivables to their net realizable values. We record these allowances based on estimates related to:

        No single customer represented 10% or more of our net sales in, or trade accounts receivable at, year-end 2015 or 2014. However, during 2015, 2014, and 2013 our ten largest customers by net sales represented approximately 15%, 13%, and 12% of our net sales, respectively. As of January 2, 2016 and January 3, 2015, our ten largest customers by trade accounts receivable represented approximately 14% and 15% of our trade accounts receivable, respectively. These customers were concentrated primarily in our Pressure-sensitive Materials reportable segment. We do not generally require our customers to provide collateral.

Inventories

        Inventories are stated at the lower-of-cost-or-market value and are categorized as raw materials, work-in-progress or finished goods. Cost is determined using the first-in, first-out method. Inventory reserves are recorded to cost of products sold for damaged, obsolete, excess and slow-moving inventory and we establish a lower cost basis for the inventory. We use estimates to record these reserves. Slow-moving inventory is reviewed by category and may be partially or fully reserved for depending on the type of product, level of usage, and the length of time the product has been included in inventory.

Property, Plant and Equipment

        Depreciation is generally computed using the straight-line method over the estimated useful lives of the assets, ranging from ten to forty-five years for buildings and improvements and three to fifteen years for machinery and equipment. Leasehold improvements are depreciated over the shorter of the useful life of the asset or the term of the associated leases. Maintenance and repair costs are expensed as incurred; renewals and betterments are capitalized. Upon the sale or retirement of assets, the accounts are relieved of the cost and the related accumulated depreciation, with any resulting gain or loss included in net income.

Software

        We capitalize internal and external software costs that are incurred during the application development stage of software development, including costs incurred for the design, coding, installation to hardware, testing, and upgrades and enhancements that provide the software or hardware with additional functionalities and capabilities. Internal and external software costs during the preliminary project stage are expensed, as are those costs during the post-implementation and/or operation stage, including internal and external training costs and maintenance costs. Capitalized software, which is included in "Other assets" in the Consolidated Balance Sheets, is amortized on a straight-line basis over the estimated useful life of the software, which is generally between five and ten years.

Impairment of Long-lived Assets

        Impairment charges are recorded when the carrying amounts of long-lived assets are determined not to be recoverable. Recoverability is measured by comparing the undiscounted cash flows expected from their use and eventual disposition to the carrying value of the related asset or asset group. The amount of impairment loss is calculated as the excess of the carrying value over the fair value. Historically, changes in market conditions and management strategy have caused us to reassess the carrying amount of our long-lived assets.

Goodwill and Other Intangibles Resulting from Business Acquisitions

        Business combinations are accounted for by the acquisition method, with the excess of the acquisition cost over the fair value of net tangible assets and identified intangible assets acquired considered goodwill. As a result, we disclose goodwill separately from other intangible assets. Other identifiable intangibles include customer relationships, patents and other acquired technology, trade names and trademarks, and other intangibles.

        We have the following reporting units: materials; retail branding and information solutions; reflective solutions; performance tapes; and medical solutions. In performing the required impairment tests, we primarily apply a present value (discounted cash flow) method to determine the fair value of the reporting units with goodwill. We perform our annual impairment test of goodwill during the fourth quarter.

        Certain factors may result in the need to perform an impairment test prior to the fourth quarter, including significant underperformance of a business relative to expected operating results, significant adverse economic and industry trends, significant decline in our market capitalization for an extended period of time relative to net book value, or a decision to divest a portion of a reporting unit.

        We determine goodwill impairment using a two-step process. The first step is to identify if a potential impairment exists by comparing the fair value of a reporting unit with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not considered to have a potential impairment and the second step of the impairment test is not necessary. However, if the carrying amount of a reporting unit exceeds its fair value, the second step is performed to determine if goodwill is impaired and to measure the amount of impairment loss to recognize, if any.

        The second step, if necessary, compares the implied fair value of goodwill with the carrying amount of goodwill. If the implied fair value of goodwill exceeds the carrying amount, then goodwill is not considered impaired. However, if the carrying amount of goodwill exceeds the implied fair value, an impairment loss is recognized in an amount equal to that excess.

        In consultation with outside specialists, we estimate the fair value of our reporting units using various valuation techniques, with the primary technique being a discounted cash flow analysis. A discounted cash flow analysis requires us to make various assumptions about the reporting units, including sales, operating margins, growth rates, and discount rates. Assumptions about discount rates are based on a weighted-average cost of capital for comparable companies. Assumptions about sales, operating margins, and growth rates are based on our forecasts, business plans, economic projections, anticipated future cash flows and marketplace data. Assumptions are also made for varying perpetual growth rates for periods beyond the long-term business plan period. We base our fair value estimates on projected financial information and assumptions that we believe are

34


Notes to Consolidated Financial Statements

reasonable. However, actual future results may differ from those estimates and projections, and those differences may be material. The valuation methodology used to estimate the fair value of reporting units requires inputs and assumptions that reflect current market conditions, as well as the impact of planned business and operational strategies that require management judgment. The estimated fair value could increase or decrease depending on changes in the inputs and assumptions.

        We test indefinite-lived intangible assets, consisting of trademarks, for impairment in the fourth quarter or whenever events or circumstances indicate that it is more likely than not that their carrying amounts exceed their fair values. Fair value is estimated as the discounted value of future revenues using a royalty rate that a third party would pay for use of the asset. Variation in the royalty rates could impact the estimate of fair value. If the carrying amount of an asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.

        See also Note 3, "Goodwill and Other Intangibles Resulting from Business Acquisitions."

Foreign Currency

        Asset and liability accounts of international operations are translated into U.S. dollars at current rates. Revenues and expenses are translated at the weighted-average currency rate for the fiscal year. Gains and losses resulting from hedging the value of investments in certain international operations and from translation of balance sheet accounts are recorded directly as a component of other comprehensive income.

Financial Instruments

        We enter into foreign exchange hedge contracts to reduce our risk from exchange rate fluctuations associated with receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S. We enter into interest rate contracts to help manage our exposure to certain interest rate fluctuations. We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The maximum length of time for which we hedge our exposure to the variability in future cash flows for forecasted transactions is 36 months.

        On the date we enter into a derivative contract, we determine whether the derivative will be designated as a hedge. Those derivatives not designated as hedges are recorded on the balance sheets at fair value, with changes in the fair value recognized in earnings. Those derivatives designated as hedges are classified as either (1) hedges of the fair value of a recognized asset or liability or an unrecognized firm commitment ("fair value" hedges); or (2) hedges of a forecasted transaction or the variability of cash flows that are to be received or paid in connection with a recognized asset or liability ("cash flow" hedges). Our policy is not to purchase or hold any foreign currency, interest rate or commodity contracts for trading purposes.

        We assess, both at the inception of the hedge and on an ongoing basis, whether hedges are highly effective. If it is determined that a hedge is not highly effective, we prospectively discontinue hedge accounting. For cash flow hedges, the effective portion of the related gains and losses is recorded as a component of other comprehensive income, and the ineffective portion is reported in earnings. Amounts in accumulated other comprehensive income (loss) are reclassified into earnings in the same period during which the hedged transaction affects earnings. In the event the anticipated transaction is no longer likely to occur, we recognize the change in fair value of the instrument in current period earnings. Changes in fair value hedges are recognized in current period earnings. Changes in the fair value of underlying hedged items (such as recognized assets or liabilities) are also recognized in current period earnings and offset the changes in the fair value of the derivative.

        In the Consolidated Statements of Cash Flows, hedges are classified in the same category as the item hedged, primarily in operating activities.

        See also Note 5, "Financial Instruments."

Fair Value Measurements

        We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability.

        We determine fair value based on a three-tier fair value hierarchy, which we use to prioritize the inputs used in measuring fair value. These tiers consist of Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring us to develop our own assumptions to determine the best estimate of fair value.

Revenue Recognition

        Sales are recognized when persuasive evidence of an arrangement exists, pricing is determinable, delivery has occurred based on applicable sales terms, and collection is reasonably assured. Sale terms are free on board (f.o.b.) shipping point or f.o.b. destination, depending upon local business customs. For most regions in which we operate, f.o.b. shipping point terms are utilized and sales are recorded at the time of shipment, because this is when title and risk of loss are transferred. In certain regions, notably in Europe and China, f.o.b. destination terms are generally utilized and sales are recorded when the products are delivered to the customer's delivery site, because this is when title and risk of loss are transferred. Furthermore, sales, provisions for estimated returns, and the cost of products sold are recorded at the time title transfers to customers and when the customers assume the risks and rewards of ownership. Actual product returns are charged against estimated sales return allowances.

        Sales rebates and discounts are common practices in the industries in which we operate. Volume, promotional, price, cash and other discounts and customer incentives are accounted for as a reduction to gross sales. Rebates and discounts are recorded based upon estimates at the time products are sold. These estimates are based on our historical experience for similar programs and products. We review these rebates and discounts on an ongoing basis and accruals for rebates and discounts are adjusted, if necessary, as additional information becomes available.

35        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

Research and Development

        Research and development costs are related to research, design and testing of new products and applications and are expensed as incurred.

Long-Term Incentive Compensation

        No long-term incentive compensation expense was capitalized in 2015, 2014, or 2013.

        Changes in estimated forfeiture rates are recorded as cumulative adjustments in the period estimates are revised.

Valuation of Stock-Based Awards

        Our stock-based compensation expense is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a straight-line basis over the requisite service period for stock options and restricted stock units ("RSUs"). Compensation expense for performance units ("PUs") is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a straight-line basis as these awards cliff-vest at the end of the requisite service period. The compensation expense related to market-leveraged stock units ("MSUs") is based on the fair value of awards, adjusted for estimated forfeitures, and amortized on a graded-vesting basis over their respective performance periods.

        Compensation expense for awards with a market condition as a performance objective, which includes PUs and MSUs, is not adjusted if the condition is not met, as long as the requisite service period is met.

        The fair value of stock options is estimated as of the date of grant using the Black-Scholes option-pricing model. This model requires input assumptions for our expected dividend yield, expected stock price volatility, risk-free interest rate and the expected option term.

        The fair value of RSUs and certain PUs that are subject to achievement of performance objectives based on a performance condition is determined based on the fair market value of our common stock as of the date of grant, adjusted for foregone dividends.

        The fair value of stock-based awards that are subject to achievement of performance objectives based on a market condition, which includes MSUs and certain PUs, is determined using the Monte-Carlo simulation model, which utilizes multiple input variables, including expected stock price volatility and other assumptions appropriate for determining fair value, to estimate the probability of satisfying the target performance objectives established for the award.

        Certain of these assumptions are based on management's estimates, in consultation with outside specialists. Significant changes in assumptions for future awards and actual forfeiture rates could materially impact stock-based compensation expense and our results of operations.

Valuation of Cash-Based Awards

        Cash-based awards consist of long-term incentive units ("LTI Units") granted to eligible employees. Cash-based awards are classified as liability awards and remeasured at each quarter-end over the applicable vesting or performance period. In addition to LTI Units with terms and conditions that mirror those of RSUs, we also grant certain employees LTI Units with terms and conditions that mirror those of PUs and MSUs.

Accounting for Income Taxes for Stock-Based Compensation

        We elected to use the short-cut method to calculate the historical pool of windfall tax benefits related to employee and non-employee director stock-based compensation awards. In addition, we elected to follow the tax law ordering approach to determine the sequence in which deductions and net operating loss carryforwards are utilized, as well as the direct-only approach to calculate the amount of windfall or shortfall tax benefits.

        See also Note 12, "Long-term Incentive Compensation."

Taxes Based on Income

        Our provision for income taxes is determined using the asset and liability approach following the provisions of ASC 740, Accounting for Income Taxes. Under this approach, deferred income taxes represent the expected future tax consequences of temporary differences between the carrying amounts and tax basis of assets and liabilities. We record a valuation allowance to reduce our deferred tax assets when uncertainty regarding their realizability exists. We recognize and measure our uncertain tax positions following the more-likely-than-not threshold for financial statement recognition and measurement for tax positions taken or expected to be taken in a tax return.

        See also Note 14, "Taxes Based on Income."

Recent Accounting Requirements

        In January 2016, the Financial Accounting Standards Board ("FASB") amended guidance to require all equity investments to be measured at fair value, with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in consolidation of the investee). In addition, the amendments eliminate certain requirements regarding equity investments. This guidance is effective for annual periods beginning after December 15, 2017, including interim periods within those fiscal years. We do not anticipate that adoption of this amended guidance will have a significant impact on our financial position, results of operations, cash flows, or disclosures.

        In November 2015, the FASB amended guidance to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods, with early application permitted for all entities as of the beginning of an interim or annual reporting period. The amendments can be applied either (i) prospectively to all deferred tax liabilities and assets or (ii) retrospectively to all periods presented. We elected to early adopt this standard for our fiscal year 2015 prospectively. The amendments had no impact on our results of operations, cash flows, or disclosures.

        In July 2015, the FASB amended guidance to simplify the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. This guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those fiscal years. We do not anticipate that adoption of this amended guidance will have a significant impact on our results of operations, cash flows, or disclosures.

        In May 2015, the FASB amended guidance to remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value ("NAV") per share (or its equivalent) practical expedient. Additionally, the amended guidance removes the requirement to make certain disclosures for all

36


Notes to Consolidated Financial Statements

investments that are eligible to be measured at fair value using the NAV per share practical expedient. We elected to early adopt this standard for our fiscal year 2015, which eliminated the requirement for us to categorize investments for which fair values are measured using the NAV per share in our consolidated financial statements. Refer to revised fair value disclosures in Note 6, "Pension and Other Postretirement Benefits."

        In April 2015, the FASB issued guidance about accounting for fees paid in a cloud computing arrangement. Examples of cloud computing arrangements include software as a service, platform as a service, infrastructure as a service, and other similar hosting arrangements. As clarified in the guidance, if a cloud computing arrangement includes a software license, the software license element of the arrangement should be accounted for consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the arrangement should be accounted for as a service contract. This guidance is effective for annual periods beginning after December 15, 2015, and interim periods within those fiscal years, and may be adopted prospectively or retrospectively. We do not anticipate that adoption of this guidance will have a significant impact on our financial position, results of operations, cash flows, or disclosures.

        In April 2015, the FASB revised guidance to allow employers with fiscal year-ends that do not coincide with a calendar month-end to make an accounting policy election to measure defined benefit plan assets and obligations as of the end of the calendar month closest to their fiscal year-end. Employers that make this election must apply the alternative measurement date to all defined benefit plans. The guidance also allows all employers to elect to remeasure defined plan assets and obligations in interim periods at the closest calendar month-end to an event that triggers the remeasurement. We elected to early adopt this standard prospectively for our fiscal year 2015. Refer to Note 6, "Pension and Other Postretirement Benefits."

        In April 2015, the FASB revised guidance on the presentation of debt issuance costs. Under this revised guidance, debt issuance costs should be presented in the balance sheet as a direct deduction from the carrying value of the associated debt, consistent with the presentation of a debt discount. In August 2015, this guidance was further revised to allow for debt issuance costs related to line-of-credit arrangements to be classified as assets and amortized ratably over the term of the arrangement. This revised guidance is effective for annual periods beginning after December 15, 2015, and interim periods within those fiscal years. We elected to early adopt this standard for our fiscal year 2015 retrospectively. The impact of this adoption is presented in "Prior Period Financial Statement Revision, Reclassifications, and Accounting Changes." We continue to present debt issuance costs related to our line-of-credit arrangements as "Other assets" in the Consolidated Balance Sheets, as allowed under the guidance.

        In January 2015, the FASB issued guidance on simplification of income statement classification by removing the concept of extraordinary items from GAAP. Items that are both unusual and infrequent will no longer be separately reported net of tax after continuing operations. The existing requirement to separately present items that are of an unusual nature or occur infrequently on a pre-tax basis within income from continuing operations has been retained and was expanded to include items that are both unusual and infrequent. These items may be presented in the income statement or disclosed in the footnotes to the financial statements. The guidance is effective for periods beginning after December 15, 2015. Early adoption is permitted, but only as of the beginning of the fiscal year of adoption. We do not expect that our adoption of this standard will have any impact on our financial position, results of operations, cash flows, or disclosures.

        In August 2014, the FASB issued a new standard that requires an entity to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern. Management's evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Under this new standard, substantial doubt exists when it is probable that the entity will be unable to meet its obligations as they become due within one year of the date the financial statements are issued. If applicable, certain disclosures are required, including management's plans to mitigate those relevant conditions or events to alleviate the substantial doubt. This standard is effective for annual periods and interim periods within those annual periods ending after December 15, 2016. Early adoption is permitted. We do not expect that adoption of this standard will have any impact on our financial position, results of operations, cash flows, or disclosures.

        In June 2014, the FASB revised guidance on share-based compensation awards that require a specific performance target to be achieved in order for the awards to vest. This revised guidance requires that a performance target that impacts vesting that can be achieved after the requisite service period be treated as a performance condition. As such, a performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that a performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The revised guidance is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, and can be applied either (i) prospectively to all awards granted or modified after the effective date or (ii) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. Early adoption is permitted. We do not anticipate that our adoption of this revised guidance will have a significant impact on our financial position, results of operations, cash flows, or disclosures.

        In May 2014, the FASB issued revised guidance on revenue recognition. This revised guidance provides a single comprehensive model for accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This revised guidance will require an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This update creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which includes (i) identifying the contract(s) with the customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv) allocating the transaction price to the separate performance obligations, and (v) recognizing revenue when each performance obligation is satisfied. This revised guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including qualitative and quantitative information about contracts with customers, significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This revised guidance is effective for fiscal years beginning after December 15, 2017, and interim

37        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

periods within those fiscal years, and can be applied retrospectively either to each prior reporting period presented or with the cumulative effect of adoption recognized at the date of initial application. Early adoption is permitted for fiscal periods beginning after December 15, 2016. Based on the information we have evaluated to date, we do not anticipate that the adoption of this revised guidance will have a significant impact on our financial position, results of operations, or cash flows.

NOTE 2. DISCONTINUED OPERATIONS, SALE OF PRODUCT LINE, AND SALE OF ASSETS

Discontinued Operations

        On January 29, 2013, we entered into an agreement to sell our former OCP and DES businesses to CCL Industries Inc. ("CCL").

        On July 1, 2013, we completed the sale for a total purchase price of $500 million ($481.2 million net of cash provided) and entered into an amendment to the purchase agreement, which, among other things, increased the target net working capital amount and amended provisions related to employee matters and indemnification. We continue to be subject to certain indemnification obligations under the terms of the purchase agreement. In addition, the tax liability associated with the sale is subject to completion of tax return filings in certain foreign jurisdictions where we operated the OCP and DES businesses.

        At closing, we entered into a supply agreement pursuant to which CCL agreed to purchase certain pressure-sensitive label stock, adhesives and other base material products from us for up to six years after closing. While the supply agreement is expected to continue generating revenues and cash flows from the OCP and DES businesses, our continuing involvement in the OCP and DES operations is not expected to be significant to us as a whole.

        The operating results of the discontinued operations and loss on sale were as follows:

(In millions)
  2015
  2014
  2013
 

Net sales

  $   $   $ 380.4  

Loss before taxes, including divestiture-related and restructuring charges

  $   $   $ (12.4 )

Provision for income taxes

            (.1 )

Loss from discontinued operations, net of tax before loss on sale

            (12.5 )

(Loss) gain on sale before taxes

        (3.3 )   49.4  

Tax (provision) benefit on sale

    (.1 )   1.1     (65.4 )

Loss from discontinued operations, net of tax

  $ (.1 ) $ (2.2 ) $ (28.5 )

        Loss from discontinued operations, net of tax, for 2015 included tax expense related to the completion of certain tax returns related to the sale of the OCP and DES businesses. The loss from discontinued operations, net of tax, for 2014 reflected costs related to the resolution of certain post-closing adjustments in the third quarter of 2014.

        The loss before taxes, including divestiture-related and restructuring charges, for 2013 included a curtailment gain associated with our postretirement health and welfare benefit plans, partially offset by divestiture-related costs. Refer to Note 6, "Pension and Other Postretirement Benefits," for information regarding the curtailment gain. The loss from discontinued operations, net of tax, reflected the elimination of certain corporate cost allocations. The income tax provision included in the net loss on sale reflected tax versus book basis differences, primarily associated with goodwill.

        Net sales from continuing operations to discontinued operations were $45.8 million during 2013. These sales have been included in "Net sales" in the Consolidated Statements of Income.

Sale of Product Line

        In May 2015, we sold certain assets and transferred certain liabilities associated with a product line in our Retail Branding and Information Solutions ("RBIS") reportable segment for $1.5 million. The pre-tax loss from the sale, when combined with exit costs related to the sale, totaled $8.5 million. The exit costs included $3.4 million of severance costs, of which $1.7 million had been paid as of January 2, 2016. In the first quarter of 2015, we recorded an impairment charge of approximately $2 million related to certain long-lived assets in this product line. This loss and these costs were included in "Other expense, net" in the Consolidated Statements of Income.

Sale of Assets

        In September 2014, we sold properties in Framingham, Massachusetts used primarily as the former headquarters of our RBIS business for $3.3 million, recognizing a pre-tax gain of $1.9 million. In April 2013, we sold the property and equipment of our former corporate headquarters in Pasadena, California for approximately $20 million, recognizing a pre-tax gain of $10.9 million. During 2013, we also completed the sale of certain property, plant and equipment in China for approximately $11 million, as well as the sale of a research facility located in Pasadena, California for approximately $5 million. These gains were recorded in "Other expense, net" in the Consolidated Statements of Income.

NOTE 3. GOODWILL AND OTHER INTANGIBLES RESULTING FROM BUSINESS ACQUISITIONS

Goodwill

        Results from our annual goodwill impairment test in the fourth quarter of 2015 indicated that no impairment occurred in 2015. The fair value of these assets was primarily based on Level 3 inputs.

        Changes in the net carrying amount of goodwill for 2015 and 2014 by reportable segment were as follows:

(In millions)
  Pressure-
sensitive
Materials

  Retail
Branding and
Information
Solutions

  Total
 

Goodwill as of December 28, 2013

  $ 334.8   $ 423.7   $ 758.5  

Translation adjustments

    (28.2 )   (8.7 )   (36.9 )

Goodwill as of January 3, 2015

    306.6     415.0     721.6  

Acquisition adjustments

        (.4 )   (.4 )

Translation adjustments

    (28.7 )   (6.3 )   (35.0 )

Goodwill as of January 2, 2016

  $ 277.9   $ 408.3   $ 686.2  
38


Notes to Consolidated Financial Statements

        The carrying amounts of goodwill at January 2, 2016 and January 3, 2015 were net of accumulated impairment losses of $820 million, which were included in our RBIS reportable segment.

        There was no goodwill associated with our Vancive Medical Technologies reportable segment.

Indefinite-Lived Intangible Assets

        In the third quarter of 2014, we determined that there was a need to conduct an interim impairment test of our indefinite-lived intangible assets, consisting of certain trade names and trademarks. The factors considered included a shortfall in 2014 full-year projected revenue and a reduction in 2015 projected revenue associated with these assets. The interim impairment test indicated that the fair value of our indefinite-lived intangible assets was less than their carrying value, which resulted in a non-cash asset impairment charge of $3 million. This charge was recorded in "Other expense, net" in the Consolidated Statements of Income and included in our RBIS reportable segment. Results from our annual impairment test in the fourth quarter of 2014 indicated that no further impairment had occurred related to indefinite-lived intangible assets. The fair value of these assets was primarily based on Level 3 inputs.

        Results from our annual indefinite-lived intangible assets impairment test in the fourth quarter of 2015 indicated that no impairment occurred in 2015.

        The carrying value of indefinite-lived intangible assets resulting from business acquisitions, consisting of trade names and trademarks, was $7.8 million and $7.9 million at January 2, 2016 and January 3, 2015, respectively.

Finite-Lived Intangible Assets

        The following table sets forth our finite-lived intangible assets resulting from business acquisitions at January 2, 2016 and January 3, 2015, which continue to be amortized:

 
  2015   2014  
(In millions)
  Gross
Carrying
Amount

  Accumulated
Amortization

  Net
Carrying
Amount

  Gross
Carrying
Amount

  Accumulated
Amortization

  Net
Carrying
Amount

 

Customer relationships

  $ 224.3   $ 193.9   $ 30.4   $ 228.9   $ 180.2   $ 48.7  

Patents and other acquired technology

    49.0     45.3     3.7     49.0     42.7     6.3  

Trade names and trademarks

    22.0     18.7     3.3     24.0     20.5     3.5  

Other intangibles

    11.8     11.2     .6     12.3     11.3     1.0  

Total

  $ 307.1   $ 269.1   $ 38.0   $ 314.2   $ 254.7   $ 59.5  

        Amortization expense from continuing operations for finite-lived intangible assets resulting from business acquisitions was $20.5 million for 2015, $24.4 million for 2014, and $28.5 million for 2013.

        The estimated amortization expense for finite-lived intangible assets resulting from business acquisitions for each of the next five fiscal years is expected to be as follows:

(In millions)
  Estimated
Amortization
Expense

 

2016

  $ 18.5  

2017

    9.8  

2018

    2.7  

2019

    1.7  

2020

    1.2  

NOTE 4. DEBT AND CAPITAL LEASES

Short-Term Borrowings

        We had $28 million and $87 million of borrowings from commercial paper issuances outstanding (weighted-average interest rate of .7% and .4%, respectively) at January 2, 2016 and January 3, 2015, respectively.

Short-Term Credit Facilities

        In October 2014, we amended and restated our revolving credit facility (the "Revolver") with certain domestic and foreign banks, increasing the amount available thereunder from $675 million to $700 million. The amendment also extended the Revolver's maturity date from December 22, 2016 to October 3, 2019 and adjusted pricing to reflect favorable market conditions. The maturity date may be extended for additional one-year periods under certain circumstances. The commitments under the Revolver may be increased by up to $325 million, subject to lender approval and customary requirements. The Revolver is used as a back-up facility for our commercial paper program and can be used for other corporate purposes.

        No balances were outstanding under the Revolver as of January 2, 2016 or January 3, 2015. Commitment fees associated with the Revolver in 2015, 2014, and 2013 were $1.9 million, $1.3 million, and $1.4 million, respectively.

        In addition to the Revolver, we have significant short-term lines of credit available in various countries totaling approximately $300 million at January 2, 2016. These lines may be cancelled at any time by us or the issuing banks. Short-term borrowings outstanding under our lines of credit were $65 million (weighted-average interest rate of 8.7%) and $111.6 million (weighted-average interest rate of 9.4%) at January 2, 2016 and January 3, 2015, respectively.

39        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

Long-Term Borrowings and Capital Leases

        Long-term debt, including its respective interest rates, and capital lease obligations at year-end consisted of the following:

(In millions)
  2015
  2014
 

Long-term debt and capital leases

             

Medium-term notes:

             

Series 1995 due 2020 through 2025

  $ 44.9   $ 49.9  

Long-term notes:

             

Senior notes due 2017 at 6.6%

    249.4     248.9  

Senior notes due 2020 at 5.4%

    249.0     248.8  

Senior notes due 2023 at 3.4%

    248.2     247.9  

Senior notes due 2033 at 6.0%

    148.6     148.5  

Capital leases

    26.0     1.8  

Less amount classified as current

    (2.5 )   (5.7 )

Total long-term debt and capital leases (1)

  $ 963.6   $ 940.1  
(1)
Includes unamortized debt issuance cost and debt discount of $4.4 million and $.5 million as of year-end 2015 and $5.2 million and $.7 million as of year-end 2014, respectively.

        At year-end 2015, our medium-term notes have maturities from 2020 through 2025 and accrue interest at an average fixed rate of 7.5%.

        Maturities of long-term debt and capital lease payments for each of the next five fiscal years and thereafter are expected to be as follows:

Year
  (In millions)
 

2016 (classified as current)

  $ 3.7  

2017

    253.7  

2018

    3.7  

2019

    3.6  

2020

    268.3  

2021 and thereafter

    444.2  

        The maturities of capital lease payments in the table above include $6.2 million of imputed interest, of which $1.2 million is expected to be paid in 2016.

        In April 2013, we issued $250 million of senior notes due April 2023. The notes bear an interest rate of 3.35% per year, payable semiannually in arrears. Net proceeds from the offering, after deducting underwriting discounts and offering expenses, of approximately $247.5 million were used to repay a portion of the indebtedness outstanding under our commercial paper program during the second quarter of 2013.

        In January 2013, we repaid $250 million of senior notes at maturity using commercial paper borrowings.

        In May 2015, we extended and amended the lease on our Mentor, Ohio facility for an additional ten years. This facility is used primarily as the North American headquarters and research center of our Materials Group business. Because ownership of the facility transfers to us at the end of the lease term, it was accounted for as a capital lease. The carrying value of the lease at January 2, 2016 was approximately $25 million, of which approximately $23 million was included in "Long-term debt and capital leases" and approximately $2 million was included in "Short-term borrowings and current portion of long-term debt and capital leases" in the Consolidated Balance Sheets at January 2, 2016.

Other

        The Revolver contains financial covenants requiring that we maintain specified ratios of total debt and interest expense in relation to certain measures of income. We were in compliance with our financial covenants as of January 2, 2016 and January 3, 2015.

        Our total interest costs from continuing operations in 2015, 2014, and 2013, were $63.5 million, $67.2 million and $64.2 million, respectively, of which $3 million, $3.9 million, and $3.3 million, respectively, were capitalized as part of the cost of assets.

        The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities on notes with similar rates, credit ratings, and remaining maturities. The fair value of short-term borrowings, which include commercial paper issuances and short-term lines of credit, approximates carrying value given the short duration of these obligations. The fair value of our total debt was $1.08 billion at January 2, 2016 and $1.22 billion at January 3, 2015. Fair value amounts were determined primarily based on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable. Refer to Note 1, "Summary of Significant Accounting Policies," for more information.

NOTE 5. FINANCIAL INSTRUMENTS

        As of January 2, 2016, the aggregate U.S. dollar equivalent notional value of our outstanding commodity contracts and foreign exchange contracts was $3.1 million and $1.11 billion, respectively.

        We recognize all derivative instruments as either assets or liabilities at fair value in the Consolidated Balance Sheets. We designate commodity forward contracts on forecasted purchases of commodities and foreign exchange contracts on forecasted transactions as cash flow hedges and designate foreign exchange contracts on existing balance sheet items as fair value hedges.

        The following table provides the fair value and balance sheet locations of derivatives as of January 2, 2016:

 
  Asset   Liability  
(In millions)
  Balance Sheet Location
  Fair Value
  Balance Sheet Location
  Fair Value
 

Foreign exchange contracts

  Other current assets   $ 5.6   Other accrued liabilities   $ 4.5  

Commodity contracts

  Other current assets       Other accrued liabilities     .7  

      $ 5.6       $ 5.2  
40


Notes to Consolidated Financial Statements

        The following table provides the fair value and balance sheet locations of derivatives as of January 3, 2015:

 
  Asset   Liability  
(In millions)
  Balance Sheet Location
  Fair Value
  Balance Sheet Location
  Fair Value
 

Foreign exchange contracts

  Other current assets   $ 10.3   Other accrued liabilities   $ 10.5  

Commodity contracts

  Other current assets       Other accrued liabilities     1.0  

            Long-term retirement benefits and other liabilities     .2  

      $ 10.3       $ 11.7  

Fair Value Hedges

        For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings, resulting in no material net impact to income.

        The following table provides the components of the net gain (loss) recognized in income related to fair value hedge contracts. The corresponding gains or losses on the underlying hedged items approximated the net gain (loss) on these fair value hedge contracts.

(In millions)
  Location of Net Gains (Losses) in Income
  2015
  2014
  2013
 

Foreign exchange contracts

  Cost of products sold   $ 2.9   $ (1.6 ) $ 2.3  

Foreign exchange contracts

  Marketing, general and administrative expense     2.9     (43.3 )   (35.9 )

      $ 5.8   $ (44.9 ) $ (33.6 )

Cash Flow Hedges

        For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of "Accumulated other comprehensive loss" and reclassified into earnings in the same period(s) during which the hedged transaction impacts earnings. Gains and losses on the derivatives, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in current earnings.

        Gains (losses) recognized in "Accumulated other comprehensive loss" (effective portion) on derivatives related to cash flow hedge contracts were as follows:

(In millions)
  2015
  2014
  2013
 

Foreign exchange contracts

  $ (.1 ) $ 1.3   $ 1.1  

Commodity contracts

    (.7 )   (1.2 )   (.1 )

  $ (.8 ) $ .1   $ 1.0  

        The amount of gain or loss recognized in income related to the ineffective portion of, and the amount excluded from, effectiveness testing for cash flow hedges and derivatives not designated as hedging instruments were not material in 2015, 2014 or 2013.

        As of January 2, 2016, we expect a net loss of approximately $2 million to be reclassified from "Accumulated other comprehensive loss" to earnings within the next 12 months.

NOTE 6. PENSION AND OTHER POSTRETIREMENT BENEFITS

Defined Benefit Plans

        We sponsor a number of defined benefit plans, the accrual of benefits under some of which has been frozen, covering eligible employees in the U.S. and certain other countries. Benefits payable to an employee are based primarily on years of service and the employee's compensation during the course of his or her employment with us.

        We are also obligated to pay unfunded termination indemnity benefits to certain employees outside of the U.S., which are subject to applicable agreements, laws and regulations. We have not incurred significant costs related to these benefits, and therefore, no related costs are included in the disclosures below.

        In December 2015, we offered eligible former employees who are vested participants in our Avery Dennison Pension Plan ("ADPP") the opportunity to receive their benefits immediately as either a lump-sum payment or an annuity, rather than waiting until they are retirement eligible under the terms of the plan. Payments associated with this offer are expected to be made out of existing plan assets during the first half of 2016. No additional contributions to the plan are required to complete the offering.

        Employees who participated in the ADPP, between December 1, 1986 and November 30, 1997, may also have had a benefit in a Stock Holding and Retirement Enhancement Account ("SHARE Account") associated with our defined contribution plan. The ADPP is a floor offset plan that coordinated the amount of projected benefit obligation to an eligible participant with his or her SHARE Account such that the total benefit payable to an eligible participant would equal the greater of the value of the participant's benefit from the ADPP or the value of the participant's SHARE Account. Lower than expected asset returns on the participant balances in the SHARE Account could have increased the projected benefit obligation under the ADPP. In the fourth quarter of 2013, we amended our plan documents to require participants to make an early election either to (a) receive their assets in the SHARE Account as a distribution, in which case their retirement benefit under the ADPP would be offset by the annuity equivalent of these assets, or (b) transfer their SHARE Account assets to the ADPP and receive the full ADPP retirement benefit in annuity form, rather than wait to make such election upon termination of employment. The amendment resulted in an actuarial loss of approximately $20 million to the ADPP in 2013. By October 2014, all participants with a SHARE Account completed their elections and the existing SHARE Accounts were terminated, resulting in our recording an additional actuarial loss of $12 million. These actuarial losses are subject to future amortization.

41        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

Plan Assets

        Our investment management of the ADPP assets utilizes a liability driven investment (LDI) strategy. Under an LDI strategy, the assets are invested in a diversified portfolio that is split into two sub-portfolios: a growth portfolio and a liability hedging portfolio. The growth portfolio consists primarily of equity and high-yield fixed income securities. The liability hedging portfolio consists primarily of investment grade fixed income securities and cash, and is intended, over time, to more closely match the liabilities of the plan. The investment objective of the portfolio is to improve the funded status of the plan; as funded status reaches certain trigger points, the portfolio moves to a more conservative asset allocation by increasing the allocation to the liability hedging portfolio. The current target allocation is 51% in the growth portfolio and 49% in the liability hedging portfolio, subject to periodic fluctuations due to market movements. The plan assets are diversified across asset classes, striving to balance risk and return within the limits of prudent risk-taking and Section 404 of the Employee Retirement Income Security Act of 1974, as amended. Because many of the pension liabilities are long-term, the investment horizon is also long-term, but the investment plan must also ensure adequate near-term liquidity to fund benefit payments.

        Assets of our international plans are invested in accordance with locally accepted practices and primarily include equity securities, fixed income securities, insurance contracts and cash. Asset allocations and investments vary by country and plan. Our target plan asset investment allocation for our international plans combined is 39% in equity securities, 49% in fixed income securities and cash, and 12% in insurance contracts and other investments, and is subject to periodic fluctuations in these respective asset classes.

Fair Value Measurements

        The following is a description of the valuation methodologies used for assets measured at fair value:

        Cash is valued at nominal value. Mutual funds are valued at fair value as determined by quoted market prices, based upon the NAV of shares held by the plans at year-end. Pooled funds are structured as collective trusts, are not publicly traded, and are valued by calculating NAV per unit based on the NAV of the underlying funds/trusts as a practical expedient for fair value of the pooled funds. Insurance contracts are valued at book value, which approximates fair value and is calculated using the prior year balance plus or minus investment returns and changes in cash flows.

        The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while we believe the valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

        Effective January 2, 2016, we adopted new accounting guidance for investments that are valued based on NAV per share (or its equivalent). As a result of the adoption of this new guidance, certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. The guidance was required to be applied retrospectively, and accordingly, prior period amounts have been revised to conform to the current period presentation.

        The following table sets forth, by level within the fair value hierarchy (as applicable), U.S. plan assets (all in the ADPP) at fair value:

 
   
  Fair Value Measurements Using  
(In millions)
  Total
  Quoted
Prices
in Active
Markets
(Level 1)

  Significant
Other
Observable
Inputs
(Level 2)

  Significant
Other
Unobservable
Inputs
(Level 3)

 

2015

                         

Cash

  $   $   $   $  

Pooled funds – liability hedging portfolio (1)

    335.9                    

Pooled funds – growth portfolio (1)

    368.9                    

Other assets (2)

    .1                    

Total U.S. plan assets

  $ 704.9                    

2014

                         

Cash

  $ 1.3   $ 1.3   $   $  

Pooled funds – liability hedging portfolio (1)

    371.5                    

Pooled funds – growth portfolio (1)

    406.0                    

Other assets (2)

    .1                    

Total U.S. plan assets

  $ 778.9                    
(1)
Pooled funds that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to reconcile to total U.S. plan assets.
(2)
Includes accrued recoverable taxes.
42


Notes to Consolidated Financial Statements

        The following table sets forth, by level within the fair value hierarchy (as applicable), international plan assets at fair value:

 
   
  Fair Value Measurements Using  
(In millions)
  Total
  Quoted
Prices
in Active
Markets
(Level 1)

  Significant
Other
Observable
Inputs
(Level 2)

  Significant
Other
Unobservable
Inputs
(Level 3)

 

2015

                         

Cash

  $ .8   $ .8   $   $  

Insurance contracts

    21.4             21.4  

Pooled funds – fixed income securities (1)

    275.7                    

Pooled funds – equity securities (1)

    218.1                    

Pooled funds – other investments (1)

    36.1                    

Total international plan assets at fair value

  $ 552.1                    

2014

                         

Cash

  $ .6   $ .6   $   $  

Mutual funds

    .3     .3          

Insurance contracts

    24.6             24.6  

Pooled funds – fixed income securities (1)

    328.4                    

Pooled funds – equity securities (1)

    230.7                    

Pooled funds – other investments (1)

    33.5                    

Total international plan assets at fair value

  $ 618.1                    
(1)
Pooled funds that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to reconcile to total international plan assets.

        The following table presents a reconciliation of Level 3 international plan assets held during the year ended January 2, 2016:

 
  Level 3 Assets  
(In millions)
  Insurance Contracts
 

Balance at January 3, 2015

  $ 24.6  

Net realized and unrealized gain

    .4  

Purchases

    2.3  

Settlements

    (4.6 )

Impact of changes in foreign currency exchange rates

    (1.3 )

Balance at January 2, 2016

  $ 21.4  

Postretirement Health Benefits

        We provide postretirement health benefits to certain U.S. retired employees up to the age of 65 under a cost-sharing arrangement and provide supplemental Medicare benefits to certain U.S. retirees over the age of 65. Our policy is to fund the cost of the postretirement benefits from operating cash flows. While we have not expressed any intent to terminate postretirement health benefits, we may do so at any time, subject to applicable laws and regulations.

Plan Assumptions

Discount Rate

        In consultation with our actuaries, we annually review and determine the discount rates to be used in connection with valuing our postretirement obligations. The assumed discount rate for each pension plan reflects market rates for high quality corporate bonds currently available. In the U.S., our discount rate is determined by evaluating yield curves consisting of large populations of high quality corporate bonds. The projected pension benefit payment streams are then matched with the bond portfolios to determine a rate that reflects the liability duration unique to our plans.

Long-term Return on Assets

        We determine the long-term rate of return assumption for plan assets by reviewing the historical and expected returns of both the equity and fixed income markets, taking into account our asset allocation, the correlation between returns in our asset classes, and the mix of active and passive investments. Additionally, current market conditions, including interest rates, are evaluated and market data is reviewed for reasonableness and appropriateness.

Healthcare Cost Trend Rate

        Our practice is to fund the cost of postretirement benefits from operating cash flows. For measurement purposes, a 6% annual rate of increase in the per capita cost of covered health care benefits was assumed for 2016. This rate is expected to decrease to approximately 5% by 2018.

        A one-percentage-point change in assumed health care cost trend rates would have the following effects:

(In millions)
  One-percentage-point
Increase

  One-percentage-point
Decrease

 

Effect on total of service and interest cost components

  $ .01   $ (.01 )

Effect on postretirement benefit obligations

    .4     (.3 )
43        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

Plan Balance Sheet Reconciliations

        The following table provides a reconciliation of benefit obligations, plan assets, funded status of the plans and accumulated other comprehensive loss for our defined benefit plans:

Plan Benefit Obligations

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2015
  2014
 
(In millions)
  U.S.
  Int'l
  U.S.
  Int'l
   
   
 

Change in projected benefit obligations

                                     

Projected benefit obligations at beginning of year

  $ 1,161.1   $ 737.1   $ 1,004.8   $ 642.8   $ 8.0   $ 9.1  

Service cost

    .4     13.8     .4     12.9          

Interest cost

    45.8     17.3     47.9     23.8     .2     .3  

Participant contribution

        3.1         4.0     .8     1.1  

Amendments (1)

        (.7 )       (7.2 )        

Actuarial (gain) loss

    (58.3 )   (1.4 )   145.6     166.1     (1.4 )   .3  

Plan transfers (2)

        2.5     21.4              

Benefits paid

    (60.1 )   (19.0 )   (59.0 )   (22.3 )   (1.7 )   (2.8 )

Curtailments

        (2.7 )       (7.6 )        

Settlements

        (13.3 )       (2.2 )        

Foreign currency translation

        (62.0 )       (73.2 )        

Projected benefit obligations at end of year

  $ 1,088.9   $ 674.7   $ 1,161.1   $ 737.1   $ 5.9   $ 8.0  

Accumulated benefit obligations at end of year

  $ 1,088.9   $ 625.4   $ 1,161.1   $ 693.9              
(1)
Amendments to international plans in 2014 related to our plans in the Netherlands, U.K. and France.
(2)
Plan transfers in 2014 for the U.S. plans represented transfers from participant SHARE Accounts.

Plan Assets

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2015
  2014
 
(In millions)
  U.S.
  Int'l
  U.S.
  Int'l
   
   
 

Change in plan assets

                                     

Plan assets at beginning of year

  $ 778.9   $ 618.1   $ 747.4   $ 566.6   $   $  

Actual return on plan assets

    (28.3 )   (7.4 )   52.9     117.9          

Plan transfers (1)

        (.3 )   21.4              

Employer contributions

    14.4     14.3     16.2     16.0     .9     1.7  

Participant contributions

        3.1         4.0     .8     1.1  

Benefits paid

    (60.1 )   (19.0 )   (59.0 )   (22.3 )   (1.7 )   (2.8 )

Settlements

        (4.6 )       (2.2 )        

Foreign currency translation

        (52.1 )       (61.9 )        

Plan assets at end of year

  $ 704.9   $ 552.1   $ 778.9   $ 618.1   $   $  
(1)
Plan transfers in 2014 for the U.S. plans represented transfers from participant SHARE Accounts.

Funded Status

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2015
  2014
 
(In millions)
  U.S.
  Int'l
  U.S.
  Int'l
   
   
 

Funded status of the plans

                                     

Other assets

  $   $   $   $ 20.0   $   $  

Other accrued liabilities

    (13.4 )   (2.2 )   (14.4 )   (2.5 )   (1.2 )   (1.6 )

Long-term retirement benefits and other liabilities (1)

    (370.6 )   (120.4 )   (367.8 )   (136.5 )   (4.7 )   (6.4 )

Plan assets less than benefit obligations

  $ (384.0 ) $ (122.6 ) $ (382.2 ) $ (119.0 ) $ (5.9 ) $ (8.0 )
(1)
Per our funding strategy, we have the option to fund certain of these liabilities with proceeds from our corporate-owned life insurance policies.
44


Notes to Consolidated Financial Statements

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2013
  2015
  2014
  2013
 
 
  U.S.
  Int'l
  U.S.
  Int'l
  U.S.
  Int'l
   
   
   
 

Weighted-average assumptions used to determine year-end benefit obligations

                                                       

Discount rate

    4.55 %   2.95 %   4.00 %   2.54 %   4.85 %   3.88 %   4.13 %   3.50 %   3.45 %

Compensation rate increase

        2.21         2.22         2.24              

        For U.S. and international plans combined, the projected benefit obligations and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets were $1.77 billion and $1.26 billion, respectively, at year-end 2015 and $1.53 billion and $997.5 million, respectively, at year-end 2014.

        For U.S. and international plans combined, the accumulated benefit obligations and fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets were $1.38 billion and $910.9 million, respectively, at year-end 2015 and $1.49 billion and $997.3 million, respectively, at year-end 2014.

Accumulated Other Comprehensive Loss

        The following table sets forth the pre-tax amounts recognized in "Accumulated other comprehensive loss" in the Consolidated Balance Sheets:

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2015
  2014
 
(In millions)
  U.S.
  Int'l
  U.S.
  Int'l
   
   
 

Net actuarial loss

  $ 585.5   $ 171.9   $ 584.4   $ 174.8   $ 20.4   $ 24.1  

Prior service cost (credit)

    18.7     (4.9 )   19.9     (5.3 )   (19.6 )   (22.9 )

Net transition obligation

        .3         .4          

Net amount recognized in accumulated other comprehensive loss

  $ 604.2   $ 167.3   $ 604.3   $ 169.9   $ .8   $ 1.2  

        The following table sets forth the pre-tax amounts, including those of discontinued operations, recognized in "Other comprehensive loss (income)":

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2013
  2015
  2014
  2013
 
(In millions)
  U.S.
  Int'l
  U.S.
  Int'l
  U.S.
  Int'l
   
   
   
 

Net actuarial loss (gain)

  $ 21.1   $ 11.3   $ 135.6   $ 51.3   $ (101.8 ) $ 6.1   $ (1.4 ) $ .3   $ (.9 )

Prior service (credit) cost

        (.7 )       (7.3 )   19.9                  

Amortization of unrecognized:

                                                       

Net actuarial loss

    (20.0 )   (9.4 )   (16.2 )   (5.2 )   (19.5 )   (8.2 )   (2.2 )   (2.8 )   (2.5 )

Prior service (cost) credit

    (1.2 )   .3     (1.2 )   (.4 )   (.3 )   (.5 )   3.3     3.3     4.1  

Net transition asset

                        .1              

Curtailments

        .2         (.6 )   (.9 )   1.5             13.1  

Settlements

        (4.3 )   (.6 )   (.4 )       (1.2 )            

Net amount recognized in other comprehensive (income) loss

  $ (.1 ) $ (2.6 ) $ 117.6   $ 37.4   $ (102.6 ) $ (2.2 ) $ (.3 ) $ .8   $ 13.8  
45        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

Plan Income Statement Reconciliations

        The following table sets forth the components of net periodic benefit cost, which are recorded in income from continuing operations, for our defined benefit plans:

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2013
  2015
  2014
  2013
 
(In millions)
  U.S.
  Int'l
  U.S.
  Int'l
  U.S
  Int'l
   
   
   
 

Service cost

  $ .4   $ 13.8   $ .4   $ 12.9   $ .4   $ 13.0   $   $   $  

Interest cost

    45.8     17.3     47.9     23.8     42.8     23.3     .3     .3     .3  

Actuarial loss (gain)

    .4         4.0         (3.8 )                

Expected return on plan assets

    (51.5 )   (21.5 )   (51.9 )   (26.0 )   (48.1 )   (22.6 )            

Amortization of actuarial loss

    20.0     9.4     16.2     5.2     19.5     6.3     2.2     2.8     2.5  

Amortization of prior service cost (credit)

    1.2     (.3 )   1.2     .4     .3     .5     (3.3 )   (3.3 )   (4.1 )

Amortization of transition asset

                        (.1 )            

Recognized (gain) loss on curtailments (1)

        (.2 )       .6         (1.5 )            

Recognized loss on settlements (2)

        4.3     .6     .4         .5              

Net periodic benefit cost (credit)

  $ 16.3   $ 22.8   $ 18.4   $ 17.3   $ 11.1   $ 19.4   $ (.8 ) $ (.2 ) $ (1.3 )
(1)
Recognized gain on curtailment in 2015 and loss on curtailment in 2014 related to a pension plan in the Netherlands. Recognized gain on curtailment in 2013 related to a pension plan in Taiwan. These amounts were recorded in "Other expense, net" in the Consolidated Statements of Income.
(2)
Recognized loss on settlement related to pension plans in Germany and France as a result of the sale of a product line in our RBIS reportable segment in 2015, and settlement events in Switzerland in 2015 and 2014. The losses on settlements were recorded in "Other expense, net" in Consolidated Statements of Income.

        In 2013, in connection with the sale of our former OCP and DES businesses, we recognized a curtailment gain of $13.1 million associated with our U.S. postretirement health benefit plan, partially offset by curtailment and settlement losses of $10.4 million associated with certain U.S. pension plans. The net gain of $2.7 million was recorded in "Income (loss) from discontinued operations, net of tax" in the Consolidated Statements of Income. Refer to Note 2, "Discontinued Operations, Sale of Product Line, and Sale of Assets," for more information on the sale.

        The following table sets forth the weighted-average assumptions used to determine net periodic cost:

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
 
  2015
  2014
  2013
  2015
  2014
  2013
 
 
  U.S.
  Int'l
  U.S.
  Int'l
  U.S.
  Int'l
   
   
   
 

Discount rate

    4.00 %   2.54 %   4.85 %   3.88 %   4.00 %   3.94 %   3.50 %   3.45 %   2.85 %

Expected return on assets

    7.50     4.27     7.75     4.82     8.00     4.78              

Compensation rate increase

        2.22         2.24         2.24              

Plan Contributions

        We make contributions to our defined benefit plans sufficient to meet the minimum funding requirements of applicable laws and regulations, plus additional amounts, if any, we determine to be appropriate. The following table sets forth expected contributions during 2016:

(In millions)
   
 

U.S. 

  $ 3.7  

Int'l

    13.6  

U.S. postretirement health benefits

    1.2  

Future Benefit Payments

        Anticipated future benefit payments, which reflect expected service periods for eligible participants, were as follows:

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
(In millions)
  U.S.
  Int'l
   
 

2016

  $ 60.4   $ 17.3   $ 1.2  

2017

    62.6     16.8     .8  

2018

    81.8     18.1     .6  

2019

    60.6     18.8     .5  

2020

    61.0     19.3     .4  

2021 - 2024

    319.5     114.5     1.5  
46


Notes to Consolidated Financial Statements

Estimated Amortization Amounts in Accumulated Other Comprehensive Loss

        Our estimates of fiscal year 2016 amortization of amounts included in "Accumulated other comprehensive loss" were as follows:

 
  Pension Benefits   U.S. Postretirement
Health Benefits
 
(In millions)
  U.S.
  Int'l
   
 

Net actuarial loss

  $ 17.3   $ 7.1   $ 1.9  

Prior service cost (credit)

    1.2     (.3 )   (3.3 )

Net transition obligation

        .1      

Net loss (gain) to be recognized

  $ 18.5   $ 6.9   $ (1.4 )

Defined Contribution Plans

        We sponsor various defined contribution plans worldwide, the largest of which is the Avery Dennison Corporation Employee Savings Plan ("Savings Plan"), a 401(k) plan for our U.S. employees.

        We recognized expense from continuing operations of $20.2 million, $19.4 million, and $21 million in 2015, 2014, and 2013, respectively, related to our employer contributions and employer match of participant contributions to the Savings Plan.

Other Retirement Plans

        We have deferred compensation plans which permit eligible employees and directors to defer a portion of their compensation. The compensation voluntarily deferred by the participant, together with certain employer contributions, earns specified and variable rates of return. As of year-end 2015 and 2014, we had accrued $77.9 million and $86 million, respectively, for our obligations under these plans. As of year-end 2015 and 2014, our deferred compensation obligations were secured by standby letters of credit of $1 million and $2.5 million, respectively. A portion of the interest on certain of our contributions may be forfeited by participants if their employment terminates before age 55 other than by reason of death or disability.

        Our Directors Deferred Equity Compensation Plan allows our non-employee directors to elect to receive their cash compensation in deferred stock units ("DSUs") issued under our stock option and incentive plan. Dividend equivalents, representing the value of dividends per share paid on shares of our common stock and calculated with reference to the number of DSUs held as of a quarterly dividend record date, are credited in the form of additional DSUs on the applicable payable date. A director's DSUs are converted into shares of our common stock upon his or her resignation or retirement. Approximately .1 million DSUs were outstanding as of year-end 2015 and 2014, with an aggregate value of $8 million and $6.1 million, respectively.

        We hold corporate-owned life insurance policies, the proceeds from which are payable to us upon the death of covered participants. The cash surrender values of these policies, net of outstanding loans, included in "Other assets" in the Consolidated Balance Sheets, were $227.1 million and $226.9 million at year-end 2015 and 2014, respectively.

NOTE 7. COMMITMENTS

Minimum annual rental commitments on operating leases having initial or remaining non-cancelable lease terms of one year or more are as follows:

Year
  (In millions)
 

2016

  $ 43.1  

2017

    27.9  

2018

    19.0  

2019

    13.9  

2020

    9.9  

2021 and thereafter

    29.2  

Total minimum lease payments

  $ 143.0  

        Rent expense for operating leases from continuing operations was approximately $58 million in 2015, $67 million in 2014, and $70 million in 2013. Operating leases primarily relate to office and warehouse space and equipment for information technology, machinery, and transportation. The terms of these leases do not impose significant restrictions or unusual obligations.

        Refer to Note 4, "Debt and Capital Leases," for information on capital lease obligations.

NOTE 8. CONTINGENCIES

Legal Proceedings

        We are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business. We have accrued liabilities for matters where it is probable that a loss will be incurred and the amount of loss can be reasonably estimated. Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.

Environmental

        Environmental expenditures are generally expensed. However, environmental expenditures for newly acquired assets and those which extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset. We review our estimates of costs of compliance with environmental laws related to remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party ("PRP"). When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate

47        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. Potential insurance reimbursements are not offset against potential liabilities, and such liabilities are not discounted.

        As of January 2, 2016, we have been designated by the U.S. Environmental Protection Agency ("EPA") and/or other responsible state agencies as a PRP at thirteen waste disposal or waste recycling sites, which are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination. No settlement of our liability related to any of the sites has been agreed upon. We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we negotiate with the EPA or other governmental authorities.

        We have accrued liabilities for sites where it is probable that a loss will be incurred and the cost or amount of loss can be reasonably estimated. These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information were to become available that allowed us to reasonably estimate a range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.

        The activity in 2015 and 2014 related to environmental liabilities was as follows:

(In millions)
  2015
  2014
 

Balance at beginning of year

  $ 26.2   $ 29.6  

Charges (reversals), net

    1.2     1.7  

Payments

    (9.7 )   (5.1 )

Balance at end of year

  $ 17.7   $ 26.2  

        As of January 2, 2016 and January 3, 2015, approximately $7 million and $10 million of the balance was classified as short-term and included in "Other accrued liabilities" in the Consolidated Balance Sheets, respectively.

NOTE 9. FAIR VALUE MEASUREMENTS

Recurring Fair Value Measurements

        The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of January 2, 2016:

 
   
  Fair Value Measurements Using  
(In millions)
  Total
  Quoted
Prices
in Active
Markets
(Level 1)

  Significant
Other
Observable
Inputs
(Level 2)

  Significant
Other
Unobservable
Inputs
(Level 3)

 

Assets

                         

Trading securities

  $ 17.9   $ 11.3   $ 6.6   $  

Derivative assets

    5.6         5.6      

Bank drafts

    24.8     24.8          

Liabilities

                         

Derivative liabilities

  $ 5.2   $ .7   $ 4.5   $  

        The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of January 3, 2015:

 
   
  Fair Value Measurements Using  
(In millions)
  Total
  Quoted
Prices
in Active
Markets
(Level 1)

  Significant
Other
Observable
Inputs
(Level 2)

  Significant
Other
Unobservable
Inputs
(Level 3)

 

Assets

                         

Trading securities

  $ 17.9   $ 7.6   $ 10.3   $  

Derivative assets

    10.3         10.3      

Bank drafts

    19.8     19.8          

Liabilities

                         

Derivative liabilities

  $ 11.7   $ 1.2   $ 10.5   $  
48


Notes to Consolidated Financial Statements

        Trading securities include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using NAV. As of January 2, 2016, trading securities of $.3 million and $17.6 million were included in "Cash and cash equivalents" and "Other current assets," respectively, in the Consolidated Balance Sheets. As of January 3, 2015, trading securities of $.8 million and $17.1 million were included in "Cash and cash equivalents" and "Other current assets," respectively, in the Consolidated Balance Sheets. Derivatives that are exchange-traded are measured at fair value using quoted market prices and classified within Level 1 of the valuation hierarchy. Derivatives measured based on foreign exchange rate inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy. Bank drafts (maturities greater than 90 days) are valued at face value due to the short-term nature of these instruments and were included in "Other current assets" in the Consolidated Balance Sheets.

Non-recurring Fair Value Measurements

        During 2013, long-lived assets with carrying amounts totaling $8.3 million were written down to their fair value of $4.8 million, resulting in an impairment charge of $3.5 million, which was included in "Other expense, net" in the Consolidated Statements of Income. The fair value was based on the sale price of the assets, less estimated broker fees, which are primarily Level 3 inputs.

NOTE 10. NET INCOME PER COMMON SHARE

        Net income per common share was computed as follows:

(In millions, except per share amounts)
  2015
  2014
  2013
 

(A)

 

Income from continuing operations

  $ 274.4   $ 247.3   $ 241.7  

(B)

 

Loss from discontinued operations, net of tax

    (.1 )   (2.2 )   (28.5 )

(C)

 

Net income available to common shareholders

  $ 274.3   $ 245.1   $ 213.2  

(D)

 

Weighted average number of common shares outstanding

    91.0     93.8     98.4  

 

Dilutive shares (additional common shares issuable under stock-based awards)

    1.9     1.9     1.7  

(E)

 

Weighted average number of common shares outstanding, assuming dilution

    92.9     95.7     100.1  

Net income (loss) per common share:

                   

Continuing operations (A) ÷ (D)

  $ 3.01   $ 2.64   $ 2.46  

Discontinued operations (B) ÷ (D)

        (.03 )   (.29 )

Net income per common share (C) ÷ (D)

  $ 3.01   $ 2.61   $ 2.17  

Net income (loss) per common share, assuming dilution:

                   

Continuing operations (A) ÷ (E)

  $ 2.95   $ 2.58   $ 2.41  

Discontinued operations (B) ÷ (E)

        (.02 )   (.28 )

Net income per common share, assuming dilution (C) ÷ (E)

  $ 2.95   $ 2.56   $ 2.13  

        Certain stock-based compensation awards were not included in the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation totaled approximately 1 million shares in 2015, 3 million shares in 2014, and 7 million shares in 2013.

NOTE 11. SUPPLEMENTAL EQUITY AND COMPREHENSIVE INCOME INFORMATION

Common Stock and Share Repurchase Program

        Our Certificate of Incorporation authorizes five million shares of $1 par value preferred stock (of which none are outstanding), with respect to which our Board of Directors ("Board") may fix the series and terms of issuance, and 400 million shares of $1 par value voting common stock.

        From time to time, our Board authorizes the repurchase of shares of our outstanding common stock. Repurchased shares may be reissued under our stock option and incentive plan or used for other corporate purposes. In 2015, we repurchased approximately 3.9 million shares of our common stock at an aggregate cost of $232.3 million.

        On December 4, 2014, our Board authorized the repurchase of shares of our common stock in the aggregate amount of up to $500 million (exclusive of any fees, commissions or other expenses related to such purchases), in addition to any outstanding shares under any previous Board authorization. This authorization is the only one currently in effect and will remain in effect until the shares authorized thereby have been repurchased.

        As of January 2, 2016, shares of our common stock in the aggregate amount of approximately $367 million remained authorized for repurchase under this Board authorization.

Treasury Shares Reissuance

        We fund a portion of our employee-related expenses using shares of our common stock held in treasury. We elected to record net gains or losses associated with our use of treasury shares to retained earnings.

Comprehensive Income

        The changes in "Accumulated other comprehensive loss" (net of tax) for 2015 and 2014 were as follows:

(In millions)
  Foreign
Currency
Translation

  Pension and
Other
Postretirement
Benefits

  Cash Flow
Hedges

  Total
 

Balance as of December 28, 2013

  $ 129.9   $ (417.3 ) $ (1.0 ) $ (288.4 )

Other comprehensive (loss) income before reclassifications, net of tax

    (149.8 )   (125.2 )   .1     (274.9 )

Reclassifications to net income, net of tax

        16.9     .9     17.8  

Net current-period other comprehensive (loss) income, net of tax

    (149.8 )   (108.3 )   1.0     (257.1 )

Balance as of January 3, 2015

    (19.9 )   (525.6 )       (545.5 )

Other comprehensive loss before reclassifications, net of tax

    (139.0 )   (18.9 )   (.5 )   (158.4 )

Reclassifications to net income, net of tax

        22.9     (2.0 )   20.9  

Net current-period other comprehensive (loss) income, net of tax

    (139.0 )   4.0     (2.5 )   (137.5 )

Balance as of January 2, 2016

  $ (158.9 ) $ (521.6 ) $ (2.5 ) $ (683.0 )
49        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

        The amounts reclassified from "Accumulated other comprehensive loss" to increase (decrease) income from continuing operations were as follows:

(In millions)
  2015
  2014
  2013
  Affected Line Item in the
Statements Where Net
Income is Presented

Cash flow hedges:

                     

Foreign exchange contracts

  $ 3.9   $ (1.2 ) $ .6   Cost of products sold

Commodity contracts

    (1.3 )   .1     (1.2 ) Cost of products sold

Interest rate contracts

    (.1 )   (.1 )   (.1 ) Interest expense

    2.5     (1.2 )   (.7 ) Total before tax

    (.5 )   .3     .2   Provision for income taxes

    2.0     (.9 )   (.5 ) Net of tax

Pension and other postretirement benefits (1)

    (33.3 )   (24.1 )   (25.3 )  

    10.4     7.2     8.6   Provision for income taxes

    (22.9 )   (16.9 )   (16.7 ) Net of tax

Total reclassifications for the period

  $ (20.9 ) $ (17.8 ) $ (17.2 ) Total, net of tax
(1)
See Note 6, "Pension and Other Postretirement Benefits," for more information.

        During 2013, we reclassified $6.4 million (net of tax) from "Accumulated other comprehensive loss" to "Loss from discontinued operations, net of tax," related to a net gain from curtailment in our domestic defined benefit plans and settlements from certain international pension plans as a result of the sale of the OCP and DES businesses. Refer to Note 6, "Pension and Other Postretirement Benefits," for more information.

        Additionally, during 2013, we recognized $10.8 million (net of tax) of currency translation loss from "Accumulated other comprehensive loss" to "Loss from discontinued operations, net of tax" as a result of the sale of the OCP and DES businesses.

        The following table sets forth the income tax (benefit) expense allocated to each component of other comprehensive (loss) income:

(In millions)
  2015
  2014
  2013
 

Pension and other postretirement benefits:

                   

Net (loss) gain recognized from actuarial gain/loss and prior service cost/credit

  $ (11.4 ) $ (54.7 ) $ 28.6  

Reclassifications to net income

    10.4     7.2     4.7  

Cash flow hedges:

                   

(Losses) gains recognized on cash flow hedges

    (.3 )   .1     .2  

Reclassifications to net income

    (.5 )   .3     .1  

Income tax (benefit) expense related to items of other comprehensive (loss) income

  $ (1.8 ) $ (47.1 ) $ 33.6  

NOTE 12. LONG-TERM INCENTIVE COMPENSATION

Equity Awards

Stock-Based Compensation

        We maintain various stock option and incentive plans and grant our annual stock-based compensation awards to eligible employees in February and non-employee directors in May. Certain awards granted to retirement-eligible employees vest in full upon retirement; awards to these employees are accounted for as fully vested on the date of grant.

        Stock-based compensation expense from continuing operations and the total related recognized tax benefit were as follows:

(In millions)
  2015
  2014
  2013
 

Stock-based compensation expense

  $ 26.3   $ 28.3   $ 32.3  

Tax benefit

    8.2     10.5     10.8  

        This expense was included in "Marketing, general and administrative expense" in the Consolidated Statements of Income.

        As of January 2, 2016, we had approximately $27 million of unrecognized compensation expense from continuing operations related to unvested stock-based awards, which is expected to be recognized over the remaining weighted-average requisite service period of approximately two years.

Stock Options

        Stock options granted to non-employee directors and employees may be granted at no less than 100% of the fair market value of our common stock on the date of the grant. Options generally vest ratably over a three-year period for non-employee directors and over a four-year period for employees. Options expire ten years from the date of grant.

        The fair value of stock option awards is estimated as of the date of grant using the Black-Scholes option-pricing model. This model requires input assumptions for our expected dividend yield, expected stock price volatility, risk-free interest rate and the expected option term. The following assumptions are used in estimating the fair value of granted stock options:

        Risk-free interest rate is based on the 52-week average of the Treasury-Bond rate that has a term corresponding to the expected option term.

        Expected stock price volatility represents an average of the implied and historical volatility.

        Expected dividend yield is based on the current annual dividend divided by the 12-month average of our monthly stock price prior to grant.

        Expected option term is determined based on historical experience under our stock option and incentive plans.

        No stock options were granted during 2015 and 2014. The weighted-average grant date fair value per share for stock options was $6.97 in 2013.

        The underlying weighted-average assumptions used were as follows:

 
  2013
 

Risk-free interest rate

    1.04 %

Expected stock price volatility

    27.17 %

Expected dividend yield

    3.40 %

Expected option term

    6.2 years  
50


Notes to Consolidated Financial Statements

        The following table sets forth stock option information related to our stock option and incentive plan during 2015:

 
  Number
of options
(in thousands)

  Weighted-average
exercise price

  Weighted-average
remaining
contractual life
(in years)

  Aggregate
intrinsic value
(in millions)

 

Outstanding at January 3, 2015

  5,178.6   $ 44.08   3.95   $ 54.6  

Exercised

  (2,493.4 )   41.71            

Forfeited or expired

  (315.3 )   53.66            

Outstanding at January 2, 2016

  2,369.9   $ 45.30   3.68   $ 43.8  

Options vested and expected to vest at January 2, 2016

  2,365.7     45.33   3.68     43.7  

Options exercisable at January 2, 2016

  2,189.0   $ 46.52   3.48   $ 38.0  

        The total intrinsic value of stock options exercised was $43.3 million in 2015, $15.4 million in 2014, and $26.1 million in 2013. We received approximately $104 million in 2015, $34.2 million in 2014, and $44.8 million in 2013 from the exercise of stock options. The tax benefit associated with these exercised options was $15.6 million in 2015, $5.3 million in 2014, and $8.5 million in 2013. The intrinsic value of a stock option is based on the amount by which the market value of the underlying stock exceeds the exercise price of the option.

Performance Units ("PUs")

        PUs are performance-based awards granted under our stock option and incentive plan to eligible employees. PUs are payable in shares of our common stock at the end of a three-year cliff vesting period provided that certain performance objectives are achieved at the end of the period. Over the performance period, the estimated number of shares of our common stock issuable upon vesting is adjusted upward or downward based upon the probability of the achievement of the performance objectives established for the award. The actual number of shares issued can range from 0% to 200% of the target shares at the time of grant. The weighted-average grant date fair value for PUs was $51.37, $47.85, and $52.93 in 2015, 2014, and 2013, respectively.

        The following table summarizes information related to awarded PUs:

 
  Number of
PUs
(in thousands)

  Weighted-
average
grant-date
fair value

 

Unvested at January 3, 2015

    689.9   $ 40.16  

Granted at target

    164.5     51.37  

Adjustment for above-target performance (1)

    23.1     34.43  

Vested

    (355.0 )   34.36  

Forfeited/cancelled

    (75.4 )   45.52  

Unvested at January 2, 2016

    447.1   $ 47.63  
(1)
Reflects awards granted in excess of target as a result of our achieving above-target performance for the 2012-2014 performance period.

        The fair value of vested PUs was $12.2 million in 2015 and $9.8 million in 2013. In 2014, PUs granted during 2011 were cancelled as the performance objective was not met as of the end of the three-year performance period.

Market-Leveraged Stock Units ("MSUs")

        In 2013, we began granting performance-based MSUs under our stock option and incentive plan to eligible employees. These units vest ratably over a four-year period provided that the performance objective is achieved as of the end of each vesting period. MSUs accrue dividend equivalents during the vesting period, which are earned and paid only at vesting. The number of MSU shares earned is based upon our absolute total shareholder return at each vesting date and can range from 0% to 200% of the target amount of MSUs subject to vesting. Each of the four vesting periods represents one tranche of MSUs and the fair value of each of these four tranches was determined using the Monte-Carlo simulation model, which utilizes multiple input variables, including expected stock price volatility and other assumptions, to estimate the probability of achieving the performance objective established for the award. The weighted-average grant date fair value for MSUs was $56.46, $52.76, and $51.40 in 2015, 2014, and 2013, respectively.

        The following table summarizes information related to awarded MSUs:

 
  Number of
MSUs
(in thousands)

  Weighted-
average
grant-date
fair value

 

Unvested at January 3, 2015

    551.8   $ 52.18  

Granted at target

    329.4     56.46  

Adjustment for above-target performance (1)

    47.6     51.58  

Vested

    (195.4 )   50.15  

Forfeited/cancelled

    (127.3 )   54.28  

Unvested at January 2, 2016

    606.1   $ 55.04  
(1)
Reflects adjustment as a result of achieving above-target performance for vesting of the tranches paid out in 2015.

        The fair value of vested MSUs was $9.8 million in 2015 and $5.6 million in 2014.

Restricted Stock Units ("RSUs")

        RSUs are service-based awards granted under our stock option and incentive plan to eligible employees that generally vest ratably over a period of three years for non-employee directors and four years for employees provided that directorship or employment continues through the applicable vesting date. If the condition is not met, unvested RSUs are generally forfeited. The weighted-average grant date fair value for RSUs was $53.29, $45.91, and $38.72 in 2015, 2014, and 2013, respectively.

51        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

        The following table summarizes information related to awarded RSUs:

 
  Number of
RSUs
(in thousands)

  Weighted-
average
grant-date
fair value

 

Unvested at January 3, 2015

    388.0   $ 32.70  

Granted

    128.3     53.29  

Vested

    (243.7 )   34.37  

Forfeited/cancelled

    (58.0 )   40.79  

Unvested at January 2, 2016

    214.6   $ 40.96  

        The fair value of vested RSUs was $8.4 million, $9.5 million, and $15.9 million in 2015, 2014, and 2013, respectively.

Cash Awards

Long-Term Incentive Units ("LTI Units")

        LTI Units are granted under our long-term incentive unit plan to eligible employees. LTI Units are service-based awards that generally vest ratably over a four-year period. The settlement value equals the number of vested LTI Units multiplied by the average of the high and low market prices of our common stock on the vesting date. The compensation expense related to these awards is amortized on a straight-line basis and the fair value is remeasured using the estimated percentage of units expected to be earned multiplied by the average of the high and low market prices of our common stock at each quarter-end.

        We also grant cash-based awards in the form of performance and market-leveraged LTI Units to eligible employees. Performance LTI Units are payable in cash at the end of a three-year cliff vesting period provided that certain performance objectives are achieved at the end of the performance period. Market-leveraged LTI Units are payable in cash and vest ratably over a period of four years. The number of performance and market-leveraged LTI Units earned at vesting is adjusted upward or downward based upon the probability of achieving the performance objectives established for the respective award and the actual number of units issued can range from 0% to 200% of the target units subject to vesting. The performance and market-leveraged LTI Units are remeasured using the estimated percentage of units expected to be earned multiplied by the average of the high and low market prices of our common stock at each quarter-end over their respective performance periods. The compensation expense related to performance LTI Units is amortized on a straight-line basis over their respective performance period. The compensation expense related to market-leveraged LTI Units is amortized on a graded-vesting basis over their respective performance periods.

        The compensation expense from continuing operations related to LTI Units was $27.1 million in 2015, $17.8 million in 2014, and $10.3 million in 2013. This expense was included in "Marketing, general and administrative expense" in the Consolidated Statements of Income. The total recognized tax benefit related to these units was $8.6 million in 2015, $5.7 million in 2014, and $3.2 million in 2013.

NOTE 13. COST REDUCTION ACTIONS

Restructuring Charges

        We have compensation plans that provide eligible employees with severance in the event of an involuntary termination due to qualifying cost reduction actions. We calculate severance using the benefit formula under the plans. Accordingly, we record provisions for severance and other exit costs (including asset impairment charges and lease and other contract cancellation costs) when they are probable and estimable. In the absence of a plan or established local practice for overseas jurisdictions, liabilities for restructuring charges are recognized when incurred.

2015/2016 Actions

        In 2015, we recorded $26.1 million in restructuring charges, net of reversals, related to restructuring actions initiated during the third quarter of 2015 ("2015/2016 Actions"), which we expect to continue through 2016. These charges consisted of severance and related costs for the reduction of approximately 430 positions, lease cancellation costs, and asset impairment charges.

        No employees impacted by our 2015/2016 Actions taken through January 2, 2016 remained employed with us as of such date. We expect charges and payments related to these actions to be substantially completed in 2016.

2014/2015 Actions

        In 2015, we recorded $33.4 million in restructuring charges, net of reversals, related to restructuring actions we initiated in 2014 that continued through the second quarter of 2015 ("2014/2015 Actions"). These charges consisted of severance and related costs for the reduction of approximately 605 positions, lease cancellation costs, and asset impairment charges.

        In 2014, we recorded $66.5 million in restructuring charges, net of reversals, related to our 2014/2015 Actions. These charges consisted of severance and related costs for the reduction of approximately 1,420 positions, lease cancellation costs, and asset impairment charges.

        Approximately 125 employees impacted by our 2014/2015 Actions remained employed with us as of January 2, 2016. We expect charges and payments related to these actions to be substantially completed in 2016.

2012 Program

        In 2013, we recorded $40.3 million in restructuring charges, net of reversals, related to the restructuring program we initiated in 2012 ("2012 Program"), which consisted of severance and related costs for the reduction of approximately 1,400 positions, lease and other contract cancellation costs, and asset impairment charges.

        No employees impacted by the 2012 Program remained employed with us as of December 28, 2013.

        Accruals for severance and related costs and lease and other contract cancellation costs were included in "Other accrued liabilities" in the Consolidated Balance Sheets. Asset impairment charges were based on the estimated market value of the assets. Restructuring charges in continuing operations were included in "Other expense, net" in the Consolidated Statements of Income.

52


Notes to Consolidated Financial Statements

        During 2015, restructuring charges and payments were as follows:

(In millions)
  Accrual at
January 3,
2015

  Charges
(Reversals),
net

  Cash
Payments

  Non-cash
Impairment

  Foreign
Currency
Translation

  Accrual at
January 2,
2016

 

2015/2016 Actions

                                     

Severance and related costs

  $   $ 22.7   $ (14.3 ) $   $   $ 8.4  

Asset impairment charges

        2.9         (2.9 )        

Lease cancellation costs

        .5     (.3 )           .2  

2014/2015 Actions

                                     

Severance and related costs

    16.8     29.8     (40.9 )       (.9 )   4.8  

Asset impairment charges

        3.3         (3.3 )        

Lease cancellation costs

    .1     .3     (.4 )            

2012 Program

                                     

Severance and related costs

    .8                 (.1 )   .7  

Total

  $ 17.7   $ 59.5   $ (55.9 ) $ (6.2 ) $ (1.0 ) $ 14.1  

        During 2014, restructuring charges and payments were as follows:

(In millions)
  Accrual at
December 28,
2013

  Charges
(Reversals),
net

  Cash
Payments

  Non-cash
Impairment

  Foreign
Currency
Translation

  Accrual at
January 3,
2015

 

2014/2015 Actions

                                     

Severance and related costs

  $   $ 55.1   $ (35.6 ) $   $ (2.7 ) $ 16.8  

Asset impairment charges

        10.8         (10.8 )        

Lease cancellation costs

        .6     (.5 )           .1  

2012 Program

                                     

Severance and related costs

    6.6     (.4 )   (5.2 )       (.2 )   .8  

Lease and other contract cancellation costs

    .2         (.2 )            

Total

  $ 6.8   $ 66.1   $ (41.5 ) $ (10.8 ) $ (2.9 ) $ 17.7  

        Restructuring charges incurred by reportable segment and Corporate were as follows:

(In millions)
  2015
  2014
  2013
 

Restructuring charges by reportable segment and Corporate

                   

Pressure-sensitive Materials

  $ 17.8   $ 40.2   $ 10.8  

Retail Branding and Information Solutions

    35.9     21.3     28.5  

Vancive Medical Technologies

    3.6     4.2     .1  

Corporate

    2.2     .4     .9  

Total

  $ 59.5   $ 66.1   $ 40.3  

NOTE 14. TAXES BASED ON INCOME

Taxes based on income (loss) were as follows:

(In millions)
  2015
  2014
  2013
 

Current:

                   

U.S. federal tax

  $ 26.4   $ 14.5   $ 1.9  

State taxes

    (.1 )   (.2 )   .3  

International taxes

    92.7     116.0     114.0  

    119.0     130.3     116.2  

Deferred:

                   

U.S. federal tax

    6.3     (16.1 )   (11.1 )

State taxes

    .5     1.9     7.4  

International taxes

    8.7     (2.6 )   11.8  

    15.5     (16.8 )   8.1  

Provision for income taxes

  $ 134.5   $ 113.5   $ 124.3  
53        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

        The principal items accounting for the difference between taxes computed at the U.S. statutory rate and taxes recorded were as follows:

(In millions)
  2015
  2014
  2013
 

Computed tax at 35% of income before taxes

  $ 143.1   $ 126.2   $ 128.1  

Increase (decrease) in taxes resulting from:

                   

State taxes, net of federal tax benefit

    1.3     1.4     2.4  

Foreign earnings taxed at different rates (1)

    (7.5 )   (14.9 )   (12.6 )

Valuation allowance

    .9     9.9     1.8  

Corporate-owned life insurance

    (1.9 )   (4.2 )   (6.9 )

U.S. federal research and development tax credits

    (2.6 )   (1.6 )   (7.0 )

Tax contingencies and audit settlements

    5.1     (1.5 )   21.9  

Other items, net

    (3.9 )   (1.8 )   (3.4 )

Provision for income taxes

  $ 134.5   $ 113.5   $ 124.3  
(1)
Included foreign earnings taxed in the U.S., net of credits, for all years.

        Income (loss) from continuing operations before taxes from our U.S. and international operations was as follows:

(In millions)
  2015
  2014
  2013
 

U.S. 

  $ 33.9   $ (.1 ) $ (33.3 )

International

    375.0     360.9     399.3  

Income from continuing operations before taxes

  $ 408.9   $ 360.8   $ 366.0  

        The effective tax rate for continuing operations was 32.9%, 31.5%, and 34% for fiscal years 2015, 2014, and 2013, respectively.

        The 2015 effective tax rate for continuing operations included the following: tax expense of $20 million associated with the tax cost to repatriate non-permanently reinvested 2015 earnings of certain foreign subsidiaries; tax benefits for changes in certain tax reserves, including interest and penalties, of $5.8 million resulting from settlements of audits and $8.2 million resulting from lapses and statute expirations; and a tax benefit of $2.6 million from the extension of the federal research and development credit.

        The 2014 effective tax rate for continuing operations included the following: tax benefits for changes in certain tax reserves, including interest and penalties, of $10.2 million resulting from settlements of audits and $18.1 million resulting from lapses and statute expirations; a repatriation tax benefit of $9.8 million related to certain foreign losses; tax expense of $9.1 million from the taxable inclusion of a net foreign currency gain related to the revaluation of certain intercompany loans; tax expense of $10.6 million related to our change in estimate of the potential outcome of uncertain tax issues in China and Germany; and state tax expense of $2.5 million primarily related to gains arising as a result of certain foreign reorganizations.

        The 2013 effective tax rate for continuing operations reflected $11 million of benefit from adjustments to federal income tax, primarily due to the enactment of the American Taxpayer Relief Act of 2012 ("ATRA"), and $24.9 million of net expense related to changes in certain tax reserves and valuation allowances. Additionally, the effective tax rate for 2013 reflected a benefit of $11.2 million from favorable tax rates on certain earnings from our operations in lower-tax jurisdictions throughout the world, offset by $12.1 million of expense related to the accrual of U.S. taxes on certain foreign earnings.

        On December 18, 2015, the Protecting Americans from Tax Hikes Act of 2015 ("PATH Act") was enacted, which included a provision making permanent the federal research and development credit for tax years 2015 and beyond. The PATH Act also retroactively extended the controlled foreign corporation ("CFC") look-through rule that had expired on December 31, 2014. For periods in which the look-though rule was effective, U.S. federal income tax on certain dividends, interest, rents, and royalties received or accrued by a CFC of a U.S. multinational enterprise from a related CFC are deferred. The retroactive effects of the extension of the CFC look-through rule did not have a material impact on our effective tax rate or operating results. The extension of the CFC look-through rule is currently scheduled to expire on December 31, 2019.

        Deferred income taxes have not been provided on approximately $1.9 billion of undistributed earnings of foreign subsidiaries as of January 2, 2016 since these amounts are intended to be indefinitely reinvested in foreign operations. It is not practicable to calculate the deferred taxes associated with these earnings because of the variability of multiple factors that would need to be assessed at the time of any assumed repatriation; however, foreign tax credits would likely be available to reduce federal income taxes in the event of distribution. In making this assertion, we evaluate, among other factors, the profitability of our U.S. and foreign operations and the need for cash within and outside the U.S., including cash requirements for capital improvements, acquisitions, market expansion, dividends, and stock repurchases.

        Deferred income taxes reflect the temporary differences between the amounts at which assets and liabilities are recorded for financial reporting purposes and the amounts utilized for tax purposes. The primary components of the temporary differences that gave rise to our deferred tax assets and liabilities were as follows:

(In millions)
  2015
  2014
 

Accrued expenses not currently deductible

  $ 35.1   $ 40.9  

Net operating losses

    253.3     277.7  

Tax credit carryforward

    114.4     104.2  

Postretirement and postemployment benefits

    93.2     103.5  

Pension costs

    148.7     142.9  

Inventory reserves

    6.9     9.0  

Other assets

    8.9     12.4  

Valuation allowance

    (73.0 )   (75.0 )

Total deferred tax assets (2)

    587.5     615.6  

Depreciation and amortization

    (101.0 )   (118.0 )

Repatriation accrual (1)

    (9.8 )   1.9  

Foreign operating loss recapture

    (108.3 )   (118.0 )

Other liabilities

    (2.9 )   (3.0 )

Total deferred tax liabilities (2)

    (222.0 )   (237.1 )

Total net deferred tax assets

  $ 365.5   $ 378.5  
(1)
Included in the repatriation accrual as of January 2, 2016 and January 3, 2015 was a net deferred tax liability of $12.5 million and $4.4 million, respectively, associated with the future tax cost to repatriate non-permanently reinvested earnings of our foreign subsidiaries, which is offset by a contra deferred tax liability of $2.7 million and $6.3 million, respectively, related to unrealized foreign exchange losses associated with earnings of our foreign subsidiaries that can be repatriated to the U.S. in future periods without incurring any additional U.S. federal income taxes.
(2)
Reflect gross amounts before jurisdictional netting of deferred tax assets and liabilities. Certain 2014 components have been adjusted for a 2015 change in presentation of the federal deduction of state income taxes.
54


Notes to Consolidated Financial Statements

        A valuation allowance is recorded to reduce deferred tax assets to the amount that is more likely than not to be realized. The valuation allowance at January 2, 2016 and January 3, 2015 was $73 million and $75 million, respectively.

        Net operating loss carryforwards of foreign subsidiaries at January 2, 2016 and January 3, 2015 were $825.8 million and $928.7 million, respectively. Tax credit carryforwards of both domestic and foreign subsidiaries at January 2, 2016 and January 3, 2015 totaled $114.4 million and $104.2 million, respectively. If unused, foreign net operating losses and tax credit carryforwards will expire as follows:

(In millions)
  Net Operating
Losses (1)

  Tax Credits
 

Expires in 2016

  $ 7.0   $ 1.1  

Expires in 2017

    15.7     .1  

Expires in 2018

    15.4     13.3  

Expires in 2019

    10.4     33.1  

Expires in 2020

    5.5     15.9  

Expires in 2021

    26.2     .3  

Expires in 2022

    3.5     9.6  

Expires in 2023

    12.0     5.1  

Expires in 2024

    4.2     .4  

Expires in 2025

    1.6     11.4  

Expires in 2026

        1.2  

Expires in 2027

    .2     .1  

Expires in 2028

        .1  

Expires in 2029

        .1  

Expires in 2030

        .1  

Expires in 2031

        1.7  

Expires in 2032

        4.1  

Expires in 2033

        2.9  

Expires in 2034

        2.5  

Expires in 2035

        2.6  

Indefinite life/no expiration

    724.1     8.7  

Total

  $ 825.8   $ 114.4  
(1)
Net operating losses are presented before tax effect and valuation allowance

        Based on current projections, certain indefinite-lived foreign net operating losses may take up to 50 years to be fully utilized.

        At January 2, 2016, we had net operating loss carryforwards in certain state jurisdictions of $503 million before tax effect. Based on our current ability to generate state taxable income, the majority of these carryforward amounts are highly unlikely to be realized before they expire. Accordingly, a valuation allowance has been recorded on $500 million of the carryforwards.

        We do not anticipate the expected expiration of our remaining tax holidays in Thailand and Vietnam in 2016 to have a material effect on our effective tax rate, operating results, or financial condition.

Unrecognized Tax Benefits

        As of January 2, 2016, our unrecognized tax benefits totaled $107.3 million, $89.0 million of which, if recognized, would reduce our annual effective income tax rate. As of January 3, 2015, our unrecognized tax benefits totaled $122.6 million, $98.7 million of which, if recognized, would reduce our annual effective income tax rate.

        Where applicable, we record potential accrued interest and penalties related to unrecognized tax benefits from our global operations in income tax expense. As a result, we recognized tax expense of $1.3 million, tax benefit of $1.3 million, and tax expense of $2.7 million in the Consolidated Statements of Income in 2015, 2014, and 2013, respectively. We have accrued $26.1 million and $26.7 million for interest and penalties, net of tax benefit, in the Consolidated Balance Sheets at January 2, 2016 and January 3, 2015, respectively.

        A reconciliation of the beginning and ending amounts of unrecognized tax benefits is set forth below:

(In millions)
  2015
  2014
 

Balance at beginning of year

  $ 122.6   $ 137.2  

Additions based on tax positions related to the current year

    11.1     18.2  

Additions for tax positions of prior years

    8.7     7.8  

Reductions for tax positions of prior years:

             

Changes in judgment

    (12.7 )   (1.8 )

Settlements

    (4.5 )   (15.8 )

Lapses and statute expirations

    (8.6 )   (13.8 )

Changes due to translation of foreign currencies

    (9.3 )   (9.2 )

Balance at end of year

  $ 107.3   $ 122.6  

        The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world. Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of relevant risks, facts, and circumstances existing at that time. We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters. However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate. As of the date the 2015 financial statements are being issued, we and our U.S. subsidiaries have completed the Internal Revenue Service's Compliance Assurance Process Program through 2014. We are subject to routine tax examinations in other jurisdictions. With a few exceptions, we are no longer subject to examinations by tax authorities for years prior to 2006.

        It is reasonably possible that, during the next 12 months, we may realize a decrease in our uncertain tax positions, including interest and penalties, of approximately $6 million, primarily as a result of closing tax years.

NOTE 15. SEGMENT INFORMATION

Segment Reporting

        We have the following operating and reportable segments:

        Intersegment sales are recorded at or near market prices and are eliminated in determining consolidated sales. We evaluate performance

55        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

based on income from operations before interest expense and taxes. General corporate expenses are also excluded from the computation of income from operations for the segments.

        We do not disclose total assets by reportable segment since we do not produce and review such information internally. As our reporting structure is not organized or reviewed internally by country, results by individual country are not provided.

        Financial information from continuing operations by reportable segment is set forth below:

(In millions)
  2015
  2014
  2013
 

Net sales to unaffiliated customers

                   

Pressure-sensitive Materials

  $ 4,373.7   $ 4,658.1   $ 4,455.0  

Retail Branding and Information Solutions

    1,520.3     1,591.6     1,611.1  

Vancive Medical Technologies

    72.9     80.6     73.9  

Net sales to unaffiliated customers

  $ 5,966.9   $ 6,330.3   $ 6,140.0  

Intersegment sales

                   

Pressure-sensitive Materials

  $ 60.9   $ 63.2   $ 64.6  

Retail Branding and Information Solutions

    1.9     2.4     2.4  

Vancive Medical Technologies

    4.9     9.6     3.6  

Intersegment sales

  $ 67.7   $ 75.2   $ 70.6  

Income from continuing operations before taxes

                   

Pressure-sensitive Materials

  $ 496.6   $ 434.4   $ 442.8  

Retail Branding and Information Solutions

    70.0     87.9     81.7  

Vancive Medical Technologies

    (4.5 )   (11.7 )   (8.3 )

Corporate expense

    (92.7 )   (86.5 )   (89.3 )

Interest expense

    (60.5 )   (63.3 )   (60.9 )

Income from continuing operations before taxes

  $ 408.9   $ 360.8   $ 366.0  

Capital expenditures

                   

Pressure-sensitive Materials

  $ 83.2   $ 110.5   $ 81.1  

Retail Branding and Information Solutions

    52.9     39.6     42.4  

Vancive Medical Technologies

    2.8     2.1     1.2  

Capital expenditures

  $ 138.9   $ 152.2   $ 124.7  

Depreciation and amortization expense

                   

Pressure-sensitive Materials

  $ 111.5   $ 116.0   $ 113.5  

Retail Branding and Information Solutions

    73.1     81.4     86.7  

Vancive Medical Technologies

    3.7     4.2     4.1  

Depreciation and amortization expense

  $ 188.3   $ 201.6   $ 204.3  

Other expense, net by reportable segment

                   

Pressure-sensitive Materials

  $ 16.3   $ 41.6   $ 10.8  

Retail Branding and Information Solutions

    45.9     22.0     20.0  

Vancive Medical Technologies

    3.6     4.2     .1  

Corporate

    2.5     .4     5.7  

Other expense, net

  $ 68.3   $ 68.2   $ 36.6  

Other expense, net by type

                   

Restructuring charges:

                   

Severance and related costs

  $ 52.5   $ 54.7   $ 27.2  

Asset impairment charges and lease and other contract cancellation costs

    7.0     11.4     13.1  

Other items:

                   

Charitable contribution to Avery Dennison Foundation

            10.0  

Indefinite-lived intangible asset impairment charge

        3.0      

Gains on sales of assets

    (1.7 )   (2.5 )   (17.8 )

Net loss (gain) from curtailment and settlement of pension obligations

    .3     1.6     (1.6 )

Legal settlements

    (.3 )       2.5  

Loss on sale of product line and related exit costs

    10.5          

Divestiture-related costs (1)

            3.2  

Other expense, net

  $ 68.3   $ 68.2   $ 36.6  
(1)
Represents only the portion allocated to continuing operations.

        Within our Pressure-sensitive Materials reportable segment, net sales to unaffiliated customers of the Materials product group were $4.06 billion, $4.33 billion, and $4.16 billion in 2015, 2014, and 2013, respectively, and net sales to unaffiliated customers of the Performance Tapes product group were $313.6 million, $332.5 million, and $293 million in 2015, 2014, and 2013, respectively.

        Revenues from continuing operations by geographic area are set forth below. Revenues are attributed to geographic areas based on the location to which the product is shipped. Export sales from the U.S. to unaffiliated customers are not a material factor in our business.

(In millions)
  2015
  2014
  2013
 

Net sales to unaffiliated customers

                   

U.S. 

  $ 1,546.8   $ 1,529.4   $ 1,537.6  

Europe

    1,753.0     2,074.4     1,958.4  

Asia

    1,924.0     1,914.2     1,823.5  

Latin America

    466.3     522.9     515.6  

Other international

    276.8     289.4     304.9  

Net sales to unaffiliated customers

  $ 5,966.9   $ 6,330.3   $ 6,140.0  
56


Notes to Consolidated Financial Statements

        Property, plant and equipment, net, in our U.S. and international operations was as follows:

(In millions)
  2015
  2014
  2013
 

Property, plant and equipment, net

                   

U.S. 

  $ 263.4   $ 261.5   $ 279.6  

International

    584.5     613.8     642.9  

Property, plant and equipment, net

  $ 847.9   $ 875.3   $ 922.5  

NOTE 16. SUPPLEMENTAL FINANCIAL INFORMATION

Inventories

        Net inventories at year-end were as follows:

(In millions)
  2015
  2014
 

Raw materials

  $ 180.5   $ 183.6  

Work-in-progress

    143.0     150.4  

Finished goods

    155.2     157.8  

Inventories, net

  $ 478.7   $ 491.8  

Property, Plant and Equipment

        Major classes of property, plant and equipment, stated at cost, at year-end were as follows:

(In millions)
  2015
  2014
 

Land

  $ 30.4   $ 32.1  

Buildings and improvements

    579.3     578.2  

Machinery and equipment

    1,922.3     1,958.2  

Construction-in-progress

    67.9     86.0  

Property, plant and equipment

    2,599.9     2,654.5  

Accumulated depreciation

    (1,752.0 )   (1,779.2 )

Property, plant and equipment, net

  $ 847.9   $ 875.3  

Software

        Capitalized software costs at year-end were as follows:

(In millions)
  2015
  2014
 

Cost

  $ 398.2   $ 445.7  

Accumulated amortization

    (270.8 )   (293.1 )

Software, net

  $ 127.4   $ 152.6  

        Software amortization expense from continuing operations was $37.6 million in 2015, $36.4 million in 2014, and $35.3 million in 2013.

Research and Development

        Research and development expense from continuing operations, which is included in "Marketing, general and administrative expense" in the Consolidated Statements of Income, was as follows:

(In millions)
  2015
  2014
  2013
 

Research and development expense

  $ 91.9   $ 102.5   $ 96.0  

Supplemental Cash Flow Information

        Cash paid for interest and income taxes, including amounts paid for discontinued operations, was as follows:

(In millions)
  2015
  2014
  2013
 

Interest, net of capitalized amounts

  $ 60.1   $ 61.6   $ 60.2  

Income taxes, net of refunds

    129.9     108.8     129.4  

        Capital expenditures accrued but not paid, including amounts for discontinued operations, were $3.1 million in 2015, $3.8 million in 2014, and $11.5 million in 2013.

Currency Effects

        Gains and losses resulting from foreign currency transactions are included in income in the period incurred. Transactions in foreign currencies (including receivables, payables and loans denominated in currencies other than the functional currency), including hedging impacts, decreased net income by $6.1 million, $8.7 million, and $7.9 million, in 2015, 2014, and 2013, respectively.

        We had no operations in hyperinflationary economies in fiscal years 2015, 2014, or 2013.

57        Avery Dennison Corporation 2015 Annual Report


Notes to Consolidated Financial Statements

NOTE 17. QUARTERLY FINANCIAL INFORMATION (Unaudited)

(In millions, except per share data)
  First Quarter
  Second Quarter
  Third Quarter
  Fourth Quarter (1)
 

2015

                         

Net sales

  $ 1,528.0   $ 1,516.0   $ 1,468.1   $ 1,454.8  

Gross profit

    430.0     417.6     405.9     392.3  

Income from continuing operations

    71.9     64.7     81.3     56.5  

(Loss) income from discontinued operations, net of tax

        (1.0 )   .4     .5  

Net income

    71.9     63.7     81.7     57.0  

Net income (loss) per common share:

                         

Continuing operations

    .79     .71     .89     .62  

Discontinued operations

        (.01 )       .01  

Net income per common share

    .79     .70     .89     .63  

Net income (loss) per common share, assuming dilution:

                         

Continuing operations

    .78     .69     .87     .61  

Discontinued operations

        (.01 )   .01     .01  

Net income per common share, assuming dilution

    .78     .68     .88     .62  

2014

                         

Net sales

  $ 1,550.1   $ 1,615.8   $ 1,559.6   $ 1,604.8  

Gross profit

    407.2     428.2     400.7     415.1  

Income from continuing operations

    66.4     50.2     60.9     69.8  

(Loss) income from discontinued operations, net of tax

    (.4 )   (1.9 )   (.7 )   .8  

Net income

    66.0     48.3     60.2     70.6  

Net income (loss) per common share:

                         

Continuing operations

    .69     .53     .65     .76  

Discontinued operations

        (.02 )       .01  

Net income per common share

    .69     .51     .65     .77  

Net income (loss) per common share, assuming dilution:

                         

Continuing operations

    .68     .52     .64     .75  

Discontinued operations

    (.01 )   (.02 )   (.01 )   .01  

Net income per common share, assuming dilution

    .67     .50     .63     .76  
(1)
Results for the fourth quarter of 2014 reflected the extra week in our 2014 fiscal year.
58


Notes to Consolidated Financial Statements

        Certain prior period amounts have been revised to reflect the impact of certain adjustments. Refer to Note 1, "General," for more information. The effects of the revision on our quarterly information were as follows:

 
  First Quarter   Second Quarter   Third Quarter   Fourth Quarter  
(In millions, except per share data)
  As
Previously
Reported

  Adjustment
  As Revised
  As
Previously
Reported

  Adjustment
  As Revised
  As
Previously
Reported

  Adjustment
  As Revised
  As
Previously
Reported

  Adjustment
  As Revised
 

2015

                                                                         

Income from continuing operations

  $ 71.6   $ .3   $ 71.9   $ 64.3   $ .4   $ 64.7                                      

Net income

    71.6     .3     71.9     63.3     .4     63.7                                      

Net income (loss) per common share:

                                                                         

Continuing operations

    .79         .79     .70     .01     .71                                      

Net income per common share

    .79         .79     .69     .01     .70                                      

Net income (loss) per common share, assuming dilution:

                                                                         

Continuing operations

    .77     .01     .78     .69         .69                                      

Net income per common share, assuming dilution

    .77     .01     .78     .68         .68                                      

2014

                                                                         

Income from continuing operations

  $ 71.6   $ (5.2 ) $ 66.4   $ 44.4   $ 5.8   $ 50.2   $ 65.0   $ (4.1 ) $ 60.9   $ 70.1   $ (.3 ) $ 69.8  

Net income

    71.2     (5.2 )   66.0     42.5     5.8     48.3     64.3     (4.1 )   60.2     70.9     (.3 )   70.6  

Net income (loss) per common share:

                                                                         

Continuing operations

    .74     (.05 )   .69     .47     .06     .53     .70     (.05 )   .65     .77     (.01 )   .76  

Discontinued operations

                (.02 )       (.02 )   (.01 )   .01         .01         .01  

Net income per common share

    .74     (.05 )   .69     .45     .06     .51     .69     (.04 )   .65     .78     (.01 )   .77  

Net income (loss) per common share, assuming dilution:

                                                                         

Continuing operations

    .73     (.05 )   .68     .46     .06     .52     .68     (.04 )   .64     .75         .75  

Discontinued operations

        (.01 )   (.01 )   (.02 )       (.02 )       (.01 )   (.01 )   .01         .01  

Net income per common share, assuming dilution

    .73     (.06 )   .67     .44     .06     .50     .68     (.05 )   .63     .76         .76  

        "Other expense, net" is presented by type for each quarter below:

(In millions)
  First Quarter
  Second Quarter
  Third Quarter
  Fourth Quarter
 

2015

                         

Restructuring charges:

                         

Severance and related costs

  $ 13.5   $ 16.8   $ 4.7   $ 17.5  

Asset impairment charges and lease cancellation costs

    .4     3.2     1.9     1.5  

Other items:

                         

Net loss from curtailment and settlement of pension obligations

                .3  

Loss on sale of product line and related exit costs

    2.6     7.7     .2      

Legal settlements

    (.5 )       .2      

Gain on sale of assets

    (1.7 )            

Other expense, net

  $ 14.3   $ 27.7   $ 7.0   $ 19.3  

2014

                         

Restructuring charges:

                         

Severance and related costs

  $ 7.0   $ 35.9   $ 5.1   $ 6.7  

Asset impairment charges and lease cancellation costs

    .3     2.6     1.6     6.9  

Other items:

                         

Indefinite-lived intangible asset impairment charge

            3.0      

Gains on sales of assets

        (.6 )   (1.9 )    

Losses from curtailment and settlement of pension obligations

        .6         1.0  

Other expense, net

  $ 7.3   $ 38.5   $ 7.8   $ 14.6  
59        Avery Dennison Corporation 2015 Annual Report

STATEMENT OF MANAGEMENT RESPONSIBILITY FOR FINANCIAL STATEMENTS

        The consolidated financial statements and accompanying information were prepared by and are the responsibility of management. The statements were prepared in conformity with accounting principles generally accepted in the United States of America and, as such, include amounts that are based on management's best estimates and judgments.

        Oversight of management's financial reporting and internal accounting control responsibilities is exercised by the Board of Directors, through the Audit and Finance Committee, which is comprised solely of independent directors. The Committee meets periodically with financial management, internal auditors and the independent registered public accounting firm to obtain reasonable assurance that each is meeting its responsibilities and to discuss matters concerning auditing, internal accounting control and financial reporting. The independent registered public accounting firm and our internal audit department have free access to meet with the Audit and Finance Committee without management present.

MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

        Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f) or 15(d)-15(f). Under the supervision and with the participation of management, including the chief executive officer and chief financial officer, the Company conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control – Integrated Framework (2013), management has concluded that internal control over financial reporting was effective as of January 2, 2016. Management's assessment of the effectiveness of internal control over financial reporting as of January 2, 2016 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report included herein.


/s/ Dean A. Scarborough

 

/s/ Anne L. Bramman
Dean A. Scarborough
Chairman and
Chief Executive Officer
  Anne L. Bramman
Senior Vice President and
Chief Financial Officer
60


Report of Independent Registered Public Accounting Firm

TO THE BOARD OF DIRECTORS AND SHAREHOLDERS OF AVERY DENNISON CORPORATION:

        In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows present fairly, in all material respects, the financial position of Avery Dennison Corporation and its subsidiaries at January 2, 2016 and January 3, 2015, and the results of their operations and their cash flows for each of the three years in the period ended January 2, 2016 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of January 2, 2016, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company's management is responsible for these financial statements, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express opinions on these financial statements and on the Company's internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

        As discussed in Note 1 to the consolidated financial statements, the Company changed the manner in which it accounts for current deferred income tax assets and liabilities in 2015.

        A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

        Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ PRICEWATERHOUSECOOPERS LLP    
PricewaterhouseCoopers LLP    

Los Angeles, California
February 24, 2016

 

 
61        Avery Dennison Corporation 2015 Annual Report

Corporate
Information

Independent Registered Public Accounting Firm

PricewaterhouseCoopers LLP
Los Angeles, California

Registrar and Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
(888) 682-5999
(720) 864-4993 (international)
(855) 627-5080 (hearing impaired)
https://investor.broadridge.com

Annual Meeting

        Our Annual Meeting of Stockholders will be held at 1:30 p.m. on April 28, 2016 at the Embassy Suites, 800 North Central Avenue, Glendale, California 91203.

The Direct Share Purchase and Sale Program

        Shareholders of record may reinvest their cash dividends in additional shares of our common stock at market price. Investors may also invest optional cash payments of up to $12,500 per month in our common stock at market price. Investors not yet participating in the program, as well as brokers and custodians who hold our common stock on behalf of clients, may obtain a copy of the program by contacting Broadridge Corporate Issuer Solutions, Inc.

Direct Deposit of Dividends

        Shareholders may receive their quarterly dividend payments by direct deposit into their checking or savings accounts. For more information, contact Broadridge Corporate Issuer Solutions, Inc.

Other Information

        We are including, as Exhibits 31.1 and 31.2 to our Annual Report on Form 10-K for our fiscal year 2015 filed with the Securities and Exchange Commission ("SEC"), certificates of our Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. We submitted to the New York Stock Exchange ("NYSE") an unqualified annual written affirmation, along with the Chief Executive Officer's certificate that he is not aware of any violation by the Company of NYSE's corporate governance listing standards, on May 6, 2015.

        A copy of our Annual Report on Form 10-K, as filed with the SEC, will be furnished to shareholders and interested investors free of charge upon written request to our Corporate Secretary. Copies may also be downloaded from our investor website at www.investors.averydennison.com.

Corporate Headquarters

Avery Dennison Corporation
207 Goode Avenue
Glendale, California 91203
Phone: (626) 304-2000

Stock and Dividend Data

Our common stock is listed on the NYSE.
Ticker symbol: AVY

 
  2015   2014  
 
  High
  Low
  High
  Low
 

Market Price

                         

First Quarter

  $ 54.64   $ 51.15   $ 52.14   $ 46.99  

Second Quarter

    63.18     51.07     51.76     46.66  

Third Quarter

    64.65     55.59     51.49     46.18  

Fourth Quarter

    66.18     58.61     52.67     41.28  

 

 
  2015
  2014
 

Dividends per Common Share

             

First Quarter

  $ .35   $ .29  

Second Quarter

    .37     .35  

Third Quarter

    .37     .35  

Fourth Quarter

    .37     .35  

  $ 1.46   $ 1.34  

Number of shareholders of record as of year-end

   
5,357
   
5,728
 
62



EXHIBIT 21

 

SUBSIDIARY(1)

U.S. STATE OR COUNTRY IN
WHICH
ORGANIZED

 

 

ADC PHILIPPINES, INC.

PHILIPPINES

ADESPAN S.R.L.

ITALY

ADHIPRESS BANGLADESH LTD.

BANGLADESH

ADHIPRESS (HONG KONG) LTD.

HONG KONG

AVERY CORP.

DELAWARE

AVERY DE MEXICO SRL DE CV

MEXICO

AVERY DENNISON AUSTRALIA GROUP HOLDINGS PTY LIMITED

AUSTRALIA

AVERY DENNISON AUSTRALIA INTERNATIONAL HOLDINGS PTY LTD.

AUSTRALIA

AVERY DENNISON AUSTRALIA PTY LTD.

AUSTRALIA

AVERY DENNISON BELGIE BVBA

BELGIUM

AVERY DENNISON BENELUX BVBA

BELGIUM

AVERY DENNISON BULGARIA EOOD

BULGARIA

AVERY DENNISON BV

NETHERLANDS

AVERY DENNISON CANADA CORPORATION

CANADA

AVERY DENNISON CENTRAL EUROPE GMBH

GERMANY

AVERY DENNISON CHILE S.A.

CHILE

AVERY DENNISON COLOMBIA S. A.

COLOMBIA

AVERY DENNISON COMMERCIAL EL SALVADOR, S.A. DE C.V.

EL SALVADOR

AVERY DENNISON CONVERTED PRODUCTS DE MEXICO, S.A. DE C.V.

MEXICO

AVERY DENNISON CONVERTED PRODUCTS EL SALVADOR S. A. DE C. V.

EL SALVADOR

AVERY DENNISON COORDINATION CENTER BVBA

BELGIUM

AVERY DENNISON, C.A.

VENEZUELA

AVERY DENNISON DE ARGENTINA S.R.L.

ARGENTINA

AVERY DENNISON DEUTSCHLAND GMBH

GERMANY

AVERY DENNISON DO BRASIL LTDA.

BRAZIL

AVERY DENNISON DOMINICAN REPUBLIC, S.R.L.

DOMINICAN REPUBLIC

AVERY DENNISON EGYPT LLC

EGYPT

AVERY DENNISON ETIKET TICARET LIMITED SIRKETI

TURKEY

AVERY DENNISON EUROPE GMBH

SWITZERLAND

AVERY DENNISON EUROPE HOLDING (DEUTSCHLAND) GMBH & CO KG

GERMANY

AVERY DENNISON FINANCE BELGIUM BVBA

BELGIUM

AVERY DENNISON FINANCE GERMANY GMBH

GERMANY

AVERY DENNISON FINANCE LUXEMBOURG II SARL

LUXEMBOURG

AVERY DENNISON FINANCE LUXEMBOURG S. A. R. L.

LUXEMBOURG

AVERY DENNISON FINANCE LUXEMBOURG III SARL

LUXEMBOURG

AVERY DENNISON G HOLDINGS I LLC

NEVADA

AVERY DENNISON G HOLDINGS III LLC

DELAWARE

AVERY DENNISON G INVESTMENTS 111 LIMITED

GIBRALTAR

AVERY DENNISON G INVESTMENTS V LIMITED

GIBRALTAR

AVERY DENNISON GROUP DANMARK APS

DENMARK

AVERY DENNISON GROUP SINGAPORE PTE LTD

SINGAPORE

AVERY DENNISON GULF FZCO

UNITED ARAB EMIRATES

AVERY DENNISON HOLDING GMBH

GERMANY

AVERY DENNISON HOLDING LIMITED

UNITED KINGDOM

AVERY DENNISON HOLDING LUXEMBOURG S. A. R. L.

LUXEMBOURG

AVERY DENNISON HOLDING & FINANCE THE NETHERLANDS BV

NETHERLANDS

AVERY DENNISON HOLDINGS LLC

DELAWARE

AVERY DENNISON HOLDINGS NEW ZEALAND LIMITED

NEW ZEALAND

AVERY DENNISON HONG KONG B.V.

NETHERLANDS

AVERY DENNISON HONG KONG HOLDING I B.V.

NETHERLANDS

 



 

AVERY DENNISON IBERICA, S.A.

SPAIN

AVERY DENNISON INNOVATIONS LLC

DELAWARE

AVERY DENNISON INTELLIGENT HEALTHCARE SOLUTIONS LLC

DELAWARE

AVERY DENNISON INVESTMENT LUXEMBOURG II SARL

LUXEMBOURG

AVERY DENNISON INVESTMENTS LUXEMBOURG S.A.R.L.

LUXEMBOURG

AVERY DENNISON INVESTMENTS LUXEMBOURG III SARL

LUXEMBOURG

AVERY DENNISON INVESTMENTS LUXEMBOURG IV SARL

LUXEMBOURG

AVERY DENNISON INVESTMENTS LUXEMBOURG V SCA

LUXEMBOURG

AVERY DENNISON ITALIA S.R.L.

ITALY

AVERY DENNISON JAPAN KK

JAPAN

AVERY DENNISON JAPAN MATERIALS COMPANY LTD.

JAPAN

AVERY DENNISON KOREA LIMITED

SOUTH KOREA

AVERY DENNISON LABEL LIMITED

HONG KONG

AVERY DENNISON LANKA (PRIVATE) LIMITED

SRI LANKA

AVERY DENNISON LUXEMBOURG SALES SARL

LUXEMBOURG

AVERY DENNISON LUXEMBOURG S.A.R.L.

LUXEMBOURG

AVERY DENNISON MANAGEMENT GMBH

GERMANY

AVERY DENNISON MANAGEMENT KGAA

LUXEMBOURG

AVERY DENNISON MANAGEMENT LUXEMBOURG S.A.R.L.

LUXEMBOURG

AVERY DENNISON MATERIALS EUROPE B.V.

NETHERLANDS

AVERY DENNISON MATERIALS EUROPE GMBH

SWITZERLAND

AVERY DENNISON MATERIALS FRANCE S.A.R.L.

FRANCE

AVERY DENNISON MATERIALS GMBH

GERMANY

AVERY DENNISON MATERIALS IRELAND LIMITED

IRELAND

AVERY DENNISON MATERIALS NEDERLAND BV

NETHERLANDS

AVERY DENNISON MATERIALS NEW ZEALAND LIMITED

NEW ZEALAND

AVERY DENNISON MATERIALS PTY LIMITED

AUSTRALIA

AVERY DENNISON MATERIALS ROM SRL

ROMANIA

AVERY DENNISON MATERIALS RUSSIA LLC

RUSSIA

AVERY DENNISON MATERIALS SALES FRANCE S. A. S.

FRANCE

AVERY DENNISON MATERIALS SALES GERMANY GMBH

GERMANY

AVERY DENNISON MATERIALS SDN BHD

MALAYSIA

AVERY DENNISON MATERIALS UKRAINE LLC

UKRAINE

AVERY DENNISON MATERIALS U.K. LIMITED

UNITED KINGDOM

AVERY DENNISON MAURITIUS LTD.

MAURITIUS

AVERY DENNISON MOROCCO SARL

MOROCCO

AVERY DENNISON NETHERLANDS INVESTMENT 0 BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT I BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT II B. V.

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT III BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT IX BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT NORTH AMERICA BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT VI BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT VII B.V.

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT VIII BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT X B V

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT XI COOPERATIEF U.A.

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT XII BV

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT XIII B.V.

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT XIV C.V.

NETHERLANDS

AVERY DENNISON NETHERLANDS INVESTMENT XV B.V.

NETHERLANDS

AVERY DENNISON NORDIC APS

DENMARK

AVERY DENNISON NTP A. S.

NORWAY

AVERY DENNISON OFFICE ACCESSORIES U.K. LIMITED

UNITED KINGDOM

AVERY DENNISON OFFICE PRODUCTS COMPANY

NEVADA

AVERY DENNISON OFFICE PRODUCTS HOLDINGS COMPANY

NEVADA

 



 

AVERY DENNISON OFFICE PRODUCTS MANUFACTURING U.K. LTD.

UNITED KINGDOM

AVERY DENNISON OFFICE PRODUCTS (PTY.) LTD.

SOUTH AFRICA

AVERY DENNISON OVERSEAS CORPORATION

MASSACHUSETTS

AVERY DENNISON PENSION TRUSTEE LIMITED

UNITED KINGDOM

AVERY DENNISON PERU S. R. L.

PERU

AVERY DENNISON POLSKA SP. Z O.O.

POLAND

AVERY DENNISON PRAHA SPOL. S R. O.

CZECH REPUBLIC

AVERY DENNISON RBIS PTY LTD

AUSTRALIA

AVERY DENNSION RBIS SINGAPORE PTE. LTD.

SINGAPORE

AVERY DENNISON RBIS (CAMBODIA) TRADING CO., LTD

CAMBODIA

AVERY DENNISON RETAIL INFORMATION SERVICES COLOMBIA S. A.

COLOMBIA

AVERY DENNISON RETAIL INFORMATION SERVICES DE MEXICO, S. A. DE C.V.

MEXICO

AVERY DENNISON RETAIL INFORMATION SERVICES DOMINICAN REPUBLIC, S. A.

DOMINICAN REPUBLIC

AVERY DENNISON RETAIL INFORMATION SERVICES EL SALVADOR LTDA. DE C. V.

EL SALVADOR

AVERY DENNISON RETAIL INFORMATION SERVICES GUATEMALA, S. A.

GUATEMALA

AVERY DENNISON RETAIL INFORMATION SERVICES HONDURAS, S. DE R.L.

HONDURAS

AVERY DENNISON RETAIL INFORMATION SERVICES LLC

NEVADA

AVERY DENNSION RETAIL INFORMATION SERVICES PERÚ SAC

PERU

AVERY DENNISON RETAIL INFORMATION SERVICES UK LTD.

UNITED KINGDOM

AVERY DENNISON RETAIL INFORMATION SERVICES (PTY) LTD

SOUTH AFRICA

AVERY DENNISON RFID COMPANY

DELAWARE

AVERY DENNISON RIS KOREA LTD.

KOREA

AVERY DENNISON RIS TAIWAN LTD.

TAIWAN

AVERY DENNISON RIS VIETNAM CO., LIMITED

VIETNAM

AVERY DENNISON R.I.S. FRANCE S. A. S.

FRANCE

AVERY DENNISON R.I.S. IBERIA S.L.

SPAIN

AVERY DENNISON R.I.S. ITALIA S.R.L.

ITALY

AVERY DENNISON R.I.S. POLSKA SP.ZO.O

POLAND

AVERY DENNISON SCANDINAVIA AB

SWEDEN

AVERY DENNISON SCANDINAVIA APS

DENMARK

AVERY DENNISON SCHWEIZ AG

SWITZERLAND

AVERY DENNISON SECURITY PRINTING EUROPE APS

DENMARK

AVERY DENNISON SHARED SERVICES, INC.

NEVADA

AVERY DENNISON SINGAPORE INVESTMENTS B.V.

NETHERLANDS

AVERY DENNISON SINGAPORE (PTE) LTD

SINGAPORE

AVERY DENNISON SOUTH AFRICA (PROPRIETARY) LIMITED

SOUTH AFRICA

AVERY DENNISON SYSTEMES D’ETIQUETAGE FRANCE S.A.S.

FRANCE

AVERY DENNISON S.R.L.

ROMANIA

AVERY DENNISON TREASURY MANAGEMENT BV

NETHERLANDS

AVERY DENNISON TEKSTIL URUNLERI SANAYI VE TICARET LIMITED SIRKETI

TURKEY

AVERY DENNISON U.K. II LIMITED

UNITED KINGDOM

AVERY DENNISON U.K. LIMITED

UNITED KINGDOM

AVERY DENNISON VERMOGENSVERWALTUNGS GMBH & CO K.G.

GERMANY

AVERY DENNISON ZWECKFORM OFFICE PRODUCTS MANUFACTURING GMBH

GERMANY

AVERY DENNISON (ASIA) HOLDINGS LIMITED

MAURITIUS

AVERY DENNISON (CHINA) COMPANY LIMITED

CHINA

AVERY DENNISON (FUZHOU) CONVERTED PRODUCTS LIMITED

CHINA

AVERY DENNISON (GUANGZHOU) CONVERTED PRODUCTS LIMITED

CHINA

AVERY DENNISON (GUANGZHOU) CO., LTD.

CHINA

AVERY DENNISON (HONG KONG) LIMITED

HONG KONG

AVERY DENNISON (INDIA) PRIVATE LIMITED

INDIA

AVERY DENNISON (IRELAND) LIMITED

IRELAND

AVERY DENNISON (KENYA) PRIVATE LIMITED

KENYA

AVERY DENNISON (KUNSHAN) COMPANY LIMITED

CHINA

AVERY DENNISON (MALAYSIA) SDN. BHD.

MALAYSIA

 



 

AVERY DENNISON (QINGDAO) CONVERTED PRODUCTS LIMITED

CHINA

AVERY DENNISON (SUZHOU) CO. LIMITED

CHINA

AVERY DENNISON (THAILAND) LTD.

THAILAND

AVERY DENNISON (VIETNAM) LIMITED

VIETNAM

AVERY DENNISON, S.A. DE C.V.

MEXICO

AVERY GRAPHIC SYSTEMS, INC.

DELAWARE

AVERY HOLDING S.A.S.

FRANCE

AVERY LLC

DELAWARE

AVERY OFFICE PRODUCTS PUERTO RICO L.L.C.

PUERTO RICO

AVERY PACIFIC LLC

CALIFORNIA

AVERY PROPERTIES PTY. LIMITED

AUSTRALIA

BEST COURAGE INTERNATIONAL LIMITED

BRITISH VIRGIN ISLANDS

BONFIRE MANAGEMENT LIMITED

BRITISH VIRGIN ISLANDS

CREATERO GMBH

GERMANY

DENNISON INTERNATIONAL COMPANY

MASSACHUSETTS

DENNISON MANUFACTURING COMPANY

NEVADA

EUSTON FINANCIAL LIMITED

BRITISH VIRGIN ISLANDS

INFODRAGON MANAGEMENT LIMITED

BRITISH VIRGIN ISLANDS

JAC ASIA PACIFIC SDN BHD

MALAYSIA

JAC CARIBE C.S.Z.

DOMINICAN REPUBLIC

JAC DO BRASIL - LOCAÇÃO DE EQUIPAMENTOS INDUSTRIAIS LTDA

BRAZIL

JAC NEW ZEALAND LIMITED

NEW ZEALAND

JACKSTADT FRANCE S.N.C.

FRANCE

JACKSTADT SOUTH AFRICA (PTY) LTD.

SOUTH AFRICA

JINTEX LIMITED

JERSEY, CHANNEL ISLANDS

KUNSHAN DAHMEI WEAVING CO. LTD

CHINA

L&E AMERICAS SERVICIOS, S. A. DE C.V.

MEXICO

MARKSTAR INTERNATIONAL LIMITED

HONG KONG

MODERN MARK INTERNATIONAL LIMITED

HONG KONG

MONARCH MARKING SYSTEMS HOLDINGS LTD

UNITED KINGDOM

NAPERVILLE GLOBAL LIMITED

BRITISH VIRGIN ISLANDS

NEW WALES FINANCE LIMITED

BRITISH VIRGIN ISLANDS

NEWCLASSIC INVESTMENT LIMITED

BRITISH VIRGIN ISLANDS

NINGBO AVERY DENNISON SHENZHOU EMBELLISHMENT CO. LTD.

CHINA

PAXAR BANGLADESH LIMITED

BANGLADESH

PAXAR B. V.

NETHERLANDS

PAXAR CANADA CORPORATION

CANADA

PAXAR CORPORATION

NEW YORK

PAXAR CORPORATION (MALAYSIA) SDN. BHD.

MALAYSIA

PAXAR DE EL SALVADOR S. A. DE C. V.

EL SALVADOR

PAXAR DE GUATEMALA, S. A.

GUATEMALA

PAXAR DE MEXICO S. A. DE C. V.

MEXICO

PAXAR DE NICARAGUA. S.A.

NICARAGUA

PAXAR DO BRASIL LTDA

BRAZIL

PAXAR FAR EAST LIMITED

HONG KONG

PAXAR KOREA LIMITED

SOUTH KOREA

PAXAR PACKAGING (GUANGZHOU) LTD.

CHINA

PAXAR PAKISTAN (PRIVATE) LIMITED

PAKISTAN

PAXAR (CHINA) LTD.

HONG KONG

PAXAR (THAILAND) LIMITED

THAILAND

PT AVERY DENNISON INDONESIA

INDONESIA

PT AVERY DENNISON PACKAGING INDONESIA

INDONESIA

P. T. PACIFIC LABEL INDONESIA

INDONESIA

P. T. PAXAR INDONESIA

INDONESIA

RVL AMERICAS, S DE R.L. DE C.V.

MEXICO

RVL CENTRAL AMERICA, S. A.

GUATEMALA

 



 

RVL PACKAGING FAR EAST LIMITED

HONG KONG

RVL SERVICE, S. DE R. L. DE C. V.

MEXICO

SECURITY PRINTING DIVISION, INC.

DELAWARE

SKILLFIELD INVESTMENTS LIMITED

BRITISH VIRGIN ISLANDS

SU ZHOU JI ZHONG GARMENTS ACCESSORY CO. LTD.

CHINA

SUZHOU FENG YI HENG YE DYE CO., LTD.

CHINA

TIGER EIGHT GROUP LIMITED

BRITISH VIRGIN ISLANDS

WORLDWIDE RISK INSURANCE, INC.

HAWAII

 

(1)   Each subsidiary listed on this Exhibit 21 is a Consolidated Subsidiary

 




Exhibit 23

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-191228) and Form S-8 (File Nos. 33-54411, 33-58921, 33-63979, 333-38707, 333-38709, 333-107370, 333-107371, 333-107372, 333-109814, 333-124495, 333-143897, 333-152508, 333-166832, 333-166836, 333-166837, 333-181221, and 333-197631) of Avery Dennison Corporation of our report dated February 24, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K.

 

 

/s/  PRICEWATERHOUSECOOPERS LLP

 

PricewaterhouseCoopers LLP

 

Los Angeles, California

 

February 24, 2016

 

 




Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

CERTIFICATION

 

I, Dean A. Scarborough, certify that:

 

1.                   I have reviewed this annual report on Form 10-K of Avery Dennison Corporation;

 

2.                   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.                   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and we have:

 

a)                  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)                  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)                   evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)                  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.                   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

a)                  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)                  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

/s/     Dean A. Scarborough

 

Dean A. Scarborough

 

Chairman and Chief Executive Officer

 

February 24, 2016

 




Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

CERTIFICATION

 

I, Anne L. Bramman, certify that:

 

1.                   I have reviewed this annual report on Form 10-K of Avery Dennison Corporation;

 

2.                   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.                   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and we have:

 

a)                  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)                  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)                   evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)                  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.                   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

a)                  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)                  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

/s/     Anne L. Bramman

 

Anne L. Bramman

 

Senior Vice President and

 

Chief Financial Officer

 

February 24, 2016

 




Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER*

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:

 

(i)             the Annual Report on Form 10-K of the Company for the fiscal year ended January 2, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

 

(ii)          the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

February 24, 2016

 

 

 

/s/     Dean A. Scarborough

 

Dean A. Scarborough

 

Chairman and Chief Executive Officer

 

 

 

*            The above certification accompanies the Company’s Annual Report on Form 10-K and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.

 




Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER*

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the “Company”) hereby certifies, to the best of his knowledge, that:

 

(i)             the Annual Report on Form 10-K of the Company for the fiscal year ended January 2, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

 

(ii)          the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

February 24, 2016

 

 

 

/s/     Anne L. Bramman

 

Anne L. Bramman

 

Senior Vice President and

 

Chief Financial Officer

 

 

 

*            The above certification accompanies the Company’s Annual Report on Form 10-K and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.